Document:

Rights Agreement

 Exhibit 4.1 

 
  

RIGHTS AGREEMENT 

TITAN PHARMACEUTICALS, INC. 
 and 
 Continental Stock Transfer & Trust Company, 

as Rights Agent 

Dated December 20, 2011 
  

 

 TABLE OF CONTENTS 

 

							
	 	  	 	  	Page	 
			
	Section 1.	  	Certain Definitions	  	 	1	  
			
	Section 2.	  	Appointment of Rights Agent	  	 	5	  
			
	Section 3.	  	Issuance of Right Certificates	  	 	5	  
			
	Section 4.	  	Form of Right Certificates	  	 	8	  
			
	Section 5.	  	Countersignature and Registration	  	 	8	  
			
	Section 6.	  	Transfer, Split Up, Combination and Exchange of Right Certificates; Mutilated, Destroyed, Lost or Stolen Right Certificates	  	 	9	  
			
	Section 7.	  	Exercise of Rights, Purchase Price; Expiration Date of Rights	  	 	9	  
			
	Section 8.	  	Cancellation and Destruction of Right Certificates	  	 	11	  
			
	Section 9.	  	Availability of Shares of Junior Preferred Stock	  	 	11	  
			
	Section 10.	  	Junior Preferred Stock Record Date	  	 	13	  
			
	Section 11.	  	Adjustment of Purchase Price, Number and Kind of Shares and Number of Rights	  	 	13	  
			
	Section 12.	  	Certificate of Adjusted Purchase Price or Number of Shares	  	 	20	  
			
	Section 13.	  	Consolidation, Merger or Sale or Transfer of Assets or Earnings Power	  	 	21	  
			
	Section 14.	  	Fractional Rights and Fractional Shares	  	 	24	  
			
	Section 15.	  	Rights of Action	  	 	25	  
			
	Section 16.	  	Agreement of Right Holders	  	 	26	  
			
	Section 17.	  	Right Certificate Holder Not Deemed a Stockholder	  	 	27	  
			
	Section 18.	  	Concerning the Rights Agent	  	 	27	  
			
	Section 19.	  	Merger or Consolidation or Change of Name of Rights Agent	  	 	27	  
			
	Section 20.	  	Duties of Rights Agent	  	 	28	  
			
	Section 21.	  	Change of Rights Agent	  	 	30	  
			
	Section 22.	  	Issuance of New Right Certificates	  	 	31	  

  
 -i-

							
			
	Section 23.  	  	Redemption	  	 	31	  
			
	Section 24.	  	Exchange	  	 	32	  
			
	Section 25.	  	Notice of Certain Events	  	 	33	  
			
	Section 26.	  	Notices	  	 	34	  
			
	Section 27.	  	Supplements and Amendments	  	 	35	  
			
	Section 28.	  	Successors	  	 	35	  
			
	Section 29.	  	Benefits of this Rights Agreement	  	 	35	  
			
	Section 30.	  	Determinations and Actions by the Board of Directors	  	 	35	  
			
	Section 31.	  	Severability	  	 	36	  
			
	Section 32.	  	Governing Law	  	 	36	  
			
	Section 33.	  	Counterparts	  	 	36	  
			
	Section 34.	  	Descriptive Headings	  	 	36	  

 EXHIBITS 
 Exhibit A – Form of Certificate of Designations 
 Exhibit B – Form of Right Certificate

 Exhibit C – Summary of Rights 

  
 -ii-

 INDEX OF CERTAIN DEFINED TERMS 

 

											
	 	  	Page	 	  	 	  	Page	 
				
	Acquiring Person	  	 	1	  	  	Person	  	 	4	  
	Authorized Officer	  	 	8	  	  	Preferred Stock	  	 	1	  
	Board	  	 	1	  	  	Principal Party	  	 	22	  
	Board of Directors	  	 	1	  	  	Purchase Price	  	 	10	  
	Book Entry	  	 	3	  	  	Record Date	  	 	1	  
	Business Day	  	 	3	  	  	Redemption Price	  	 	31	  
	close of business	  	 	3	  	  	Right	  	 	5	  
	Common Stock	  	 	3	  	  	Right Certificate	  	 	6	  
	Common Stock equivalents	  	 	15	  	  	Rights	  	 	1	  
	Company	  	 	1	  	  	Rights Agent	  	 	1, 5	  
	Current Value	  	 	15	  	  	Rights Agreement	  	 	1	  
	Distribution Date	  	 	4, 6	  	  	Section 11(a)(ii) Trigger Date	  	 	15	  
	equivalent preferred shares	  	 	16	  	  	Securities Act	  	 	5	  
	Exchange Act	  	 	4	  	  	Security	  	 	17	  
	Exchange Act Regulations	  	 	4	  	  	Spread	  	 	15	  
	Exchange Ratio	  	 	32	  	  	Stock Acquisition Date	  	 	5	  
	Exempted Entity	  	 	4	  	  	Subsidiary	  	 	5	  
	invalidation time	  	 	14	  	  	Substitution Period	  	 	15	  
	Junior Preferred Stock	  	 	4	  	  	Summary of Rights	  	 	6	  
	OTCBB	  	 	4	  	  	Trading Day	  	 	17	  

  
 -iii-

 RIGHTS AGREEMENT 
 Rights Agreement, dated as of December 20, 2011 (as amended, supplemented or otherwise modified from time to time, the “Rights Agreement”) between Titan Pharmaceuticals, Inc., a
Delaware corporation (the “Company”), and Continental Transfer & Trust Company, a New York banking corporation (the “Rights Agent”). 
 RECITALS 
 WHEREAS, the Board of Directors of the Company (hereinafter being
referred to as the “Board of Directors” or the “Board”) has adopted resolutions creating a series of preferred stock, par value $0.001 per share (“Preferred Stock”) designated as “Junior
Participating Preferred Stock” and authorized and declared a dividend of one preferred share purchase right (a “Right” and together with all other such rights distributed or issued pursuant hereto, the
“Rights”) for each share of Common Stock (as defined below) of the Company outstanding as of the close of business (as defined below) on January 3, 2012 (the “Record Date”), each Right initially representing
the right to purchase one one-thousandth (subject to adjustment) of a share of Junior Preferred Stock (as defined below), upon the terms and subject to the conditions herein set forth, and the Board of Directors has further authorized and directed
the issuance of one Right (subject to adjustment as provided herein) with respect to each share of Common Stock that shall become outstanding between the Record Date and the earlier of the Distribution Date and the Expiration Date (as such terms are
hereinafter defined); provided, however, that Rights may be issued with respect to shares of Common Stock that shall become outstanding after the Distribution Date and prior to the Expiration Date in accordance with
Section 22. 
 NOW THEREFORE, in consideration of the premises and the mutual agreements herein set forth, the
parties hereby agree as follows: 
 Section 1. Certain Definitions. For purposes of this Rights Agreement, the following
terms have the meaning indicated: 
 (a) “Acquiring Person” shall mean any Person who is or becomes the
Beneficial Owner of 15% or more of the shares of Common Stock then outstanding, but shall not include (i) any Exempted Entity, or (ii) any Person who, in the good faith judgment of the Board, inadvertently has become an Acquiring Person or
otherwise becomes an Acquiring Person (including, without limitation, because (A) such Person was unaware that it was or became an Acquiring Person or (B) such Person was aware that it was an Acquiring Person but had no actual knowledge of
the consequences of such fact under this Rights Agreement), so long as such Person enters into, and delivers to the Company as soon as practicable (as determined, in good faith, by the Board), an irrevocable commitment to promptly divest, and
thereafter promptly divests (without exercising or retaining any power, including voting, with respect to such securities), sufficient securities of the Company so that such Person ceases to be an “Acquiring Person”. 

Notwithstanding the foregoing, no Person shall become an Acquiring Person solely as a result of (i) an acquisition of Common Stock
by the Company, which, by reducing the number of shares of Common Stock outstanding, increases the percentage of shares of Common Stock 

 
Beneficially Owned by such Person, individually or together with all other Persons who collectively form a Coordinating Group with such Person to 15% or more shares of Common Stock then
outstanding, (ii) the grant of any equity compensation award (including, without limitation, an equity compensation award in the form of options, warrants, rights, restricted stock, or similar securities) by the Company to such Person if such
person is a director, officer, employee, or agent of the Company, or any adjustment to the number of shares of Common Stock represented by such equity compensation award pursuant to the terms thereof, or (iii) any unilateral grant of any
security by the Company to such Person that was approved in advance by the Board; provided, however, that a Person who or which becomes the Beneficial Owner of shares of Common Stock representing 15% or more of the shares of Common
Stock then outstanding by reason of any of the foregoing transactions shall nevertheless be deemed to be an Acquiring Person if such Person thereafter (and while such Person continues to be the Beneficial Owner of 15% or more of the then outstanding
shares of Common Stock) becomes the Beneficial Owner of any additional shares of Common Stock, except as a result of (w) a dividend or distribution of shares by the Company made on a pro rata basis to all holders of Common Stock, (x) the
issuance of shares by the Company pursuant to a split or subdivision of the outstanding Common Stock, (y) the grant of any equity compensation award (including, without limitation, any equity compensation award in the form of options, warrants,
rights, restricted stock, or similar securities) by the Company to such Person if such person is a director, officer, employee, or agent of the Company, or any adjustment to the number of shares of Common Stock represented by such equity
compensation award pursuant to the terms thereof, or (z) any unilateral grant of any security by the Company to such Person that was approved in advance by the Board. 
 (b) “Affiliate” and “Associate” shall have the respective meanings ascribed to such terms in Rule 12b-2 of the Exchange Act Regulations. 

(c) A Person shall be deemed the “Beneficial Owner”, and to have “Beneficial Ownership” of, and to
“Beneficially Own”, any securities (i) as to which such Person or any of such Person’s Affiliates or Associates is or may be deemed to be the beneficial owner, directly or indirectly, pursuant to Rules 13d-3 and 13d-5 of
the Exchange Act Regulations; (ii) as to which such Person or any of such Person’s Affiliates or Associates has the right to become the Beneficial Owner (whether such right is exercisable immediately or only after the passage of time or
the occurrence of conditions), directly or indirectly, pursuant to any agreement, arrangement or understanding, whether or not in writing (other than customary agreements with and between underwriters and selling group members with respect to a bona
fide public offering of securities), or upon the exercise of conversion rights, exchange rights, rights (other than the Rights), warrants or options, or otherwise; (iii) which are Beneficially Owned, directly or indirectly, by any other Person
or any of such other Person’s Affiliates or Associates with which such first Person or any of such first Person’s Affiliates or Associates has any agreement, arrangement or understanding, whether or not in writing, (x) for the purpose
of acquiring, holding, voting (except pursuant to a revocable proxy as described in clause (B) of the proviso to this sentence) or disposing of any voting securities of the Company, or (y) to cooperate in obtaining, changing or influencing
the control of the Company; and (iv) that such Person or any of such Person’s Affiliates or Associates are determined to Constructively Own; provided, however, that a Person shall not be deemed the “Beneficial
Owner,” or to have “Beneficial Ownership” of, or to “Beneficially Own,” any security (A) solely because such 

  
 - 2 -

 
security has been tendered pursuant to a tender or exchange offer made by such Person or any of such Person’s Affiliates or Associates until such tendered security is accepted for payment or
exchange, or (B) solely because such Person or any of such Person’s Affiliates or Associates has or shares the power to vote or direct the voting of such security pursuant to a revocable proxy or consent given in response to a public proxy
or consent solicitation made to more than ten holders of shares of a class of stock of the Company registered under Section 12 of the Exchange Act and pursuant to, and in accordance with, the applicable provisions of the Exchange Act
Regulations, except if such power (or the arrangements relating thereto (whether or not in writing)) is then reportable under Item 6 of Schedule 13D under the Exchange Act (or any similar provision of a comparable or successor statement).
Notwithstanding the foregoing, (i) nothing in this Section 1(c) shall cause a Person engaged in business as an underwriter of securities to be the “Beneficial Owner” of, or to have “Beneficial Ownership”
of, or to “Beneficially Own”, any securities acquired through such Person’s participation in good faith in a firm commitment underwriting until the expiration of forty days after the date of such acquisition, and then only if
such securities continue to be owned by such Person at such expiration of forty days; (ii) no Person who is an officer, director, or employee of an Exempted Entity shall be deemed, solely by reason of such Person’s status or authority as
such, to be the “Beneficial Owner” of, to have “Beneficial Ownership” of or to “Beneficially Own” any securities that are “Beneficially Owned” (as defined in this
Section 1(c), including, without limitation, in a fiduciary capacity, by an Exempted Entity or by any other such officer, director or employee of an Exempted Entity; (iii) a Person shall not be deemed the “Beneficial
Owner” of, to have “Beneficial Ownership” of or to “Beneficially Own”, shares of Common Stock (or securities convertible into, exchangeable into or exercisable for Common Stock) held by such Person in trust
accounts, managed accounts and the like, or otherwise held in a fiduciary capacity, that are beneficially owned by third Persons. For purposes of this Agreement, in determining the percentage of the outstanding shares of Common Stock with
respect to which a Person is the Beneficial Owner, all shares as to which such Person is deemed the Beneficial Owner shall be deemed to be outstanding. 
 (d) “Book Entry” shall mean an uncertificated book entry for shares of Common Stock. 
 (e) “Business Day” shall mean any day other than a Saturday, a Sunday, or a day on which banking institutions in the State of New York, or the State in which the principal office of the
Rights Agent is located, are authorized or obligated by law or executive order to close. 
 (f) “close of
business” on any given date shall mean 5:00 P.M., New York, New York time, on such date; provided, however, that if such date is not a Business Day it shall mean 5:00 P.M., New York, New York time, on the next succeeding Business Day.

 (g) “Common Stock” when used with reference to the Company shall mean the common stock, par value $0.001 per
share, of the Company, except that, “Common Stock” when used with reference to any Person other than the Company shall mean the capital stock (or, in the case of an unincorporated entity, the equivalent equity interest) with the
greatest voting power of such other Person or, if such other Person is a subsidiary of another Person, the Person or Persons which ultimately control such first-mentioned Person. 

  
 - 3 -

 (h) A Person shall be deemed to “Constructively Own” shares of Common
Stock in respect of which such Person has a Synthetic Long Position, calculated in the manner set forth below. The number of shares of Common Stock in respect of a Synthetic Long Position that shall be deemed to be Constructively Owned is the
notional or other number of shares of Common Stock in respect of such Synthetic Long Position that is specified in a filing by such Person or any of such Person’s Affiliates or Associates with the SEC or in the documentation evidencing such
Synthetic Long Position as the basis upon which the value or settlement amount of such right or derivative, or the opportunity of the holder of such right or derivative to profit or share in any profit, is to be calculated in whole or in part, and
in any case (or if no such number of shares of Common Stock is specified in any filing or documentation), as determined by the Board of Directors of the Company in good faith to be the number of shares of Common Stock to which such Synthetic Long
Position relates. 
 (i) “Distribution Date” shall have the meaning set forth in Section 3(a).

 (j) “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended and in effect on the date of
the Rights Agreement. 
 (k) “Exchange Act Regulations” shall mean the General Rules and Regulations under the
Exchange Act. 
 (l) “Exempted Entity” shall mean (i) the Company, (ii) any Subsidiary (as defined
below) of the Company (in the case of subclauses (i) and (ii) including, without limitation, in its fiduciary capacity), (iii) any employee benefit plan of the Company or of any Subsidiary of the Company, or (iv) any entity or
trustee holding (or acting in a fiduciary capacity in respect of) Common Stock for or pursuant to the terms of any such plan or for the purpose of funding any such plan or funding other employee benefits for employees of the Company or of any
Subsidiary of the Company. 
 (m) “Expiration Date” shall mean the earliest of (i) the exchange of all
outstanding Rights pursuant to Section 24, (ii) the redemption of all outstanding Rights pursuant to Section 23, and (iii) the close of business on December 20, 2012. 

(n) “Junior Preferred Stock” shall mean the Junior Participating Preferred Stock, par value $0.001 per share, of the
Company having the powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations and restrictions set forth in the Certificate of Designations attached to this Rights Agreement as Exhibit A
and, to the extent that there are not a sufficient number of shares of Junior Participating Preferred Stock authorized to permit the full exercise of the Rights, any other series of preferred stock of the Company designated for such purpose
containing terms substantially similar to the terms of the Junior Participating Preferred Stock. 
 (o) “OTCBB”
shall mean The Over the Counter Bulletin Board. 
 (p) “Person” shall mean any individual, corporation
(including not-for-profit), general or limited partnership, limited liability company, joint venture, estate, trust, association, organization, governmental entity or agency or other entity of any kind or nature. 

  
 - 4 -

 (q) “Right” shall have the meaning set forth in the Recitals. 

(r) “Rights Agent” shall have the meaning set forth in the Preamble. 

(s) “Securities Act” shall mean the Securities Act of 1933, as amended. 

(t) “Stock Acquisition Date” shall mean the first date of public announcement (which for purposes of this definition
shall include, without limitation, a report filed pursuant to Section 13(d) of the Exchange Act) by the Company or an Acquiring Person that an Acquiring Person has become such. 

(u) “Subsidiary” of any Person shall mean any corporation or other entity of which securities or other ownership
interests having ordinary voting power sufficient to elect a majority of the board of directors or other persons performing similar functions are beneficially owned, directly or indirectly, by such Person, and any corporation or other entity that is
otherwise controlled by such Person. 
 (v) “Synthetic Long Position” shall mean any option, warrant,
convertible security, stock appreciation right, swap agreement or other security, contract right or derivative position, whether or not presently exercisable, that has an exercise or conversion privilege or a settlement payment or mechanism at a
price related to the value of Common Stock or a value determined in whole or part with reference to, or derived in whole or in part from, the value of Common Stock and that increases in value as the value of Common Stock increases or that provides
to the holder an opportunity, directly or indirectly, to profit or share in any profit derived from any increase in the value of Common Stock, in any case without regard to whether (i) such derivative conveys any voting rights in such
securities to such Person or any of such Person’s Affiliates or Associates, (ii) such derivative is required to be, or capable of being, settled through delivery of such securities, or (iii) such Person or any of such Person’s
Affiliates or Associates may have entered into other transactions that hedge the economic effect of such derivative. A Synthetic Long Position shall not include any interests, rights, options or other securities set forth in Rule
16a-1(c)(1)-(5) or (7) of the Exchange Act Regulations. 
 Section 2. Appointment of Rights Agent. The Company
hereby appoints Continental Transfer & Trust Company as Rights Agent to act as agent for the Company and the holders of the Rights (who, in accordance with Section 3 hereof, shall prior to the Distribution Date also be the
holders of Common Stock) in accordance with the terms and conditions hereof, and the Rights Agent hereby accepts such appointment. The Company may from time to time appoint such co-Rights Agents as it may deem necessary or desirable upon ten
(10) days’ prior notice to the Rights Agent. The Rights Agent shall have no duty to supervise, and shall in no event be liable for the acts or omissions of any such co-Rights Agent. 

Section 3. Issuance of Right Certificates. (a) Until the close of business on the earlier of (i) the tenth Business Day
after the Stock Acquisition Date or (ii) the tenth Business Day (or such later date as may be determined by action of a majority of the Board of Directors before such time as any Person becomes an Acquiring Person and of which later date the
Company will give the Rights Agent prompt written notice) after the date that a tender or exchange offer by any Person (other than an Exempted Entity) is first published or sent or given 

  
 - 5 -

 
within the meaning of Rule 14d-4(a) of the Exchange Act Regulations or any successor rule, the consummation of which would result in any Person becoming an Acquiring Person (including, in
the case of both clause (i) and (ii), any such date which is after the date of this Rights Agreement and prior to the issuance of the Rights) (the earlier of such dates referred to in clauses (i) and (ii) being herein referred to as
the “Distribution Date”), (x) the Rights will be evidenced (subject to the provisions of Section 3(b) hereof) by the balances indicated in the Book Entry account system of the transfer agent for the Common Stock
registered in the names of the holders thereof (which Common Stock will also be deemed to represent certificates for Rights) or, in the case of certificated shares, by the certificates for Common Stock registered in the names of the holders thereof
(which certificates for shares of Common Stock shall be deemed also to be certificates for Rights) and not by separate Right Certificates (as defined below), and (y) the Rights will be transferable only in connection with the transfer of the
underlying shares of Common Stock, associated with such Right (including a transfer to the Company). 
 As soon as practicable
after the Distribution Date, the Company will prepare and execute, the Rights Agent will countersign, and the Company will send or cause to be sent (and the Rights Agent will, if requested, send) by first-class, insured, postage-prepaid mail, to
each record holder of shares of Common Stock as of the close of business on the Distribution Date (other than any Acquiring Person), at the address of such holder shown on the records of the Company, a Right Certificate, in substantially the form of
Exhibit B attached hereto (a “Right Certificate”), evidencing one Right (subject to adjustment as provided herein) for each share of Common Stock so held. If an adjustment in the number of Rights per share of Common Stock has
been made pursuant to Section 11(i) or Section 11(n) hereof, at the time of distribution of the Right Certificates, the Company may make the necessary and appropriate rounding adjustments (in accordance with
Section 14(a) hereof) so that Right Certificates representing only whole numbers of Rights are distributed and cash is paid in lieu of any fractional Rights. As of and after the Distribution Date, the Rights will be evidenced solely by
such Rights Certificates. 
 (b) On the Record Date, or as soon as practicable thereafter, the Company will send a copy of a
Summary of Rights to Purchase Shares of Junior Preferred Stock, in substantially the form of Exhibit C attached hereto (the “Summary of Rights”), which may be appended to certificates that represent shares of Common Stock, by
first-class, postage-prepaid mail, to each record holder of shares of Common Stock as of the close of business on the Record Date (other than any Acquiring Person), at the address of such holder shown on the records of the Company. With respect to
Common Stock outstanding as of the Record Date, until the Distribution Date, the Rights will be evidenced by the balances indicated in the Book Entry account system of the transfer agent for such stock (if applicable), or in the case of certificated
shares, by such certificates registered in the names of the holders thereof together with the Summary of Rights attached thereto. Until the Distribution Date (or, if earlier, the Expiration Date), the surrender for transfer of any shares of Common
Stock outstanding on the Record Date (whether represented by certificate(s) or evidenced by the balances indicated in the Book Entry account system of the transfer agent for such stock), with or without a copy of the Summary of Rights, shall also
constitute the transfer of the Rights associated with the Common Stock represented thereby. 
 (c) Rights shall be issued in
respect of all shares of Common Stock that become outstanding (whether originally issued or delivered from the Company’s treasury) after 

  
 - 6 -

 
the Record Date but prior to the earlier of the Distribution Date and the Expiration Date, or in certain circumstances provided in Section 22 hereof, after the Distribution Date.
Confirmation and account statements sent to holders of Common Stock for Book Entry form or, in the case of certificated shares, certificates representing shares of Common Stock (including, without limitation, upon transfer of outstanding shares of
Common Stock, disposition of shares of Common Stock, out of treasury stock or issuance or reissuance of shares of Common Stock, out of authorized but unissued shares) after the Record Date but prior to the earlier of the Distribution Date and the
Expiration Date, or in certain circumstances provided in Section 22 hereof, after the Distribution Date shall have impressed on, printed on, written on or otherwise affixed to them the following legend: 

“This certificate also evidences and entitles the holder hereof to certain rights as set forth in a Rights Agreement between Titan
Pharmaceuticals, Inc. and Continental Transfer & Trust Company, as Rights Agent, dated as of December 20, 2011, as the same may be amended, supplemented or otherwise modified from time to time (the “Rights Agreement”),
the terms of which are hereby incorporated herein by reference and a copy of which is on file at the principal executive offices of Titan Pharmaceuticals, Inc. Under certain circumstances, as set forth in the Rights Agreement, such Rights will be
evidenced by separate certificates and will no longer be evidenced by this certificate. Titan Pharmaceuticals, Inc. will mail to the holder of this certificate a copy of the Rights Agreement without charge after receipt of a written request
therefor. Under certain circumstances, as set forth in the Rights Agreement, Rights owned by or transferred to any Person who is, was or becomes an Acquiring Person (as defined in the Rights Agreement) and certain transferees thereof will become
null and void and will no longer be transferable.” 
 With respect to such certificates containing the foregoing legend, until the earliest
of the Distribution Date and the Expiration Date, the Rights associated with the Common Stock, represented by such certificates shall be evidenced by certificates alone and registered holders of Common Stock shall also be registered holders of
Rights, and the surrender for transfer of any such certificates, except as otherwise provided herein, shall also constitute the transfer of the Rights associated with such shares of Common Stock. With respect to Common Stock in Book Entry form for
which there has been sent a confirmation or account statement containing the foregoing legend, until the earliest of the Distribution Date or the Expiration Date, the Rights associated with the Common Stock shall be evidenced by such Common Stock
alone and registered holders of Common Stock shall also be the registered holders of the associated Rights, and the transfer of any such Common Stock shall also constitute the transfer of the Rights associated with such shares of Common Stock. In
the event that the Company purchases or otherwise acquires any Common Stock, after the Record Date but prior to the Distribution Date, any Rights associated with such Common Stock, shall be deemed cancelled and retired so that the Company shall not
be entitled to exercise any Rights associated with the shares of Common Stock which are no longer outstanding. 

  
 - 7 -

 Notwithstanding this paragraph (c), the omission of a legend shall not affect the
enforceability of any part of this Rights Agreement or the rights of any holder of the Rights. 
 Section 4. Form of Right
Certificates. The Right Certificates (and the forms of election to purchase shares and of assignment to be printed on the reverse thereof) shall be substantially in the form set forth in Exhibit B attached hereto and may have such marks
of identification or designation and such legends, summaries or endorsements printed thereon as the Company may deem appropriate and as are not inconsistent with the provisions of this Rights Agreement, or as may be required to comply with any
applicable law or with any rule or regulation made pursuant thereto or with any rule or regulation of the OTCBB or of any other stock exchange or automated quotation system on which the Rights may from time to time be listed, or to conform to usage.
Subject to the provisions of Sections 11, 13, 22, 23, 24 and 27 hereof, the Right Certificates shall entitle the holders thereof to purchase such number of one one-thousandth of a share of Junior Preferred
Stock as shall be set forth therein at the Purchase Price (as determined pursuant to Section 7), but the amount and type of securities purchasable upon the exercise of each Right and the Purchase Price thereof shall be subject to
adjustment as provided herein. 
 Any Right Certificate issued pursuant hereto that represents Rights beneficially owned by:
(i) an Acquiring Person, (ii) a transferee of an Acquiring Person that becomes a transferee after the Acquiring Person becomes such, or (iii) a transferee of an Acquiring Person that becomes a transferee prior to or concurrently with
the Acquiring Person becoming such and that receives such Rights pursuant to either (A) a transfer (whether or not for consideration) from the Acquiring Person to holders of equity interests in such Acquiring Person or to any Person with whom
such Acquiring Person has any continuing written or oral agreement, arrangement, or understanding regarding either the transferred Rights, shares of Common Stock, or the Company, or (B) a transfer that the Board of Directors has determined in
good faith to be part of a plan, agreement, arrangement, or understanding, written or otherwise, that has as a primary purpose or effect the avoidance of Section 11(a)(ii) hereof, and subsequent transferees of such Persons shall, upon
the written direction of the Board of Directors, contain (to the extent feasible), the following legend: 

“The Rights represented by this Rights Certificate are or were beneficially owned by a Person who was or became an
Acquiring Person (as such capitalized terms are defined in the Rights Agreement, dated as of December 20, 2011 (the “Rights Agreement”), by and between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust
Company, as Rights Agent). Accordingly, this Rights Certificate and the Rights represented hereby may become null and void in the circumstances specified in Section 11(a)(ii) of the Rights Agreement.” 

Section 5. Countersignature and Registration. (a) The Right Certificates shall be executed on behalf of the Company by the
Chief Executive Officer, Chief Financial Officer, any of the Vice Presidents of the Company (each an “Authorized Officer”), either manually or by facsimile signature, shall have affixed thereto the Company’s seal or a facsimile
thereof and shall be attested by the Corporate Secretary or an Assistant Secretary of the Company, either manually or by facsimile signature. The Right Certificates shall be countersigned by the Rights Agent, either manually or by facsimile
signature, and shall not be 

  
 - 8 -

 
valid for any purpose unless countersigned. In case any Authorized Officer who shall have signed any Right Certificate shall cease to be an Authorized Officer of the Company before
countersignature by the Rights Agent and issuance and delivery by the Company, such Right Certificates, nevertheless, may be countersigned by the Rights Agent and issued and delivered by the Company with the same force and effect as though the
Person who signed such Right Certificates had not ceased to be an Authorized Officer of the Company; and any Right Certificate may be signed on behalf of the Company by any Person who, at the actual date of the execution of such Right Certificate,
shall be a proper Authorized Officer of the Company to sign such Right Certificate, although at the date of the execution of this Rights Agreement any such Person was not such an Authorized Officer. 

(b) Following the Distribution Date, the Rights Agent will keep or cause to be kept, at an office or agency designated for such purpose,
books for registration and transfer of the Right Certificates issued hereunder. Such books shall show the names and addresses of the respective holders of the Right Certificates, the number of Rights evidenced on its face by each Right Certificate
and the date of each Right Certificate. 
 Section 6. Transfer, Split Up, Combination and Exchange of Right Certificates;
Mutilated, Destroyed, Lost or Stolen Right Certificates. (a) Subject to the provisions of this Rights Agreement, at any time after the close of business on the Distribution Date, and prior to the close of business on the Expiration Date,
any Right Certificate or Right Certificates may be transferred, split up, combined or exchanged for another Right Certificate or Right Certificates, entitling the registered holder to purchase a like number of one one-thousandth of a share of Junior
Preferred Stock (or, following such time, other securities, cash or assets as the case may be) as the Right Certificate or Right Certificates surrendered then entitled such holder to purchase. Any registered holder desiring to transfer, split up,
combine or exchange any Right Certificate or Right Certificates shall make such request in writing delivered to the Rights Agent, and shall surrender the Right Certificate or Right Certificates to be transferred, split up, combined or exchanged at
the office or agency of the Rights Agent designated for such purpose. Thereupon the Rights Agent, subject to the provisions of this Rights Agreement, shall countersign and deliver to the Person entitled thereto a Right Certificate or Right
Certificates, as the case may be, as so requested. The Company may require payment of a sum sufficient to cover any tax or governmental charge that may be imposed in connection with any transfer, split up, combination or exchange of Right
Certificates. 
 (b) Subject to the provisions of this Rights Agreement, at any time after the Distribution Date and prior to
the Expiration Date, upon receipt by the Company and the Rights Agent of evidence reasonably satisfactory to them of the loss, theft, destruction or mutilation of a Right Certificate, and, in case of loss, theft or destruction, of indemnity or
security reasonably satisfactory to them, and, at the Company’s request, reimbursement to the Company and the Rights Agent of all reasonable expenses incidental thereto, and upon surrender to the Rights Agent and cancellation of the Right
Certificate if mutilated, the Company will make and deliver a new Right Certificate of like tenor to the Rights Agent for delivery to the registered holder in lieu of the Right Certificate so lost, stolen, destroyed or mutilated. 

Section 7. Exercise of Rights, Purchase Price; Expiration Date of Rights. (a) Except as otherwise provided herein, the Rights
shall become exercisable on the Distribution 

  
 - 9 -

 
Date, and thereafter the registered holder of any Right Certificate may, subject to Section 11(a)(ii) hereof and except as otherwise provided herein, exercise the Rights evidenced
thereby in whole or in part upon surrender of the Right Certificate, with the form of election to purchase on the reverse side thereof duly executed, to the Rights Agent at the office or agency of the Rights Agent designated for such purpose,
together with payment of the Purchase Price for each one one-thousandth of a share of Junior Preferred Stock (or other securities, cash or assets, as the case may be) as to which the Rights are exercised, at any time which is both after the
Distribution Date and prior to the Expiration Date. 
 (b) The purchase price (the “Purchase Price”) shall be
initially $4.41 for each one one-thousandth of a share of Junior Preferred Stock purchasable upon the exercise of a Right. The Purchase Price and the number of one one-thousandth of a share of Junior Preferred Stock or other securities or property
to be acquired upon exercise of a Right shall be subject to adjustment from time to time as provided in Sections 11 and 13 hereof and shall be payable in lawful money of the United States of America in accordance with paragraph
(c) of this Section 7. 
 (c) Except as otherwise provided herein, upon receipt of a Right Certificate
representing exercisable Rights, with the form of election to purchase duly executed, accompanied by payment of the aggregate Purchase Price for the number of shares of Junior Preferred Stock to be purchased and an amount equal to any applicable
transfer tax required to be paid by the holder of such Right Certificate in accordance with Section 9(e) hereof, by certified check, cashier’s check or money order payable to the order of the Rights Agent, the Rights Agent shall
thereupon promptly (i) (A) requisition from any transfer agent of the Junior Preferred Stock or make available if the Rights Agent is the transfer agent for the Junior Preferred Stock certificates for the number of shares of Junior
Preferred Stock to be purchased (and the Company hereby irrevocably authorizes its transfer agent to comply with all such requests), or (B) requisition from the depositary agent appointed by the Company depositary receipts representing
interests in such number of one one-thousandth of a share of Junior Preferred Stock as are to be purchased, in which case certificates for the Junior Preferred Stock represented by such receipts shall be deposited by the transfer agent with the
depositary agent (and the Company hereby directs the depositary agent to comply with such request), (ii) when appropriate, requisition from the Company the amount of cash to be paid in lieu of issuance of fractional shares in accordance with
Section 14 hereof, (iii) promptly after receipt of such certificates or depositary receipts, cause the same to be delivered to or upon the order of the registered holder of such Right Certificate, registered in such name or names as
may be designated by such holder and (iv) when appropriate, after receipt, promptly deliver such cash to or upon the order of the registered holder of such Right Certificate. 

(d) Except as otherwise provided herein, in case the registered holder of any Right Certificate shall exercise less than all the Rights
evidenced thereby, a new Right Certificate evidencing Rights equivalent to the exercisable Rights remaining unexercised shall be issued by the Rights Agent to the registered holder of such Right Certificate or to his duly authorized assigns, subject
to the provisions of Section 6 and 14 hereof. 
 (e) Notwithstanding anything in this Rights Agreement to the
contrary, neither the Rights Agent nor the Company shall be obligated to undertake any action with respect to a registered holder of Rights upon the occurrence of any purported transfer or exercise

  
 - 10 -

 
of Rights pursuant to Section 6 hereof or this Section 7 unless such registered holder shall have (i) completed and signed the certificate contained in the form of
assignment or election to purchase set forth on the reverse side of the Right Certificate surrendered for such transfer or exercise and (ii) provided such additional evidence of the identity of the Beneficial Owner (or former Beneficial Owner)
thereof as the Company shall reasonably request. 
 Section 8. Cancellation and Destruction of Right Certificates. All
Right Certificates surrendered for the purpose of exercise, transfer, split up, combination or exchange shall, if surrendered to the Company or to any of its agents, be delivered to the Rights Agent for cancellation or in cancelled form, or, if
surrendered to the Rights Agent, shall be cancelled by it, and no Right Certificates shall be issued in lieu thereof except as expressly permitted by any of the provisions of this Rights Agreement. The Company shall deliver to the Rights Agent for
cancellation and retirement, and the Rights Agent shall so cancel and retire, any other Right Certificate purchased or acquired by the Company otherwise than upon the exercise thereof. The Rights Agent shall deliver all cancelled Right Certificates
to the Company, or shall, at the written request of the Company, destroy or cause to be destroyed such cancelled Right Certificates, and in such case shall deliver a certificate of destruction thereof to the Company. 

Section 9. Availability of Shares of Junior Preferred Stock. (a) The Company covenants and agrees that it will cause to be
reserved and kept available out of its authorized and unissued shares of Junior Preferred Stock or any shares of Junior Preferred Stock held in its treasury, the number of shares of Junior Preferred Stock that will be sufficient to permit the
exercise in full of all outstanding Rights. 
 (b) So long as the shares of Junior Preferred Stock (and, following the time that
a Person becomes an Acquiring Person, shares of Common Stock and other securities) issuable upon the exercise of Rights may be listed or admitted to trading on the OTCBB or listed on any other national securities exchange or quotation system, the
Company shall use its best efforts to cause, from and after such time as the Rights become exercisable, all shares reserved for such issuance to be listed or admitted to trading on the OTCBB or listed on any other exchange or quotation system upon
official notice of issuance upon such exercise. 
 (c) From and after such time as the Rights become exercisable, the Company
shall use its best efforts, if then necessary to permit the issuance of shares of Junior Preferred Stock (and following the time that a Person first becomes an Acquiring Person, shares of Common Stock and other securities) upon the exercise of
Rights, to register and qualify such shares of Junior Preferred Stock (and following the time that a Person first becomes an Acquiring Person, shares of Common Stock and other securities) under the Securities Act and any applicable state securities
or “Blue Sky” laws (to the extent exemptions therefrom are not available), cause such registration statement and qualifications to become effective as soon as possible after such filing and keep such registration and qualifications
effective until the earlier of (x) the date as of which the Rights are no longer exercisable for such securities and (y) the Expiration Date. The Company may temporarily suspend, for a period of time not to exceed ninety (90) days,
the exercisability of the Rights in order to prepare and file a registration statement under the Securities Act and permit it to become effective. Upon any such suspension, the Company shall notify the Rights Agent thereof in writing and shall issue
a public announcement stating that the exercisability of the Rights has been temporarily suspended, as 

  
 - 11 -

 
well as a public announcement at such time as the suspension is no longer in effect. Notwithstanding any provision of this Rights Agreement to the contrary, the Rights shall not be exercisable in
any jurisdiction unless the requisite qualification or exemption in such jurisdiction shall have been obtained and until a registration statement under the Securities Act (if required) shall have been declared effective. 

(d) The Company covenants and agrees that it will take all such action as may be necessary to ensure that all shares of Junior Preferred
Stock (and, following the time that a Person becomes an Acquiring Person, shares of Common Stock and other securities) delivered upon exercise of Rights shall, at the time of delivery of the certificates therefor (subject to payment of the Purchase
Price), be duly and validly authorized and issued and fully paid and nonassessable shares. 
 (e) The Company further covenants
and agrees that it will pay when due and payable any and all federal and state transfer taxes and charges which may be payable in respect of the issuance or delivery of the Right Certificates or of any shares of Junior Preferred Stock (or shares of
Common Stock or other securities) upon the exercise of Rights. The Company shall not, however, be required to pay any transfer tax or charge which may be payable in respect of any transfer or delivery of Right Certificates to a Person other than, or
the issuance or delivery of certificates or depositary receipts or entries in the Book Entry account system of the transfer agent for the Junior Preferred Stock (or shares of Common Stock or other securities) in a name other than that of, the
registered holder of the Right Certificate evidencing Rights surrendered for exercise or to issue or deliver any certificates or depositary receipts or entries in the Book Entry account system of the transfer agent for Junior Preferred Stock (or
shares of Common Stock or other securities) upon the exercise of any Rights until any such tax or charge shall have been paid (any such tax or charge being payable by that holder of such Right Certificate at the time of surrender) or until it has
been established to the Company’s reasonable satisfaction that no such tax or charge is due. 
 (f) The Company shall use
its reasonable best efforts, on or prior to the date that is either (A) as soon as practicable following the first occurrence of an event under Section 11(a)(ii) and a determination by the Company in accordance with
Section 11(a)(iii) hereof, if applicable, of the consideration to be delivered by the Company upon exercise of the Rights, or (B) if so required by law, as soon as required following the Distribution Date, to obtain any and all
regulatory approvals that may be required with respect to the securities purchasable upon exercise of the Rights. The Company may temporarily suspend, for a period of time not to exceed 90 days after the date set forth in the first sentence of this
Section 9(f), the exercise of the Rights in order to permit the Company to obtain the necessary regulatory approvals. Upon any such suspension, the Company shall notify the Rights Agent thereof in writing and issue a public announcement
stating that the exercise of the Rights has been temporarily suspended, as well as a public announcement (with written notice thereof to the Rights Agent) at such time as the suspension is no longer in effect stating that the suspension on the
exercise of the Rights is no longer in effect. Notwithstanding any provision of this Rights Agreement to the contrary, the Rights shall not be exercisable unless and until all required regulatory approvals have been obtained with respect to the
securities purchasable upon exercise of the Rights. 

  
 - 12 -

 Section 10. Junior Preferred Stock Record Date. Each Person in whose name any
certificate or entry in Book Entry account system of the transfer agent for Junior Preferred Stock (or shares of Common Stock or other securities) is issued upon the exercise of Rights shall for all purposes be deemed to have become the holder of
record of the shares of Junior Preferred Stock (or shares of Common Stock or other securities) represented thereby on, and such certificate or entry in the Book Entry account system of the transfer agent shall be dated, the date upon which the Right
Certificate evidencing such Rights was duly surrendered and payment of the Purchase Price (and any applicable transfer taxes or charges) was made; provided, however, that if the date of such surrender and payment is a date upon which the Junior
Preferred Stock (or shares of Common Stock or other securities) transfer books of the Company are closed, such Person shall be deemed to have become the record holder of such shares on, and such certificate or entry in Book Entry account system of
the transfer agent shall be dated, the next succeeding Business Day on which such transfer books are open. Prior to the exercise of the Rights evidenced thereby, the holder of a Right Certificate shall not be entitled to any rights of a stockholder
of the Company with respect to securities for which the Rights shall be exercisable, including, without limitation, the right to vote or to receive dividends or other distributions, and shall not be entitled to receive any notice of any proceedings
of the Company, except as provided herein. 
 Section 11. Adjustment of Purchase Price, Number and Kind of Shares and Number
of Rights. The Purchase Price, the number of shares of Junior Preferred Stock or other securities or property purchasable upon exercise of each Right and the number of Rights outstanding are subject to adjustment from time to time as provided in
this Section 11. 
 (a)(i) In the event the Company shall at any time after the date of this Rights
Agreement (A) declare a dividend on the Junior Preferred Stock payable in shares of Junior Preferred Stock, (B) subdivide the outstanding shares of Junior Preferred Stock, (C) combine the outstanding shares of Junior Preferred Stock
into a smaller number of shares of Junior Preferred Stock or (D) issue any shares of its capital stock in a reclassification of the shares of Junior Preferred Stock (including any such reclassification in connection with a consolidation or
merger in which the Company is the continuing or surviving corporation), except as otherwise provided in this Section 11(a), the Purchase Price in effect at the time of the record date for such dividend or of the effective date of such
subdivision, combination or reclassification, as the case may be, and the number and kind of shares of capital stock issuable upon exercise of a Right, shall be proportionately adjusted so that the holder of any Right exercised after such time shall
be entitled to receive the aggregate number and kind of shares of capital stock which, if such Right had been exercised immediately prior to such date and at a time when the Junior Preferred Stock transfer books of the Company were open, the holder
would have owned upon such exercise and been entitled to receive by virtue of such dividend, subdivision, combination or reclassification; provided, however, that in no event shall the consideration to be paid upon the exercise of one Right be less
than the aggregate par value of the shares of capital stock of the Company issuable upon exercise of one Right. If an event occurs that would require an adjustment under both this Section 11(a)(i) and Section 11(a)(ii)
hereof, the adjustment provided for in this Section 11(a)(i) shall be in addition to, and shall be made prior to, any adjustment required pursuant to Section 11(a)(ii) hereof. 

  
 - 13 -

 (ii) Subject to Sections 24 and 13 of this Rights Agreement
and except as otherwise provided in this Section 11(a)(ii) and Section 11(a)(iii), in the event that any Person becomes an Acquiring Person, each holder of a Right shall thereafter have the right to receive, upon exercise
thereof, at a price equal to the then-current Purchase Price, in accordance with the terms of this Rights Agreement and in lieu of shares of Junior Preferred Stock, such number of shares of Common Stock (or at the option of the Company, such number
of one one-thousandth of a share of Junior Preferred Stock) as shall equal the result obtained by (x) multiplying the then-current Purchase Price by the number of one one-thousandth of a share of Junior Preferred Stock for which a Right is then
exercisable and dividing that product by (y) 50% of the then-current per share market price of the Company’s Common Stock (determined pursuant to Section 11(d) hereof) on the date of the occurrence of such event;
provided, however, that the Purchase Price (as so adjusted) and the number of shares of Common Stock so receivable upon exercise of a Right shall thereafter be subject to further adjustment as appropriate in accordance with
Section 11(f) hereof. Notwithstanding anything in this Rights Agreement to the contrary, however, from and after the time (the “invalidation time”) when any Person first becomes an Acquiring Person, any Rights that are
beneficially owned by (x) any Acquiring Person, (y) a transferee of any Acquiring Person who becomes a transferee after the invalidation time or (z) a transferee of any Acquiring Person who became a transferee prior to or concurrently
with the invalidation time pursuant to either (I) a transfer from the Acquiring Person to holders of its equity securities or to any Person with whom it has any continuing agreement, arrangement or understanding, written or otherwise, regarding
the transferred Rights, shares of Common Stock or the Company or (II) a transfer that the Board of Directors has determined in good faith is part of a plan, arrangement or understanding, written or otherwise, which has the purpose or effect of
avoiding the provisions of this paragraph, and subsequent transferees of such Persons, shall be void without any further action and any holder of such Rights shall thereafter have no rights whatsoever with respect to such Rights under any provision
of this Rights Agreement. The Company shall use all reasonable efforts to ensure that the provisions of this Section 11(a)(ii) are complied with, but shall have no liability to any holder of Right Certificates or other Person as a result
of its determination, or failure to make any determinations, with respect to an Acquiring Person or transferees hereunder. From and after the invalidation time, no Right Certificate shall be issued pursuant to Section 3 or
Section 6 hereof that represents Rights that are or have become void pursuant to the provisions of this paragraph, and any Right Certificate delivered to the Rights Agent that represents Rights that are or have become void pursuant to
the provisions of this paragraph shall be cancelled. From and after the occurrence of an event specified in Section 13(a) hereof, any Rights that theretofore have not been exercised pursuant to this Section 11(a)(ii) shall
thereafter be exercisable only in accordance with Section 13 and not pursuant to this Section 11(a)(ii). 
 (iii) The Company may at its option substitute for a share of Common Stock issuable upon the exercise of Rights in accordance with the foregoing subparagraph (ii) such number or fractions of shares
of Junior Preferred Stock having an aggregate current market value equal to the current per share market price of a share of Common Stock. In the event that there shall be an insufficient number of Common Stock authorized but unissued (and
unreserved) to permit the exercise in full of the Rights in accordance with the foregoing subparagraph (ii), the Board of Directors shall, with respect to such deficiency, to the extent permitted by applicable law and any material agreements then in
effect to which the Company is a party (A) determine the excess of (x) the value of the shares of Common Stock issuable upon the exercise of a Right in accordance with 

  
 - 14 -

 
the foregoing subparagraph (ii) (the “Current Value”) over (y) the then-current Purchase Price multiplied by the number of one one-thousandth of shares of Junior
Preferred Stock for which a Right was exercisable immediately prior to the time that the Acquiring Person became such (such excess, the “Spread”), and (B) with respect to each Right (other than Rights which have become void
pursuant to Section 11(a)(ii)), make adequate provision to substitute for the shares of Common Stock issuable in accordance with subparagraph (ii) upon exercise of the Right and payment of the applicable Purchase Price,
(1) cash, (2) a reduction in such Purchase Price, (3) shares of Junior Preferred Stock or other equity securities of the Company (including, without limitation, shares or fractions of shares of preferred stock which, by virtue of
having dividend, voting and liquidation rights substantially comparable to those of the shares of Common Stock, are deemed in good faith by the Board of Directors to have substantially the same value as the shares of Common Stock (such shares of
preferred stock and shares or fractions of shares of preferred stock are hereinafter referred to as “Common Stock equivalents”), (4) debt securities of the Company, (5) other assets or (6) any combination of the
foregoing, having a value which, when added to the value of the shares of Common Stock actually issued upon exercise of such Right, shall have an aggregate value equal to the Current Value (less the amount of any reduction in such Purchase Price),
where such aggregate value has been determined by the Board of Directors upon the advice of a nationally recognized investment banking firm selected in good faith by the Board of Directors; provided, however, if the Company shall not
make adequate provision to deliver value pursuant to clause (B) above within thirty (30) days following the date that the Acquiring Person became such (the “Section 11(a)(ii) Trigger Date”), then the Company shall be
obligated to deliver, to the extent permitted by applicable law and any material agreements then in effect to which the Company is a party, upon the surrender for exercise of a Right and without requiring payment of the Purchase Price, shares of
Common Stock (to the extent available), and then, if necessary, such number or fractions of shares of Junior Preferred Stock (to the extent available) and then, if necessary, cash, which shares and/or cash have an aggregate value equal to the
Spread. If within the thirty (30) day period referred to above, the Board of Directors shall determine in good faith that it is likely that sufficient additional shares of Common Stock could be authorized for issuance upon exercise in full of
the Rights, then, if the Board of Directors so elects, such thirty (30) day period may be extended to the extent necessary, but not more than ninety (90) days after the Section 11(a)(ii) Trigger Date, in order that the Company
may seek stockholder approval for the authorization of such additional shares (such thirty (30) day period, as it may be extended, is hereinafter called the “Substitution Period”). To the extent that the Company determines that
some action need be taken pursuant to the second and/or third sentence of this Section 11(a)(iii), the Company (x) shall provide, subject to Section 11(a)(ii) hereof and the last sentence of this
Section 11(a)(iii) hereof, that such action shall apply uniformly to all outstanding Rights and (y) may suspend the exercisability of the Rights until the expiration of the Substitution Period in order to seek any authorization of
additional shares and/or to decide the appropriate form of 

  
 - 15 -

 
distribution to be made pursuant to such second sentence and to determine the value thereof. In the event of any such suspension, the Company shall issue a public announcement stating that the
exercisability of the Rights has been temporarily suspended, as well as a public announcement at such time as the suspension is no longer in effect. For purposes of this Section 11(a)(iii), the value of the shares of Common Stock shall
be the current per share market price (as determined pursuant to Section 11(d)(i)) on the Section 11(a)(ii) Trigger Date and the per share or fractional value of any Common Stock equivalent shall be deemed to equal the current per
share market price of the Common Stock. The Board of Directors of the Company may, but shall not be required to, establish procedures to allocate the right to receive shares of Common Stock upon the exercise of the Rights among holders of Rights
pursuant to this Section 11(a)(iii). 
 (b) In case the Company shall fix a record date for the issuance of rights,
options or warrants to all holders of Junior Preferred Stock entitling them (for a period expiring within 45 calendar days after such record date) to subscribe for or purchase Junior Preferred Stock (or shares having similar rights, privileges and
preferences as the Junior Preferred Stock (“equivalent preferred shares”)) or securities convertible into Junior Preferred Stock or equivalent preferred shares at a price per share of Junior Preferred Stock or equivalent preferred
shares (or having a conversion price per share, if a security convertible into shares of Junior Preferred Stock or equivalent preferred shares) less than the then-current per share market price of the Junior Preferred Stock (determined pursuant to
Section 11(d) hereof) on such record date, the Purchase Price to be in effect after such record date shall be determined by multiplying the Purchase Price in effect immediately prior to such record date by a fraction, the numerator of
which shall be the number of shares of Junior Preferred Stock and equivalent preferred shares outstanding on such record date plus the number of shares of Junior Preferred Stock and equivalent preferred shares which the aggregate offering price of
the total number of such shares so to be offered (and/or the aggregate initial conversion price of the convertible securities so to be offered) would purchase at such current market price, and the denominator of which shall be the number of shares
of Junior Preferred Stock and equivalent preferred shares outstanding on such record date plus the number of additional shares of Junior Preferred Stock and/or equivalent preferred shares to be offered for subscription or purchase (or into which the
convertible securities so to be offered are initially convertible); provided, however, that in no event shall the consideration to be paid upon the exercise of one Right be less than the aggregate par value of the shares of capital
stock of the Company issuable upon exercise of one Right. In case such subscription price may be paid in a consideration part or all of which shall be in a form other than cash, the value of such consideration shall be as determined in good faith by
the Board of Directors of the Company, whose determination shall be described in a statement filed with the Rights Agent and which shall be binding on the Rights Agent. Shares of Junior Preferred Stock and equivalent preferred shares owned by or
held for the account of the Company shall not be deemed outstanding for the purpose of any such computation. Such adjustment shall be made successively whenever such a record date is fixed; and in the event that such rights, options or warrants are
not so issued, the Purchase Price shall be adjusted to be the Purchase Price which would then be in effect if such record date had not been fixed. 
 (c) In case the Company shall fix a record date for the making of a distribution to all holders of the Junior Preferred Stock (including any such distribution made in

  
 - 16 -

 
connection with a consolidation or merger in which the Company is the continuing or surviving corporation) of evidences of indebtedness or assets (other than a regular quarterly cash dividend or
a dividend payable in Junior Preferred Stock) or subscription rights or warrants (excluding those referred to in Section 11(b) hereof), the Purchase Price to be in effect after such record date shall be determined by multiplying the
Purchase Price in effect immediately prior to such record date by a fraction, the numerator of which shall be the then-current per share market price of the Junior Preferred Stock (determined pursuant to Section 11(d) hereof) on such
record date, less the fair market value (as determined in good faith by the Board of Directors of the Company whose determination shall be described in a statement filed with the Rights Agent and shall be binding on the Rights Agent) of the portion
of such assets or evidences of indebtedness so to be distributed or of such subscription rights or warrants applicable to one share of Junior Preferred Stock, and the denominator of which shall be such current per share market price of the Junior
Preferred Stock; provided, however, that in no event shall the consideration to be paid upon the exercise of one Right be less than the aggregate par value of the shares of capital stock of the Company to be issued upon exercise of one
Right. Such adjustments shall be made successively whenever such a record date is fixed; and in the event that such distribution is not so made, the Purchase Price shall again be adjusted to be the Purchase Price which would then be in effect if
such record date had not been fixed. 
 (d)(i) Except as otherwise provided herein, for the purpose of any computation
hereunder, the “current per share market price” of any security (a “Security” for the purpose of this Section 11(d)(i)) on any date shall be deemed to be the average of the daily closing prices per share of
such Security for the 30 consecutive Trading Days (as such term is hereinafter defined) immediately prior to such date; provided, however, that in the event that the current per share market price of the Security is determined during a
period following the announcement by the issuer of such Security of (A) a dividend or distribution on such Security payable in shares of such Security or securities convertible into such shares, or (B) any subdivision, combination or
reclassification of such Security, and prior to the expiration of 30 Trading Days after the ex-dividend date for such dividend or distribution, or the record date for such subdivision, combination or reclassification, then, and in each such case,
the current per share market price shall be appropriately adjusted to reflect the current market price per share equivalent of such Security. The closing price for each day shall be the last sale price, regular way, or, in case no such sale takes
place on such day, the average of the closing bid and asked prices, regular way, in either case as reported by (w) the principal consolidated transaction reporting system with respect to securities listed or admitted to trading on the OTCBB or,
(x) if the Security is not listed or admitted to trading on the OTCBBQ, as reported in the principal consolidated transaction reporting system with respect to securities listed on the principal national securities exchange on which the Security
is listed or admitted to trading or, if (y) the Security is not listed or admitted to trading on any national securities exchange, the last quoted price or, if not so quoted, the average of the high bid and low asked prices in the
over-the-counter market, as reported by the OTCBB or such other system then in use, or, (z) if on any such date the Security is not quoted by any such organization, the average of the closing bid and asked prices as furnished by a professional
market maker making a market in the Security selected by the Board of Directors of the Company. The term “Trading Day” shall mean a day on which the principal national securities exchange on which the Security is listed or admitted
to trading is open for the transaction of business or, if the Security is not listed or admitted to trading on any national securities exchange, a Business Day. 

  
 - 17 -

 (ii) For the purpose of any computation hereunder, if the Junior Preferred
Stock is publicly traded, the “current per share market price” of the Junior Preferred Stock shall be determined in accordance with the method set forth in Section 11(d)(i). If the Junior Preferred Stock is not publicly traded
but the Common Stock is publicly traded, the “current per share market price” of the Junior Preferred Stock shall be conclusively deemed to be the current per share market price of the Common Stock, as determined pursuant to
Section 11(d)(i), multiplied by one hundred (appropriately adjusted to reflect any stock split, stock dividend or similar transaction occurring after the date hereof). If neither the Common Stock nor the Junior Preferred Stock is
publicly traded, “current per share market price” shall mean the fair value per share as determined in good faith by the Board of Directors of the Company, whose determination shall be described in a statement filed with the Rights Agent
and shall be binding on the Rights Agent. 
 (e) No adjustment in the Purchase Price shall be required unless such adjustment
would require an increase or decrease of at least 1% in the Purchase Price; provided, however, that any adjustments not required to be made by reason of this Section 11(e) shall be carried forward and taken into account in
any subsequent adjustment. All calculations under this Section 11 shall be made to the nearest cent or to the nearest one ten-thousandth of a share of Junior Preferred Stock or share of Common Stock or other share or security as the case
may be. Notwithstanding the first sentence of this Section 11(e), any adjustment required by this Section 11 shall be made no later than the earlier of (i) two years from the date of the transaction which requires such
adjustment or (ii) the Expiration Date. 
 (f) If, as a result of an adjustment made pursuant to Section 11(a)
or Section 13 hereof, the holder of any Right thereafter exercised shall become entitled to receive any shares of capital stock of the Company other than the Junior Preferred Stock, thereafter the Purchase Price and the number of such
other shares so receivable upon exercise of a Right shall be subject to adjustment from time to time in a manner and on terms as nearly equivalent as practicable to the provisions with respect to the Junior Preferred Stock contained in Sections
11(a), 11(b), 11(c), 11(e), 11(h), 11(i) and 11(m) and the provisions of Sections 7, 9, 10, 13 and 14 hereof with respect to the Junior Preferred Stock shall apply on
like terms to any such other shares. 
 (g) All Rights originally issued by the Company subsequent to any adjustment made to the
Purchase Price hereunder shall evidence the right to purchase, at the adjusted Purchase Price, the number of one one-thousandth of a share of Junior Preferred Stock purchasable from time to time hereunder upon exercise of the Rights, all subject to
further adjustment as provided herein. 
 (h) Unless the Company shall have exercised its election as provided in
Section 11(i), upon each adjustment of the Purchase Price as a result of the calculations made in Section 11(b) and (c), each Right outstanding immediately prior to the making of such adjustment shall thereafter
evidence the right to purchase, at the adjusted Purchase Price, that number of one one-thousandth of a share of Junior Preferred Stock (calculated to the nearest one - thousandth of a share of Junior Preferred Stock) obtained by (i) multiplying
(x) the number of one one-thousandth of a share of Junior Preferred Stock purchasable upon the exercise of a Right 

  
 - 18 -

 
immediately prior to such adjustment by (y) the Purchase Price in effect immediately prior to such adjustment of the Purchase Price and (ii) dividing the product so obtained by the
Purchase Price in effect immediately after such adjustment of the Purchase Price. 
 (i) The Company may elect on or after the
date of any adjustment of the Purchase Price pursuant to Sections 11(b) or 11(c) hereof to adjust the number of Rights, in substitution for any adjustment in the number of one one-thousandth of a share of Junior Preferred Stock
purchasable upon the exercise of a Right. Each of the Rights outstanding after such adjustment of the number of Rights shall be exercisable for the number of one one-thousandth of a share of Junior Preferred Stock for which a Right was exercisable
immediately prior to such adjustment. Each Right held of record prior to such adjustment of the number of Rights shall become that number of Rights (calculated to the nearest one ten-thousandth) obtained by dividing the Purchase Price in effect
immediately prior to adjustment of the Purchase Price by the Purchase Price in effect immediately after adjustment of the Purchase Price. The Company shall make a public announcement, and notify the Rights Agent in writing of its election to adjust
the number of Rights, indicating the record date for the adjustment, and, if known at the time, the amount of the adjustment to be made. This record date may be the date on which the Purchase Price is adjusted or any day thereafter, but, if the
Right Certificates have been issued, shall be at least 10 days later than the date of the public announcement. If Right Certificates have been issued, upon each adjustment of the number of Rights pursuant to this Section 11(i), the
Company may, as promptly as practicable, cause to be distributed to holders of record of Right Certificates on such record date Right Certificates evidencing, subject to Section 14 hereof, the additional Rights to which such holders
shall be entitled as a result of such adjustment, or, at the option of the Company, shall cause to be distributed to such holders of record in substitution and replacement for the Right Certificates held by such holders prior to the date of
adjustment, and upon surrender thereof, if required by the Company, new Right Certificates evidencing all the Rights to which such holders shall be entitled as a result of such adjustment. Right Certificates so to be distributed shall be issued,
executed and countersigned in the manner provided for herein and shall be registered in the names of the holders of record of Right Certificates on the record date specified in the public announcement. 

(j) Irrespective of any adjustment or change in the Purchase Price or the number of one one-thousandth of a share of Junior Preferred
Stock issuable upon the exercise of the Rights, the Right Certificates theretofore and thereafter issued may continue to express the Purchase Price and the number of one one-thousandth of a share of Junior Preferred Stock which were expressed in the
initial Right Certificates issued hereunder. 
 (k) Before taking any action that would cause an adjustment reducing the
Purchase Price below the then par value, if any, of the shares of Junior Preferred Stock or other shares of capital stock issuable upon exercise of the Rights, the Company shall take any corporate action which may, in the opinion of its counsel, be
necessary in order that the Company may validly and legally issue fully paid and nonassessable shares of Junior Preferred Stock or other such shares at such adjusted Purchase Price. 

(l) In any case in which this Section 11 shall require that an adjustment in the Purchase Price be made effective as of a
record date for a specified event, the Company may elect to defer (and shall notify the Rights Agent in writing of any such election) until the 

  
 - 19 -

 
occurrence of such event the issuing to the holder of any Right exercised after such record date the Junior Preferred Stock, Common Stock or other capital stock or securities of the Company, if
any, issuable upon such exercise over and above the Junior Preferred Stock, Common Stock or other capital stock or securities of the Company, if any, issuable upon such exercise on the basis of the Purchase Price in effect prior to such adjustment;
provided, however, that the Company shall deliver to such holder a due bill or other appropriate instrument evidencing such holder’s right to receive such additional shares upon the occurrence of the event requiring such
adjustment. 
 (m) Notwithstanding anything in this Section 11 to the contrary, the Company shall be entitled to
make such adjustments in the Purchase Price, in addition to those adjustments expressly required by this Section 11, as and to the extent that it in its sole discretion shall determine to be advisable in order that any consolidation or
subdivision of the Junior Preferred Stock, issuance (wholly for cash) of any shares of Junior Preferred Stock at less than the current market price, issuance (wholly for cash) of Junior Preferred Stock or securities which by their terms are
convertible into or exchangeable for Junior Preferred Stock, dividends on Junior Preferred Stock payable in shares of Junior Preferred Stock or issuance of rights, options or warrants referred to hereinabove in Section 11(b), hereafter
made by the Company to holders of its Junior Preferred Stock shall not be taxable to such stockholders. 
 (n) Notwithstanding
anything in this Rights Agreement to the contrary, in the event that at any time after the date of this Rights Agreement and prior to the Distribution Date, the Company shall (i) declare and pay any dividend on the shares of any class or series
of Common Stock payable in shares of Common Stock or (ii) effect a subdivision, combination or consolidation of the shares of any class or series of Common Stock (by reclassification or otherwise than by payment of a dividend payable in shares
of Common Stock) into a greater or lesser number of shares of Common Stock, then in any such case, the number of Rights associated with each share of Common Stock then outstanding, or issued or delivered thereafter, shall be proportionately adjusted
so that the number of Rights thereafter associated with each share of Common Stock following any such event shall equal the result obtained by multiplying the number of Rights associated with each share of Common Stock immediately prior to such
event by a fraction the numerator of which shall be the total number of shares of Common Stock outstanding immediately prior to the occurrence of the event and the denominator of which shall be the total number of shares of Common Stock outstanding
immediately following the occurrence of such event. 
 (o) So long as any rights shall then be outstanding (other than Rights
that have become null and void pursuant to Section 11(a)(ii) hereof), the Company agrees that, after the earlier of the Distribution Date or the Stock Acquisition Date, it will not, except as permitted by Sections 23, 24 or
27 hereof, take (or permit any Subsidiary to take) any action if at the time such action is taken it is reasonably foreseeable that such action will diminish substantially or eliminate the benefits intended to be afforded by the Rights.

 Section 12. Certificate of Adjusted Purchase Price or Number of Shares. Whenever an adjustment is made as provided in
Section 11 or 13 hereof, the Company shall promptly (a) prepare a certificate setting forth such adjustment, and a brief statement of the facts accounting for such adjustment, (b) file with the Rights Agent and with each
transfer agent for 

  
 - 20 -

 
the Common Stock or the Junior Preferred Stock a copy of such certificate and (c) mail a brief summary thereof to each holder of a Right Certificate in accordance with Section 25
hereof (if so required under Section 25 hereof). The Rights Agent shall be fully protected in relying on any such certificate and on any adjustment therein contained and shall not be deemed to have knowledge of any such adjustment unless
and until it shall have received such certificate. 
 Section 13. Consolidation, Merger or Sale or Transfer of Assets or
Earnings Power. (a) In the event, directly or indirectly, at any time after any Person has become an Acquiring Person, (i) the Company shall merge with and into any other Person, (ii) any Person shall consolidate with the Company,
or any Person shall merge with and into the Company and the Company shall be the continuing or surviving corporation of such merger and, in connection with such merger, all or part of the Common Stock shall be changed into or exchanged for stock or
other securities of any other Person (or of the Company) or cash or any other property, or (iii) the Company shall sell or otherwise transfer (or one or more of its Subsidiaries shall sell or otherwise transfer), in one or more transactions,
assets or earning power aggregating to 50% or more of the assets or earning power of the Company and its Subsidiaries (taken as a whole) to any other Person (other than the Company or one or more of its wholly-owned Subsidiaries), then, and in each
such case, proper provision shall be made so that: 
 (A) each holder of record of a Right (other than Rights
which have become void pursuant to Section 11(a)(ii)) shall thereafter have the right to receive, upon the exercise thereof at a price equal to the then-current Purchase Price multiplied by the number of one one-thousandth of a share of
Junior Preferred Stock for which a Right was exercisable (whether or not such Right was then exercisable) immediately prior to the time that any Person first became an Acquiring Person (each as subsequently adjusted thereafter pursuant to
Section 11(a)(i), 11(b), 11(c), 11(e), 11(f), 11(h), 11(i) and 11(m)), in accordance with the terms of this Rights Agreement and in lieu of Junior Preferred Stock, such number of validly
issued, fully paid and non-assessable and freely tradeable shares of Common Stock of the Principal Party (as defined below) not subject to any liens, encumbrances, rights of first refusal or other adverse claims, as shall be equal to the result
obtained by (1) multiplying the then-current Purchase Price by the number of one one-thousandth of a share of Junior Preferred Stock for which a Right was exercisable immediately prior to the time that any Person first became an Acquiring
Person (as subsequently adjusted thereafter pursuant to Section 11(a)(i), 11(b), 11(c), 11(e), 11(f), 11(h), 11(i) and 11(m)) and (2) dividing that product by 50% of the then-current per
share market price of the Common Stock of such Principal Party (determined pursuant to Section 11(d)(i) hereof) on the date of consummation of such consolidation, merger, sale or transfer; provided that the Purchase Price and the
number of shares of Common Stock of such Principal Party issuable upon exercise of each Right shall be further adjusted as provided in Section 11(f) of this Rights Agreement to reflect any events occurring in respect of such Principal
Party after the date of such consolidation, merger, sale or transfer; 
 (B) such Principal Party shall
thereafter be liable for, and shall assume, by virtue of such consolidation, merger, sale or transfer, all the obligations and duties of the Company pursuant to this Rights Agreement; 

  
 - 21 -

 (C) the term “Company” as used herein shall thereafter be deemed
to refer to such Principal Party; and 
 (D) such Principal Party shall take such steps (including, but not
limited to, the reservation of a sufficient number of its shares of its Common Stock) in connection with such consummation of any such transaction as may be necessary to assure that the provisions hereof shall thereafter be applicable, as nearly as
reasonably may be, in relation to the shares of its Common Stock thereafter deliverable upon the exercise of the Rights; provided that, upon the subsequent occurrence of any consolidation, merger, sale or transfer of assets or other
extraordinary transaction in respect of such Principal Party, each holder of a Right shall thereupon be entitled to receive, upon exercise of a Right and payment of the Purchase Price as provided in this Section 13(a), such cash, shares,
rights, warrants and other property which such holder would have been entitled to receive had such holder, at the time of such transaction, owned the Common Stock of the Principal Party receivable upon the exercise of a Right pursuant to this
Section 13(a), and such Principal Party shall take such steps (including, but not limited to, reservation of shares of stock) as may be necessary to permit the subsequent exercise of the Rights in accordance with the terms hereof for
such cash, shares, rights, warrants and other property. 
 (b) “Principal Party” shall mean:

 (i) in the case of any transaction described in clauses (i) or (ii) of the first sentence of
Section 13(a) hereof: (A) the Person that is the issuer of the securities into which the shares of Common Stock are converted in such merger or consolidation, or, if there is more than one such issuer, the issuer of the shares of
Common Stock of which have the greatest aggregate market value of shares outstanding, or (B) if no securities are so issued, (x) the Person that is the other party to the merger, if such Person survives said merger, or, if there is more
than one such Person, the Person the shares of Common Stock of which have the greatest aggregate market value of shares outstanding or (y) if the Person that is the other party to the merger does not survive the merger, the Person that does
survive the merger (including the Company if it survives) or (z) the Person resulting from the consolidation; and 
 (ii) in the case of any transaction described in clause (iii) of the first sentence in Section 13(a) hereof, the Person that is the party receiving the greatest portion of the assets or
earning power transferred pursuant to such transaction or transactions, or, if each Person that is a party to such transaction or transactions receives the same portion of the assets or earning power so transferred or if the Person receiving the
greatest portion of the assets or earning power cannot be determined, whichever of such Persons is the issuer of Common Stock having the greatest aggregate market value of shares outstanding; 
 provided, however, that in any such case described in the foregoing clause (b)(i) or (b)(ii), if the Common Stock of such Person is not at such time or has not been continuously over the
preceding 12-month period registered under Section 12 of the Exchange Act, then (1) if such Person is a direct or indirect Subsidiary of another Person the Common Stock of which is and has been so registered, the term “Principal
Party” shall refer to such other Person, or (2) if such 

  
 - 22 -

 
Person is a Subsidiary, directly or indirectly, of more than one Person, and the Common Stock of all of such persons have been so registered, the term “Principal Party” shall refer to
whichever of such Persons is the issuer of Common Stock having the greatest aggregate market value of shares outstanding, or (3) if such Person is owned, directly or indirectly, by a joint venture formed by two or more Persons that are not
owned, directly or indirectly, by the same Person, the rules set forth in clauses (1) and (2) above shall apply to each of the owners having an interest in the venture as if the Person owned by the joint venture was a Subsidiary of both or
all of such joint venturers, and the Principal Party in each such case shall bear the obligations set forth in this Section 13 in the same ratio as its interest in such Person bears to the total of such interests. 

(c) The Company shall not consummate any consolidation, merger, sale or transfer referred to in Section 13(a) hereof unless
prior thereto the Company and the Principal Party involved therein shall have executed and delivered to the Rights Agent an agreement confirming that the requirements of Sections 13(a) and (b) hereof shall promptly be performed in
accordance with their terms and that such consolidation, merger, sale or transfer of assets shall not result in a default by the Principal Party under this Rights Agreement as the same shall have been assumed by the Principal Party pursuant to
Sections 13(a) and (b) hereof and providing that, as soon as practicable after executing such agreement pursuant to this Section 13, the Principal Party will: 

(i) prepare and file a registration statement under the Securities Act, if necessary, with respect to the Rights and the
securities purchasable upon exercise of the Rights on an appropriate form, use its best efforts to cause such registration statement to become effective as soon as practicable after such filing and use its best efforts to cause such registration
statement to remain effective (with a prospectus at all times meeting the requirements of the Securities Act) until the Expiration Date, and similarly comply with applicable state securities laws; 

(ii) use its best efforts, if the Common Stock of the Principal Party shall be listed or admitted to trading on the Nasdaq
Stock Market, LLC (“Nasdaq”) or on another national securities exchange, to list or admit to trading (or continue the listing of) the Rights and the securities purchasable upon exercise of the Rights on the Nasdaq or such securities
exchange, or, if the Common Stock of the Principal Party shall not be listed or admitted to trading on the Nasdaq or a national securities exchange, to cause the Rights and the securities receivable upon exercise of the Rights to be reported by such
other system then in use; 
 (iii) deliver to holders of the Rights historical financial statements for the
Principal Party which comply in all respects with the requirements for registration on Form 10 (or any successor form) under the Exchange Act; and 
 (iv) obtain waivers of any rights of first refusal or preemptive rights in respect of the Common Stock of the Principal Party subject to purchase upon exercise of outstanding Rights. 

(d) In case the Principal Party has a provision in any of its authorized securities or in its certificate of incorporation or by-laws or
other instrument governing its 

  
 - 23 -

 
affairs, which provision would have the effect of (i) causing such Principal Party to issue (other than to holders of Rights pursuant to this Section 13), in connection with, or
as a consequence of, the consummation of a transaction referred to in this Section 13, shares of Common Stock or Common Stock equivalents of such Principal Party at less than the then-current market price per share thereof (determined
pursuant to Section 11(d) hereof) or securities exercisable for, or convertible into, Common Stock or Common Stock equivalents of such Principal Party at less than such then-current market price, or (ii) providing for any special
payment, tax or similar provision in connection with the issuance of the Common Stock of such Principal Party pursuant to the provisions of Section 13, then, in such event, the Company hereby agrees with each holder of Rights that it
shall not consummate any such transaction unless prior thereto the Company and such Principal Party shall have executed and delivered to the Rights Agent a supplemental agreement providing that the provision in question of such Principal Party shall
have been canceled, waived or amended, or that the authorized securities shall be redeemed, so that the applicable provision will have no effect in connection with, or as a consequence of, the consummation of the proposed transaction. 

(e) The Company covenants and agrees that it shall not, at any time after a Person first becomes an Acquiring Person enter into any
transaction of the type contemplated by Sections 13(a)(i)-(iii) hereof if (x) at the time of or immediately after such consolidation, merger, sale, transfer or other transaction there are any rights, warrants or other
instruments or securities outstanding or agreements in effect which would substantially diminish or otherwise eliminate the benefits intended to be afforded by the Rights, (y) prior to, simultaneously with or immediately after such
consolidation, merger, sale, transfer or other transaction, the stockholders of the Person who constitutes, or would constitute, the Principal Party for purposes of Section 13(b) hereof shall have received a distribution of Rights
previously owned by such Person or any of its Affiliates or Associates or (z) the form or nature of organization of the Principal Party would preclude or limit the exercisability of the Rights. 

(f) The provisions of this Section 13 shall similarly apply to successive mergers or consolidations or sales or other transfers. In
the event that a consolidation, merger, sale or transfer shall occur at any time after the occurrence of an event under Section 11(a)(ii), the Rights that have not theretofore been exercised shall thereafter become exercisable in the manner
described in Section 13(a). 
 Section 14. Fractional Rights and Fractional Shares. (a) The Company shall not
be required to issue fractions of Rights (except prior to the Distribution Date in accordance with Section 11(n) hereof) or to distribute Right Certificates which evidence fractional Rights. In lieu of such fractional Rights, there shall
be paid to the registered holders of the Right Certificates with regard to which such fractional Rights would otherwise be issuable, an amount in cash equal to the same fraction of the current market value of a whole Right. For the purposes of this
Section 14(a), the current market value of a whole Right shall be the closing price of the Rights for the Trading Day immediately prior to the date on which such fractional Rights would have been otherwise issuable. The closing price for
any day shall be the last sale price, regular way, or, in case no such sale takes place on such day, the average of the closing bid and asked prices, regular way, in either case as reported (x) in the principal consolidated transaction
reporting system with respect to securities listed on the principal national securities exchange on which the Rights are listed or admitted to trading or, (y) if the Rights are not listed or admitted to

  
 - 24 -

 
trading on any national securities exchange, the last quoted price or, if not so quoted, the average of the high bid and low asked prices in the over-the-counter market, as reported by the OTCBB
or such other system then in use or, (z) if on any such date the Rights are not quoted by any such organization, the average of the closing bid and asked prices as furnished by a professional market maker making a market in the Rights selected
by the Board of Directors of the Company. If on any such date no such market maker is making a market in the Rights, the fair value of the Rights on such date as determined in good faith by the Board of Directors of the Company shall be used.

 (b) The Company shall not be required to issue fractions of shares of Junior Preferred Stock (other than fractions which are
integral multiples of one one-thousandth of a share of Junior Preferred Stock) upon exercise of the Rights or to distribute certificates which evidence fractional shares of Junior Preferred Stock (other than fractions which are integral multiples of
one one-thousandth of a share of Junior Preferred Stock). Interests in fractions of Junior Preferred Stock in integral multiples of one one-thousandth of a share of Junior Preferred Stock may, at the election of the Company, be evidenced by
depositary receipts, pursuant to an appropriate agreement between the Company and a depositary selected by it; provided, that such agreement shall provide that the holders of such depositary receipts shall have all the rights, privileges and
preferences to which they are entitled as beneficial owners of the Junior Preferred Stock represented by such depositary receipts. In lieu of fractional shares of Junior Preferred Stock that are not integral multiples of one one-thousandth of a
share of Junior Preferred Stock, the Company shall pay to the registered holders of Right Certificates at the time such Rights are exercised for shares of Junior Preferred Stock as herein provided an amount in cash equal to the same fraction of the
current market value of one share of Junior Preferred Stock. For the purposes of this Section 14(b), the current market value of a share of Junior Preferred Stock shall be the closing price of a share of Junior Preferred Stock (as
determined pursuant to Section 11(d)(i) hereof) for the Trading Day immediately prior to the date of such exercise. 

(c) The Company shall not be required to issue fractions of shares of Common Stock or to distribute certificates which evidence
fractional shares of Common Stock or make any entries in the Book Entry account system of the transfer agent that evidence such fractional shares of Common Stock upon the exercise or exchange of Rights. In lieu of such fractional shares of Common
Stock, the Company shall pay to the registered holders of the Right Certificates at the time such Rights are exercised or exchanged for shares of Common Stock as herein provided an amount in cash equal to the same fraction of the current market
value of a whole share of Common Stock (as determined in accordance with Section 11(d)(i) hereof) for the Trading Day immediately prior to the date of such exercise or exchange. 

(d) The holder of a Right by the acceptance of the Right expressly waives the right to receive any fractional Rights or any fractional
shares upon exercise or exchange of a Right (except as provided above). 
 Section 15. Rights of Action. All rights of
action in respect of this Rights Agreement, excepting the rights of action given to the Rights Agent under Section 18 hereof, are vested in the respective registered holders of the Right Certificates (and, prior to the Distribution Date,
the registered holders of the Common Stock); and any registered holder of any Right Certificate (or, prior to the Distribution Date, of the Common Stock), without the consent of the 

  
 - 25 -

 
Rights Agent or of the holder of any other Right Certificate (or, prior to the Distribution Date, of the Common Stock), on such holder’s own behalf and for such holder’s own benefit,
may enforce, and may institute and maintain any suit, action or proceeding against the Company to enforce, or otherwise act in respect of, such holder’s right to exercise the Rights evidenced by such Right Certificate (or, prior to the
Distribution Date, such Common Stock) in the manner provided in such Right Certificate and in this Rights Agreement. Without limiting the foregoing or any remedies available to the holders of Rights, it is specifically acknowledged that the holders
of Rights would not have an adequate remedy at law for any breach of this Rights Agreement and will be entitled to specific performance of the obligations under, and injunctive relief against actual or threatened violations of the obligations of any
Person subject to, this Rights Agreement. 
 Section 16. Agreement of Right Holders. Every holder of a Right, by
accepting the same, consents and agrees with the Company and the Rights Agent and with every other holder of a Right that: 
 (i) prior to the Distribution Date, the Rights will be evidenced by the balances indicated in the Book Entry account system of the transfer agent for the Common Stock registered in the names of the
holders of Common Stock (which Common Stock shall also be deemed to represent certificates for Rights) or, in the case of certificated shares, the certificates for the Common Stock registered in the names of the holders of the Common Stock which
certificates for shares of Common Stock shall also constitute certificates for Rights) and each Right will be transferable only in connection with the transfer of the Common Stock; 

(ii) after the Distribution Date, the Right Certificates are transferable only on the registry books of the Rights Agent
if surrendered at the office or agency of the Rights Agent designated for such purpose, duly endorsed or accompanied by a proper instrument of transfer; 
 (iii) the Company and the Rights Agent may deem and treat the Person in whose name the Right Certificate (or, prior to the Distribution Date, the associate balance indicated in the Book Entry account
system of the transfer agent for the Common Stock or, in the case of certificated shares, by the associated certificate) is registered as the absolute owner thereof and of the Rights evidenced thereby (notwithstanding any notations of ownership or
writing on the Right Certificates or the associated balance indicated in the Book Entry account system of the transfer agent for the Common Stock or, in the case of certificated shares, by the associated certificate made by anyone other than the
Company or the Rights Agent) for all purposes whatsoever, and neither the Company nor the Rights Agent, subject to Section 7(e) hereof, shall be affected by any notice to the contrary; and 

(iv) notwithstanding anything in this Rights Agreement to the contrary, neither the Company nor the Rights Agent shall
have any liability to any holder of a Right or any other Person as a result of its inability to perform any of its obligations under this Rights Agreement by reason of any preliminary or permanent injunction or other order, decree, judgment, or
ruling issued by a court of competent jurisdiction or by 

  
 - 26 -

 
a governmental, regulatory, or administrative agency or commission, or any statute, rule, regulation, or executive order promulgated or enacted by any governmental authority, prohibiting or
otherwise restraining performance of such obligation; provided, however, the Company must use its best efforts to have any such order, decree, judgment, or ruling lifted or otherwise overturned as promptly as practicable. 

Section 17. Right Certificate Holder Not Deemed a Stockholder. No holder, as such, of any Right Certificate shall be entitled to
vote, receive dividends or be deemed for any purpose the holder of the Junior Preferred Stock or any other securities of the Company which may at any time be issuable on the exercise or exchange of the Rights represented thereby, nor shall anything
contained herein or in any Right Certificate be construed to confer upon the holder of any Right Certificate, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted
to stockholders at any meeting thereof, or to give or withhold consent to any corporate action, or to receive notice of meetings or other actions affecting stockholders (except as provided in this Rights Agreement), or to receive dividends or
subscription rights, or otherwise, until the Rights evidenced by such Right Certificate shall have been exercised or exchanged in accordance with the provisions hereof. 
 Section 18. Concerning the Rights Agent. 
 (a) The Company agrees to pay to
the Rights Agent reasonable compensation for all services rendered by it hereunder and, from time to time, on demand of the Rights Agent, its reasonable expenses and counsel fees and other disbursements incurred in the administration and execution
of this Rights Agreement and the exercise and performance of its duties hereunder. The Company also agrees to indemnify the Rights Agent for, and to hold it harmless against, any loss, liability or expense, incurred without gross negligence, bad
faith or willful misconduct on the part of the Rights Agent, for anything done or omitted by the Rights Agent in connection with the acceptance and administration of this Rights Agreement, including the costs and expenses of defending against any
claim of liability arising therefrom, directly or indirectly. 
 (b) The Rights Agent shall be protected and shall incur no
liability for, or in respect of any action taken, suffered or omitted by it in connection with, its administration of this Rights Agreement in reliance upon any Right Certificate or certificate for the Junior Preferred Stock or Common Stock or any
balance indicated in the Book Entry account system of the transfer agent or for other capital stock securities of the Company, instrument of assignment or transfer, power of attorney, endorsement, affidavit, letter, notice, direction, consent,
certificate, statement, or other paper or document reasonably believed by it to be genuine and to be signed, executed and, where necessary, verified or acknowledged, by the proper Person or Persons, or otherwise upon the advice of counsel as set
forth in Section 20 hereof. 
 (c) The provisions of this Section 18 and Section 20 below shall survive
the termination of this Rights Agreement, the exercise or expiration of the Rights, and the resignation, replacement, or removal of the Rights Agent. 
 Section 19. Merger or Consolidation or Change of Name of Rights Agent. (a) Any corporation into which the Rights Agent or any successor Rights Agent may be merged or with which it may be
consolidated, or any corporation resulting from any merger or 

  
 - 27 -

 
consolidation to which the Rights Agent or any successor Rights Agent shall be a party, or any corporation succeeding to the stock transfer or corporate trust powers of the Rights Agent or any
successor Rights Agent, shall be the successor to the Rights Agent under this Rights Agreement without the execution or filing of any paper or any further act on the part of any of the parties hereto; provided, that such corporation would be
eligible for appointment as a successor Rights Agent under the provisions of Section 21 hereof. In case at the time such successor Rights Agent shall succeed to the agency created by this Rights Agreement, any of the Right Certificates
shall have been countersigned but not delivered, such successor Rights Agent may adopt the countersignature of the predecessor Rights Agent and deliver such Right Certificates so countersigned; and in case at that time any of the Right Certificates
shall not have been countersigned, any successor Rights Agent may countersign such Right Certificates either in the name of the predecessor Rights Agent or in the name of such successor Rights Agent; and in all such cases such Right Certificates
shall have the full force provided in the Right Certificates and in this Rights Agreement. 
 (b) In case at any time the name
of the Rights Agent shall be changed and at such time any of the Right Certificates shall have been countersigned but not delivered the Rights Agent may adopt the countersignature under its prior name and deliver Right Certificates so countersigned;
and in case at that time any of the Right Certificates shall not have been countersigned, the Rights Agent may countersign such Right Certificates either in its prior name or in its changed name and in all such cases such Right Certificates shall
have the full force provided in the Right Certificates and in this Rights Agreement. 
 Section 20. Duties of Rights
Agent. The Rights Agent undertakes the duties and obligations imposed by this Rights Agreement upon the following terms and conditions, by all of which the Company and the holders of Right Certificates, by their acceptance thereof, shall be
bound: 
 (a) The Rights Agent may consult with legal counsel (who may be legal counsel for the Company), and the opinion of
such counsel shall be full and complete authorization and protection to the Rights Agent as to any action taken or omitted by it in accordance with such opinion. 
 (b) Whenever in the performance of its duties under this Rights Agreement the Rights Agent shall deem it necessary or desirable that any fact or matter be proved or established by the Company prior to
taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by a certificate signed by any Authorized Officer and
delivered to the Rights Agent; and such certificate shall be full authorization to the Rights Agent for any action taken or suffered by it under the provisions of this Rights Agreement in reliance upon such certificate. 

(c) The Rights Agent shall be liable hereunder to the Company and any other Person only for its own gross negligence, bad faith or
willful misconduct. 
 (d) The Rights Agent shall not be liable for or by reason of any of the statements of fact or recitals
contained in this Rights Agreement or in the Right Certificates (except its countersignature thereof) or be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by the Company only. 

  
 - 28 -

 (e) The Rights Agent shall not be under any responsibility in respect of the validity of
this Rights Agreement or the execution and delivery hereof (except the due execution hereof by the Rights Agent) or in respect of the validity or execution of any Right Certificate (except its countersignature thereof); nor shall it be responsible
for any breach by the Company of any covenant or condition contained in this Rights Agreement or in any Right Certificate; nor shall it be responsible for any change in the exercisability of the Rights (including the Rights becoming void pursuant to
Section 11(a)(ii) hereof) or any adjustment in the terms of the Rights (including the manner, method or amount thereof) provided for in Sections 3, 11, 13, 23 and 24, or the ascertaining of the
existence of facts that would require any such change or adjustment (except with respect to the exercise of Rights evidenced by Right Certificates after receipt of a certificate furnished pursuant to Section 12, describing such change or
adjustment); nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any shares of Junior Preferred Stock or other securities to be issued pursuant to this Rights Agreement or any
Right Certificate or as to whether any shares of Junior Preferred Stock or other securities will, when issued, be validly authorized and issued, fully paid and nonassessable. 
 (f) The Company agrees that it will perform, execute, acknowledge and deliver or cause to be performed, executed, acknowledged and delivered all such further and other acts, instruments and assurances as
may reasonably be required by the Rights Agent for the carrying out or performing by the Rights Agent of the provisions of this Rights Agreement. 
 (g) The Rights Agent is hereby authorized and directed to accept instructions with respect to the performance of its duties hereunder from any person reasonably believed by the Rights Agent to be one of
the Authorized Officers, and to apply to such Authorized Officers for advice or instructions in connection with its duties, and it shall not be liable for any action taken or suffered by it in good faith in accordance with instructions of any such
Authorized Officer or for any delay in acting while waiting for those instructions. Any application by the Rights Agent for written instructions from the Company may, at the option of the Rights Agent, set forth in writing any action proposed to be
taken or omitted by the Rights Agent under this Rights Agreement and the date on and/or after which such action shall be taken or such omission shall be effective. The Rights Agent shall not be liable for any action taken by, or omission of, the
Rights Agent in accordance with a proposal included in any such application on or after the date specified in such application (which date shall not be less than five Business Days after the date any Authorized Officer of the Company actually
receives such application, unless any such Authorized Officer shall have consented in writing to an earlier date) unless, prior to taking any such action (or the effective date in the case of an omission), the Rights Agent shall have received
written instructions in response to such application specifying the action to be taken or omitted. 
 (h) The Rights Agent and
any stockholder, director, officer or employee of the Rights Agent may buy, sell or deal in any of the Rights or other securities of the Company or become pecuniarily interested in any transaction in which the Company may be interested, or contract
with or lend money to the Company or otherwise act as fully and freely as though it were not Rights Agent under this Rights Agreement. Nothing herein shall preclude the Rights Agent from acting in any other capacity for the Company or for any other
legal entity. 

  
 - 29 -

 (i) The Rights Agent may execute and exercise any of the rights or powers hereby vested in
it or perform any duty hereunder either itself or by or through its attorneys or agents, and the Rights Agent shall not be answerable or accountable for any act, default, neglect or misconduct of any such attorneys or agents or for any loss to the
Company resulting from any such act, default, neglect or misconduct, provided reasonable care was exercised in the selection and continued employment thereof. 
 (j) If, with respect to any Right Certificate surrendered to the Rights Agent for exercise or transfer, the certificate contained in the form of assignment or the form of election to purchase set forth on
the reverse thereof, as the case may be, has not been completed to certify the holder is not an Acquiring Person (or an Affiliate or Associate thereof) or a transferee thereof, the Rights Agent shall not take any further action with respect to such
requested exercise or transfer without first consulting with the Company. 
 (k) No provision of this Agreement shall require
the Rights Agent to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of its rights hereunder if the Rights Agent shall have reasonable grounds for believing
that repayment of such funds or adequate indemnification against such risk or liability is not reasonably assured to it. 

Section 21. Change of Rights Agent. The Rights Agent or any successor Rights Agent may resign and be discharged from its duties
under this Rights Agreement upon 30 days’ notice in writing mailed to the Company and to each transfer agent of the Common Stock or the Junior Preferred Stock by registered or certified mail, and, following the Distribution Date, to the holders
of the Right Certificates by first-class mail. The Company may remove the Rights Agent or any successor Rights Agent upon 30 days’ notice in writing, mailed to the Rights Agent or successor Rights Agent, as the case may be, and to each transfer
agent of the Common Stock or the Junior Preferred Stock by registered or certified mail, and, following the Distribution Date, to the holders of the Right Certificates by first-class mail. If the Rights Agent shall resign or be removed or shall
otherwise become incapable of acting, the Company shall appoint a successor to the Rights Agent. If the Company shall fail to make such appointment within a period of 30 days after giving notice of such removal or after it has been notified in
writing of such resignation or incapacity by the resigning or incapacitated Rights Agent or by the holder of a Right Certificate (who shall, with such notice, submit his Right Certificate for inspection by the Company), then the registered holder of
any Right Certificate may apply to any court of competent jurisdiction for the appointment of a new Rights Agent. Any successor Rights Agent, whether appointed by the Company or by such a court, shall be (A) a corporation organized and doing
business under the laws of the United States or any State thereof, which is authorized under such laws to exercise corporate trust or stock transfer powers and is subject to supervision or examination by federal or state authority and which has at
the time of its appointment as Rights Agent a combined capital and surplus of at least $100 million or (B) an affiliate of a corporation described in clause (A) of this sentence. After appointment, the successor Rights Agent shall be
vested with the same powers, rights, duties and responsibilities as if it had been originally named as Rights Agent without further act or deed; but the predecessor Rights Agent 

  
 - 30 -

 
shall deliver and transfer to the successor Rights Agent any property at the time held by it hereunder, and execute and deliver any further assurance, conveyance, act or deed necessary for the
purpose. Not later than the effective date of any such appointment the Company shall file notice thereof in writing with the predecessor Rights Agent and each transfer agent of the Common Stock or the Junior Preferred Stock, and, following the
Distribution Date, mail a notice thereof in writing to the registered holders of the Right Certificates. Failure to give any notice provided for in this Section 21, however, or any defect therein, shall not affect the legality or
validity of the resignation or removal of the Rights Agent or the appointment of the successor Rights Agent, as the case may be. 
 Section 22. Issuance of New Right Certificates. Notwithstanding any of the provisions of this Rights Agreement or of the Rights to the contrary, the Company may, at its option, issue new Right
Certificates evidencing Rights in such forms as may be approved by its Board of Directors to reflect any adjustment or change in the Purchase Price and the number or kind or class of shares or other securities or property purchasable under the Right
Certificates made in accordance with the provisions of this Rights Agreement. In addition, in connection with the issuance or sale of Common Stock following the Distribution Date and prior to the Expiration Date, the Company may with respect to
shares of Common Stock so issued or sold pursuant to (i) the exercise of stock options, (ii) under any employee plan or arrangement, (iii) the exercise, conversion or exchange of securities, notes or debentures issued by the Company
or (iv) a contractual obligation of the Company, in each case existing prior to the Distribution Date, issue Right Certificates representing the appropriate number of Rights in connection with such issuance or sale. 

Section 23. Redemption. 
 (a) The Board of Directors of the Company may, at any time prior to such time as any Person first becomes an Acquiring Person, redeem all but not less than all the then-outstanding Rights at a redemption
price of $0.0001 per Right, appropriately adjusted to reflect any stock split, stock dividend or similar transaction occurring after the date hereof (the “Redemption Price”). The redemption of the Rights may be made effective at
such time, on such basis and with such conditions as the Board of Directors in its sole discretion may establish. The Company may, at its option, pay the Redemption Price in cash, shares of Common Stock (based on the current market price of the
Common Stock at the time of the election by the Board of Directors to redeem the Rights as determined pursuant to Section 11(d)(i) hereof) or any other form of consideration deemed appropriate by the Board of Directors. 

(b) Immediately upon the action of the Board of Directors ordering the redemption of the Rights pursuant to paragraph (a) of this
Section 23 (or at such later time as the Board of Directors may establish for the effectiveness of such redemption), and without any further action and without any notice, the right to exercise the Rights will terminate and the only
right thereafter of the holders of Rights shall be to receive the Redemption Price. The Company shall promptly give (i) written notice to the Rights Agent of any such redemption, and (ii) public notice of any such redemption;
provided, however, that the failure to give, or any defect in, any such notice shall not affect the validity of such redemption. Within 10 days after such action of the Board of Directors ordering the redemption of the Rights (or such
later time as the Board of Directors may establish for the effectiveness of such redemption), the Company shall mail a 

  
 - 31 -

 
notice of redemption to all the holders of the then-outstanding Rights at their last addresses as they appear upon the registry books of the Rights Agent or, prior to the Distribution Date, on
the registry books of the transfer agent for the Common Stock. Any notice which is mailed in the manner herein provided shall be deemed given, whether or not the holder receives the notice. Each such notice of redemption shall state the method by
which the payment of the Redemption Price will be made. 
 Section 24. Exchange. (a) The Board of Directors of the
Company may, at its option, at any time after any Person first becomes an Acquiring Person, exchange all or part of the then-outstanding and exercisable Rights (which shall not include Rights that have become void pursuant to the provisions of
Section 11(a)(ii) hereof) for shares of Common Stock (or shares of Junior Preferred Stock) at an exchange ratio of one share of Common Stock (or one-thousandth of a share of Junior Preferred Stock) per Right, appropriately adjusted to
reflect any stock split, stock dividend or similar transaction occurring after the date hereof (such amount per Right being hereinafter referred to as the “Exchange Ratio”). Notwithstanding the foregoing, the Board of Directors
shall not be empowered to effect such exchange at any time after an Acquiring Person becomes the Beneficial Owner of shares of Common Stock aggregating 50% or more of the shares of Common Stock then outstanding. From and after the occurrence of an
event specified in Section 13(a) hereof, any Rights that theretofore have not been exchanged pursuant to this Section 24(a) shall thereafter be exercisable only in accordance with Section 13 and may not be
exchanged pursuant to this Section 24(a). The exchange of the Rights by the Board of Directors may be made effective at such time, on such basis and with such conditions as the Board of Directors in its sole discretion may establish.
Following the action of the Board of Directors ordering the exchange of any Rights pursuant to this Section 24, the Company may implement such procedures as it deems appropriate, in its sole discretion, for the purpose of ensuring that
the Common Stock (or such other consideration) issuable upon an exchange pursuant to this Section 24 is not received by holders of Rights that have become null and void pursuant to Section 11(a)(ii). Before effecting an
exchange pursuant to this Section 24, the Board of Directors may direct the Company to enter into a Trust Agreement in such form and with such terms as the Board of Directors shall then approve (the “Trust Agreement”).
If the Board of Directors so directs, the Company shall enter into the Trust Agreement and shall issue to the trust created by such agreement (the “Trust”) all or a portion (as designated by the Board of Directors) of the shares of
Common Stock (or shares of Junior Preferred Stock) issuable pursuant to the exchange, and all holders of Rights entitled to receive such shares pursuant to the exchange shall be entitled to receive such shares (and any dividends paid or
distributions made thereon after the date on which such shares are deposited in the Trust) only from the Trust and solely upon compliance with the relevant terms and provisions of the Trust Agreement and this Rights Agreement. Prior to effecting an
exchange and registering shares of Common Stock (or shares of Junior Preferred Stock) in any Person’s name, including any nominee or transferee of a Person, the Company may require (or cause the trustee of the Trust to require), as a condition
thereof, that any holder of Rights provide evidence, including, without limitation, the identity of the Beneficial Owners thereof (or former Beneficial Owners thereof) as the Company shall reasonably request in order to determine if such Rights are
null and void. If any Person shall fail to comply with such request, the Company shall be entitled conclusively to deem the Rights formerly held by such Person to be null and void pursuant to Section 11(a)(ii) and not transferable or
exercisable or exchangeable in connection herewith. Any shares of Common Stock or shares of Junior Preferred Stock issued at the direction of the Board in connection 

  
 - 32 -

 
herewith shall be validly issued, fully paid and nonassessable shares of Common Stock or shares of Junior Preferred Stock (as the case may be), and the Company shall be deemed to have received as
consideration for such issuance a benefit having a value that is at least equal to the aggregate par value of the shares so issued. 
 (b) Immediately upon the effectiveness of the action of the Board of Directors of the Company ordering the exchange of any Rights pursuant to paragraph (a) of this Section 24 and without
any further action and without any notice, the right to exercise such Rights shall terminate and the only right thereafter of a holder of such Rights shall be to receive that number of shares of Common Stock equal to the number of such Rights held
by such holder multiplied by the Exchange Ratio. The Company shall promptly give (i) written notice to the Rights Agent of any such exchange and (ii) public notice of any such exchange; provided, however, that the failure to give, or any
defect in, such notice shall not affect the validity of such exchange. The Company shall promptly mail a notice of any such exchange to all of the holders of the Rights so exchanged at their last addresses as they appear upon the registry books of
the Rights Agent. Any notice which is mailed in the manner herein provided shall be deemed given, whether or not the holder receives the notice. Each such notice of exchange will state the method by which the exchange of the shares of Common Stock
for Rights will be effected and, in the event of any partial exchange, the number of Rights which will be exchanged. Any partial exchange shall be effected pro rata based on the number of Rights (other than Rights which have become void pursuant to
the provisions of Section 11(a)(ii) hereof) held by each holder of Rights. 
 (c) The Company may at its option
substitute and, in the event that there shall not be sufficient shares of Common Stock issued but not outstanding or authorized but unissued (and unreserved) to permit an exchange of Rights as contemplated in accordance with this
Section 24, the Company shall substitute to the extent of such insufficiency, for each share of Common Stock that would otherwise be issuable upon exchange of a Right, a number of shares of Junior Preferred Stock or fraction thereof (or
equivalent preferred shares as such term is defined in Section 11(b)) such that the current per share market price (determined pursuant to Section 11(d) hereof) of one share of Junior Preferred Stock (or equivalent preferred
share) multiplied by such number or fraction is equal to the current per share market price of one share of Common Stock (determined pursuant to Section 11(d) hereof) as of the date of such exchange. 

Section 25. Notice of Certain Events. (a) In case the Company shall at any time after the earlier of the Distribution Date or
the Stock Acquisition Date propose (i) to pay any dividend payable in stock of any class to the holders of its Junior Preferred Stock or to make any other distribution to the holders of its Junior Preferred Stock (other than a regular quarterly
cash dividend), (ii) to offer to the holders of its Junior Preferred Stock rights or warrants to subscribe for or to purchase any additional shares of Junior Preferred Stock or shares of stock of any class or any other securities, rights or
options, (iii) to effect any reclassification of its Junior Preferred Stock (other than a reclassification involving only the subdivision or combination of outstanding Junior Preferred Stock), (iv) to effect the liquidation, dissolution or
winding up of the Company, or (v) to declare or pay any dividend on the shares of any class or series of Common Stock payable in the shares of any class or series of Common Stock or to effect a subdivision, combination or consolidation of the
shares of any class or series of Common Stock (by reclassification or otherwise than by payment of dividends in Common Stock), then, in each such case, the Company shall give to each holder of a Rights Certificate, to the extent feasible,

  
 - 33 -

 
and to the Rights Agent, in accordance with Section 26 hereof, a notice of such proposed action, which shall specify the record date for the purposes of such stock dividend, or
distribution or offering of rights or warrants, or the date on which such liquidation, dissolution, reclassification, subdivision, combination, consolidation or winding up is to take place and the date of participation therein by the holders of the
Common Stock and/or Junior Preferred Stock, if any such date is to be fixed, and such notice shall be so given in the case of any action covered by clause (i) or (ii) above at least 10 days prior to the record date for determining holders
of the Junior Preferred Stock for purposes of such action, and in the case of any such other action, at least 10 days prior to the date of the taking of such proposed action or the date of participation therein by the holders of the Common Stock
and/or Junior Preferred Stock, whichever shall be the earlier. 
 (b) In case any event described in
Section 11(a)(ii) or Section 13 shall occur then, in any such case, (i) the Company shall as soon as practicable thereafter give to each holder of a Right Certificate (or if occurring prior to the Distribution Date, the
holders of the Common Stock) in accordance with Section 26 hereof, to the extent feasible, and to the Rights Agent in accordance with Section 26 hereof, a written notice of the occurrence of such event, which notice shall describe
such event and the consequences of such event to holders of Rights under Section 11(a)(ii) and Section 13 hereof; and (ii) with respect to any event described in Section 11(a)(ii), all references in the
preceding Section 25(a) to Junior Preferred Stock shall be deemed to refer, if appropriate, to any other securities that may be acquired upon exercise of a Right. 
 Section 26. Notices. Notices or demands authorized by this Rights Agreement to be given or made by the Rights Agent or by the holder of any Right Certificate to or on the Company shall be
sufficiently given or made if sent by first-class mail, postage prepaid, addressed (until another address is filed in writing with the Rights Agent) as follows: 
 Titan Pharmaceuticals, Inc. 
 400 Oyster Pond Blvd., Suite 505 

South San Francisco, CA 94080 
 Attention: Sunil Bhonsle, President 
 Subject to the provisions of Section 21 hereof,
any notice or demand authorized by this Rights Agreement to be given or made by the Company or by the holder of any Right Certificate to or on the Rights Agent shall be sufficiently given or made if sent by first-class mail, postage prepaid,
addressed (until another address is filed in writing with the Company) as follows: 
 Continental Stock Transfer & Trust
Company 
 17 Battery Place, 8th Floor 
 New York, NY 10004 
 Attention: Compliance Department 

Notices or demands authorized by this Rights Agreement to be given or made by the Company or the Rights Agent to the holder of any Right Certificate
shall be sufficiently given or made if sent by first-class mail, postage prepaid, addressed to such holder at the address of such holder as shown on the registry books of the Company. 

  
 - 34 -

 Section 27. Supplements and Amendments. Except as otherwise provided in this
Section 27, the Company, by action of the Board of Directors, may from time to time and in its sole and absolute discretion, and the Rights Agent shall if the Company so directs, supplement or amend any provision of this Rights Agreement
in any respect without the approval of any holders of Rights, including, without limitation, in order to (a) cure any ambiguity, (b) correct or supplement any provision contained herein that may be defective or inconsistent with any other
provisions herein, (c) shorten or lengthen any time period hereunder, (d) otherwise change, amend, or supplement any provisions hereunder in any manner that the Company may deem necessary or desirable; provided, however, that
from and after such time as any Person becomes an Acquiring Person, this Rights Agreement shall not be supplemented or amended in any manner that would adversely affect the interests of the holders of Rights (other than Rights that have become null
and void pursuant to Section 11(a)(ii) hereof) as such or cause this Rights Agreement to become amendable other than in accordance with this Section 27. Without limiting the foregoing, the Company, by action of the Board of
Directors thereof, may at any time before any Person becomes an Acquiring Person amend this Rights Agreement to make the provisions of this Rights Agreement inapplicable to a particular transaction by which a Person might otherwise become an
Acquiring Person or to otherwise alter the terms and conditions of this Rights Agreement as they may apply with respect to any such transaction. Upon the delivery of a certificate from an appropriate officer of the Company that states that the
proposed supplement or amendment is in compliance with the terms of this Section 27, the Rights Agent shall execute such supplement or amendment. 
 Section 28. Successors. All the covenants and provisions of this Rights Agreement by or for the benefit of the Company or the Rights Agent shall bind and inure to the benefit of their respective
successors and assigns hereunder. 
 Section 29. Benefits of this Rights Agreement. Nothing in this Rights Agreement
shall be construed to give to any Person other than the Company, the Rights Agent and the registered holders of the Right Certificates (and, prior to the Distribution Date, the Common Stock) any legal or equitable right, remedy or claim under this
Rights Agreement; but this Rights Agreement shall be for the sole and exclusive benefit of the Company, the Rights Agent and the registered holders of the Right Certificates (and, prior to the Distribution Date, the Common Stock). 

Section 30. Determinations and Actions by the Board of Directors. The Board of Directors of the Company shall have the exclusive
power and authority to administer this Rights Agreement and to exercise the rights and powers specifically granted to the Board of Directors of the Company or to the Company, or as may be necessary or advisable in the administration of this Rights
Agreement, including, without limitation, the right and power to (i) interpret the provisions of this Rights Agreement and (ii) make all determinations deemed necessary or advisable for the administration of this Rights Agreement
(including, without limitation, a determination to redeem or not redeem the Rights or to amend this Rights Agreement). All such actions, calculations, interpretations and determinations that are done or made by the Board of Directors of the Company
in good faith, shall be final, conclusive and binding on the Company, the Rights Agent, the holders of the Rights, as such, and all other parties. 

  
 - 35 -

 Section 31. Severability. If any term, provision, covenant or restriction of this
Rights Agreement or applicable to this Rights Agreement is held by a court of competent jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Rights Agreement
shall remain in full force and effect and shall in no way be affected, impaired or invalidated. 
 Section 32. Governing
Law. This Rights Agreement and each Right Certificate issued hereunder shall be deemed to be a contract made under the laws of the State of Delaware and for all purposes shall be governed by and construed in accordance with the laws of such
State applicable to contracts to be made and performed entirely within such State. 
 Section 33. Counterparts. This
Rights Agreement may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. 

Section 34. Descriptive Headings. Descriptive headings of the several Sections of this Rights Agreement are inserted for
convenience only and shall not control or affect the meaning or construction of any of the provisions hereof. 

Section 35. USA PATRIOT Act. Each Person that is a party hereto acknowledges that the Rights Agent is subject to the customer
identification program (“Customer Identification Program”) requirements under the USA PATRIOT Act and its implementing regulations, and that the Rights Agent must obtain, verify and record information that allows the Rights Agent to
identify each such person or entity. Accordingly, prior to accepting an appointment hereunder, the Rights Agent may request information from any such person or entity that will help the Rights Agent to identify such person or entity, including,
without limitation, as applicable, such person or entity’s physical address, tax identification number, organizational documents, certificate of good standing, license to do business, or any other information that the Rights Agent deems
necessary. Each Person that is a party hereto acknowledges that the Rights Agent cannot accept an appointment hereunder unless and until the Rights Agent verifies each such person or entity’s identity in accordance with the Customer
Identification Program requirements. 

  
 - 36 -

 IN WITNESS WHEREOF, the parties hereto have caused this Rights Agreement to be duly executed
and attested, all as of the day and year first above written. 
  

											
		 		 		 	TITAN PHARMACEUTICALS, INC.
					
	Attest:	 	 /s/Fran Stoller
	 		 	By:	 	 /s/ Sunil Bhonsle

		 		 		 		 	Name:	 	Sunil Bhonsle
		 		 		 		 	Title:	 	President
				
		 		 		 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY
					
	Attest:	 	 /s/ Leslie A. Deluca
	 		 	By:	 	 /s/ John W. Comer, Jr.

		 	Leslie A. Deluca	 		 		 	Name:	 	John W. Comer, Jr.
		 	Vice President	 		 		 	Title:	 	Vice President

 EXHIBIT A 
 FORM 
 OF 
 CERTIFICATE OF DESIGNATIONS 
 OF 

JUNIOR PARTICIPATING PREFERRED STOCK 
 OF 
 TITAN PHARMACEUTICALS, INC. 

(Pursuant to Section 151 of the 
 General Corporation Law of the State of Delaware) 
  

 
 Titan
Pharmaceuticals, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Company”), hereby certifies that pursuant to the authority contained in Article Fourth of its Certificate
of Incorporation, as amended and in accordance with the provisions of Section 151 of the General Corporation Law of the State of Delaware, the following resolution was duly adopted by the Board of Directors of the Company at a meeting held on
December 19, 2011, which resolution remains in full force and effect on the date hereof: 
 RESOLVED, that pursuant to the
authority vested in the Board of Directors of the Company (hereinafter being referred to as the “Board of Directors” or the “Board”) in accordance with the provisions of the Company’s Certificate of
Incorporation (hereinafter being referred to as the “Certificate of Incorporation”), the Board of Directors hereby creates a series of preferred stock, par value $0.001 per share, of the Company, to be designated the “Junior
Participating Preferred Stock” and hereby adopts the resolution establishing the designations, number of shares, voting powers, preferences and relative, participating, optional and other rights, and the qualifications, restrictions and
limitations thereof, of the shares of such series as set forth below: 
 Section 1. Designation and
Amount. The shares of such series shall be designated as “Junior Participating Preferred Stock” (the “Junior Preferred Stock”) and the number of shares constituting the Junior Preferred Stock shall be 500,000 Such
number of shares may be increased or decreased by resolution of the Board of Directors; provided, that no decrease shall reduce the number of shares of Junior Preferred Stock to a number less than the number of shares then outstanding plus
the number of shares reserved for issuance upon the exercise of outstanding options, rights or warrants or upon the conversion of any outstanding securities issued by the Company convertible into Junior Preferred Stock. 

Section 2. Dividends and Distributions. 

(A) Subject to the rights of the holders of any shares of any series of preferred stock of the Company (the
“Preferred Stock”) ranking prior and superior 

  
 A-1

 
to the Junior Preferred Stock with respect to dividends, the holders of shares of Junior Preferred Stock, in preference to the holders of Common Stock, par value $0.001 per share, of the Company
(the “Common Stock”) and of any other stock of the Company ranking junior to the Junior Preferred Stock, shall be entitled to receive, when, as and if declared by the Board of Directors out of funds legally available therefor,
dividends (A) on each date that dividends or other distributions (other than dividends or distributions payable in Common Stock of the Company) are payable on or in respect of Common Stock comprising part of the Reference Package (as defined
below), in an amount per whole share of this Series equal to the aggregate amount of dividends or other distributions (other than dividends or distributions payable in Common Stock of the Company) that would be payable on such date to a holder of
the Reference Package, and (B) on the last day of March, June, September and December in each year, in an amount per whole share of this Series equal to the excess (if any) of a dollar amount equal to 0.025% of $1,000.00 over the aggregate
dividends paid per whole share of this Series during the three month period ending on such last day. The term “Reference Package” shall initially mean 1,000 shares of Common Stock, provided that in the event the Company shall at any
time after December 20, 2011 (the “Rights Agreement Date”) declare and pay any dividend on the Common Stock payable in shares of Common Stock, or effect a subdivision or combination or consolidation of the outstanding shares of
Common Stock (by reclassification or otherwise than by payment of a dividend in shares of Common Stock) into a greater or lesser number of shares of Common Stock, then and in each such case the Reference Package after such event shall be the Common
Stock that a holder of the Reference Package immediately prior to such event would hold thereafter as a result thereof. 
 (B) The Company shall declare a dividend or distribution on the Junior Preferred Stock as provided in paragraph (A) of this Section immediately after it declares a dividend or distribution on the
Common Stock (other than a dividend payable in shares of Common Stock); provided that, in the event no dividend or distribution shall have been declared on the Common Stock during the period between any Dividend Payment Date and the next
subsequent Dividend Payment Date, a dividend of the excess (if any) of a dollar amount equal to 0.025% of $1,000.00 over the aggregate dividends paid per whole share of this Series during the three month period ending on such subsequent Dividend
Payment Date per share on the Junior Preferred Stock shall nevertheless be payable, when, as and if declared, on such subsequent Dividend Payment Date. 
 (C) Dividends shall begin to accrue and be cumulative, whether or not earned or declared, on outstanding shares of Junior Preferred Stock from the Dividend Payment Date next preceding the date of issue of
such shares, unless the date of issue of such shares is prior to the record date for the first Dividend Payment Date, in which case dividends on such shares shall begin to accrue from the date of issue of such shares, or unless the date of issue is
a Dividend Payment Date or is a date after the record date for the determination of holders of shares of Junior Preferred Stock entitled to receive a quarterly dividend and before such 

  
 A-2

 
Dividend Payment Date, in either of which events such dividends shall begin to accrue and be cumulative from such Dividend Payment Date. Accrued but unpaid dividends shall not bear interest.
Dividends paid on the shares of Junior Preferred Stock in an amount less than the total amount of such dividends at the time accrued and payable on such shares shall be allocated pro rata on a share-by-share basis among all such shares at the time
outstanding. The Board of Directors may fix a record date for the determination of holders of shares of Junior Preferred Stock entitled to receive payment of a dividend or distribution declared thereon, which record date shall be not more than 60
days prior to the date fixed for the payment thereof. 
 Section 3. Voting Rights. The holders of shares
of Junior Preferred Stock shall have the following voting rights: 
 (A) Subject to the provision for adjustment
hereinafter set forth and except as otherwise provided in the Certificate of Incorporation or required by law, each share of Junior Preferred Stock shall entitle the holder thereof to 1,000 votes on all matters upon which the holders of the Common
Stock of the Company are entitled to vote. In the event the Company shall at any time after the Rights Agreement Date declare or pay any dividend on the Common Stock payable in shares of Common Stock, or effect a subdivision or combination or
consolidation of the outstanding shares of Common Stock (by reclassification or otherwise than by payment of a dividend in shares of Common Stock) into a greater or lesser number of shares of Common Stock, then in each such case the number of votes
per share to which holders of shares of Junior Preferred Stock were entitled immediately prior to such event shall be adjusted by multiplying such number by a fraction, the numerator of which is the number of shares of Common Stock outstanding
immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event. 
 (B) Except as otherwise provided herein, in the Certificate of Incorporation or in any other Certificate of Designations creating a series of Preferred Stock, and except as otherwise required by law, the
holders of shares of Junior Preferred Stock and the holders of shares of Common Stock and any other capital stock of the Company having general voting rights shall vote together as one class on all matters submitted to a vote of stockholders of the
Company. 
 (C) Except as set forth herein, or as otherwise provided by law, holders of Junior Preferred Stock
shall have no special voting rights and their consent shall not be required (except to the extent they are entitled to vote with holders of Common Stock as set forth herein) for taking any corporate action. 

(D) If, at the time of any annual meeting of stockholders for the election of directors, the equivalent of six quarterly
dividends (whether or not consecutive) payable on any share or shares of Junior Preferred Stock are in default, the number of directors constituting the Board of Directors of the 

  
 A-3

 
Company shall be increased by two. In addition to voting together with the holders of Common Stock for the election of other directors of the Company, the holders of record of the Junior
Preferred Stock, together with the holders of outstanding shares of any one or more other classes or series of capital stock of the Company upon which like voting rights have been conferred and are exercisable (voting together as a class) shall be
entitled at said meeting of stockholders (and at each subsequent annual meeting of stockholders), unless all dividends in arrears on the Junior Preferred Stock have been paid or declared and set apart for payment prior thereto, to vote for the
election of two directors of the Company, the holders of any Junior Preferred Stock being entitled to cast a number of votes per share of Junior Preferred Stock as is specified in paragraph (A) of this Section 3. Each such
additional director shall serve until the next annual meeting of stockholders for the election of directors, or until his successor shall be elected and shall qualify, or until his right to hold such office terminates pursuant to the provisions of
this Section 3(D). Until the default in payments of all dividends which permitted the election of said directors shall cease to exist, any director who shall have been so elected pursuant to the provisions of this
Section 3(D) may be removed at any time, without cause, only by the affirmative vote of a majority of the voting power of the holders of the shares of Junior Preferred Stock together with the holders of outstanding shares of any one or
more other classes or series of capital stock of the Company upon which like voting rights have been conferred and are exercisable (voting together as a class) at a special meeting of such holders called for that purpose, and any vacancy thereby
created may be filled by the vote of such holders. If and when such default shall cease to exist, the holders of the Junior Preferred Stock shall be divested of the foregoing special voting rights, subject to revesting in the event of each and every
subsequent like default in payments of dividends. Upon the termination of the foregoing special voting rights, the terms of office of all persons who may have been elected directors pursuant to said special voting rights shall forthwith terminate,
and the number of directors constituting the Board of Directors shall be reduced by two. The voting rights granted by this Section 3(D) shall be in addition to any other voting rights granted to the holders of the Junior Preferred Stock
in this Section 3. 
 Section 4. Certain Restrictions. 

(A) Whenever quarterly dividends or other dividends or distributions payable on the shares of Junior Preferred Stock as
provided in Section 2 are in arrears, thereafter and until all accrued and unpaid dividends and distributions, whether or not earned or declared, on shares of Junior Preferred Stock outstanding shall have been paid in full, the Company
shall not: 
 (i) declare or pay dividends, or make any other distributions, on any shares of stock ranking
junior (either as to dividends or upon liquidation, dissolution or winding up) to the Junior Preferred Stock; 

  
 A-4

 (ii) declare or pay dividends, or make any other distributions, on any
shares of stock ranking on a parity (either as to dividends or upon liquidation, dissolution or winding up) with the Junior Preferred Stock, except dividends paid ratably on the shares of Junior Preferred Stock and all such parity stock on which
dividends are payable or in arrears in proportion to the total amounts to which the holders of all such shares are then entitled; 
 (iii) redeem or purchase or otherwise acquire for consideration shares of any stock ranking junior (either as to dividends or upon liquidation, dissolution or winding up) to the Junior Preferred Stock,
provided that the Company may at any time redeem, purchase or otherwise acquire shares of any such junior stock in exchange for shares of any stock of the Company ranking junior (as to dividends and upon dissolution, liquidation or winding up) to
the Junior Preferred Stock or rights, warrants or options to acquire such junior stock; or 
 (iv) redeem or
purchase or otherwise acquire for consideration any shares of Junior Preferred Stock, or any shares of stock ranking on a parity (either as to dividends or upon liquidation, dissolution or winding up) with the Junior Preferred Stock, except in
accordance with a purchase offer made in writing or by publication (as determined by the Board of Directors) to all holders of such shares upon such terms as the Board of Directors, after consideration of the respective annual dividend rates and
other relative rights and preferences of the respective series and classes, shall determine in good faith will result in fair and equitable treatment among the respective series or classes. 

(B) The Company shall not permit any subsidiary of the Company to purchase or otherwise acquire for consideration any
shares of stock of the Company unless the Company could, under paragraph (A) of this Section 4, purchase or otherwise acquire such shares at such time and in such manner. 

Section 5. Reacquired Shares. Any shares of Junior Preferred Stock purchased or otherwise acquired by the Company
in any manner whatsoever shall be retired and cancelled promptly after the acquisition thereof. All such shares shall upon their retirement become authorized but unissued shares of Preferred Stock and may be reissued as part of a new series of
Preferred Stock to be created by resolution or resolutions of the Board of Directors, subject to any conditions and restrictions on issuance set forth herein. 
 Section 6. Liquidation, Dissolution or Winding Up. Upon any liquidation, dissolution or winding up of the Company, no distribution shall be made (A) to the holders of the Common Stock or
of shares of any other stock of the Company ranking junior, upon liquidation, dissolution or winding up, to the Junior Preferred Stock unless, prior thereto, the holders of shares of Junior Preferred Stock shall have received $1,000.00 per share,
plus an amount equal to accrued and unpaid dividends and 

  
 A-5

 
distributions thereon, whether or not earned or declared, to the date of such payment, provided that the holders of shares of Junior Preferred Stock shall be entitled to receive an aggregate
amount per share, subject to the provision for adjustment hereinafter set forth, equal to 1,000 times the aggregate amount to be distributed per share to holders of shares of Common Stock, or (B) to the holders of shares of stock ranking on a
parity upon liquidation, dissolution or winding up with the Junior Preferred Stock, except distributions made ratably on the Junior Preferred Stock and all such parity stock in proportion to the total amounts to which the holders of all such shares
are entitled upon such liquidation, dissolution or winding up. In the event, however, that there are not sufficient assets available to permit payment in full of the Junior Preferred Stock liquidation preference and the liquidation preferences of
all other classes and series of stock of the Company, if any, that rank on a parity with the Junior Preferred Stock in respect thereof, then the assets available for such distribution shall be distributed ratably to the holders of the Junior
Preferred Stock and the holders of such parity shares in the proportion to their respective liquidation preferences. In the event the Company shall at any time after the Rights Agreement Date declare or pay any dividend on the Common Stock payable
in shares of Common Stock together with the holders of outstanding shares of any one or more other classes or series of capital stock of the Company upon which like voting rights have been conferred and are exercisable (voting together as a class),
or effect a subdivision or combination or consolidation of the outstanding shares of Common Stock (by reclassification or otherwise than by payment of a dividend in shares of Common Stock) into a greater or lesser number of shares of Common Stock,
then in each such case the aggregate amount to which holders of shares of Junior Preferred Stock were entitled immediately prior to such event under the proviso in clause (A) of the preceding sentence shall be adjusted by multiplying such
amount by a fraction the numerator of which is the number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event.

 Neither the merger or consolidation of the Company into or with another entity nor the merger or consolidation of any other
entity into or with the Company (nor the sale of all or substantially all of the assets of the Company) shall be deemed to be a liquidation, dissolution or winding up of the Company within the meaning of this Section 6. 

Section 7. Consolidation, Merger, etc. In case the Company shall enter into any consolidation, merger,
combination or other transaction in which the shares of Common Stock are converted into, exchanged for or changed into other stock or securities, cash and/or any other property, then in any such case each share of Junior Preferred Stock shall at the
same time be similarly converted into, exchanged for or changed into an amount per share (subject to the provision for adjustment hereinafter set forth) equal to 1,000 times the aggregate amount of stock, securities, cash and/or any other property
(payable in kind), as the case may be, into which or for which each share of Common Stock is converted, exchanged or converted. In the event the Company shall at any time after the Rights Agreement Date declare or pay any dividend on the Common
Stock payable in shares of Common Stock, or effect a subdivision or combination or consolidation of the outstanding shares of Common Stock (by reclassification or otherwise than by payment of a dividend in shares of Common Stock) into a greater or

  
 A-6

 
lesser number of shares of Common Stock, then in each such case the amount set forth in the preceding sentence with respect to the conversion, exchange or change of shares of Junior Preferred
Stock shall be adjusted by multiplying such amount by a fraction, the numerator of which is the number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were
outstanding immediately prior to such event. 
 Section 8. No Redemption. The shares of Junior
Preferred Stock shall not be redeemable from any holder. 
 Section 9. Rank. The Junior Preferred
Stock shall rank, with respect to the payment of dividends and the distribution of assets upon liquidation, dissolution or winding up of the Company, junior to all other series of Preferred Stock and senior to the Common Stock. 

Section 10. Amendment. If any proposed amendment to the Certificate of Incorporation (including this
Certificate of Designations) would alter, change or repeal any of the preferences, powers or special rights given to the Junior Preferred Stock so as to affect the Junior Preferred Stock adversely, then the holders of shares of the Junior Preferred
Stock shall be entitled to vote separately as a class upon such amendment, and the affirmative vote of two-thirds of the outstanding shares of the Junior Preferred Stock, voting separately as a class, shall be necessary for the adoption thereof, in
addition to such other vote as may be required by the General Corporation Law of the State of Delaware. 

Section 11. Fractional Shares. Junior Preferred Stock may be issued in fractions of a share that shall entitle
the holder, in proportion to such holder’s fractional shares, to exercise voting rights, receive dividends, participate in distributions and to have the benefit of all other rights of holders of Junior Preferred Stock. 

  
 A-7

 IN WITNESS WHEREOF, this Certificate of Designations is executed on behalf of the Company
by Sunil Bhonsle, Chief Executive Officer of the Company on December 20, 2011. 
  

	
	  

	Name: Sunil Bhonsle
	Title: Chief Executive Officer

  
 A-8

 EXHIBIT B 
 FORM OF RIGHT CERTIFICATE 
  

			
	Certificate No. R-             	  	            Rights

 NOT EXERCISABLE AFTER THE EXPIRATION DATE (AS DEFINED IN THE RIGHTS AGREEMENT REFERRED TO BELOW). AT THE OPTION OF THE COMPANY, THE RIGHTS ARE SUBJECT TO REDEMPTION AT $0.0001 PER RIGHT AND TO EXCHANGE ON
THE TERMS SET FORTH IN THE RIGHTS AGREEMENT. UNDER CERTAIN CIRCUMSTANCES, AS SET FORTH IN THE RIGHTS AGREEMENT, RIGHTS OWNED BY OR TRANSFERRED TO ANY PERSON WHO IS OR BECOMES AN ACQUIRING PERSON (AS DEFINED IN THE RIGHTS AGREEMENT) AND CERTAIN
TRANSFEREES THEREOF WILL BECOME NULL AND VOID AND WILL NO LONGER BE TRANSFERABLE. 
 Right Certificate 

TITAN PHARMACEUTICALS, INC. 
 This certifies that             or registered assigns, is the registered owner of the number of Rights set forth above, each of which entitles
the owner thereof, subject to the terms, provisions and conditions of the Rights Agreement, dated as of December 20, 2011 as the same may be amended from time to time (the “Rights Agreement”), between Titan Pharmaceuticals,
Inc., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company (the “Rights Agent”), to purchase from the Company at any time after the Distribution Date (as such term is
defined in the Rights Agreement) and prior to 5:00 P.M., New York City time, on the Expiration Date at the office or agency of the Rights Agent designated for such purpose, or of its successor as Rights Agent, one one-thousandth of a fully paid
non-assessable share of Junior Participating Preferred Stock, par value $0.001 per share (the “Junior Preferred Stock”), of the Company, at a purchase price of $4.41 per one one-thousandth of a share of Junior Preferred Stock (the
“Purchase Price”), upon presentation and surrender of this Right Certificate with the Form of Election to Purchase duly executed. The number of Rights evidenced by this Right Certificate (and the number of one one-thousandth of a
share of Junior Preferred Stock which may be purchased upon exercise hereof) set forth above, and the Purchase Price set forth above, are the number and Purchase Price as of December 20, 2011, based on the Junior Preferred Stock as constituted
at such date. As provided in the Rights Agreement, the Purchase Price, the number of one one-thousandth of a share of Junior Preferred Stock (or other securities or property) which may be purchased upon the exercise of the Rights and the number of
Rights evidenced by this Right Certificate are subject to modification and adjustment upon the happening of certain events. 

Upon the occurrence of the events described in Section 11(a)(ii) and Section 13 of the Rights Agreement, if the Rights
evidenced by this Right Certificate are beneficially owned 

  
 B-1

 
by an Acquiring Person or an Affiliate or Associate of any such Acquiring Person or, under certain circumstances described in the Rights Agreement, a transferee of any such Acquiring Person,
Associate or Affiliate, such Rights shall become null and void and no holder hereof shall have any right with respect to such Rights from and after the occurrence of such events. 

In certain circumstances described in the Rights Agreement, the Rights evidenced hereby may entitle the registered holder thereof to
purchase capital stock of an entity other than the Company or receive common stock, cash or other assets of an entity other than the Company, all as provided in the Rights Agreement. 

This Right Certificate is subject to all of the terms, provisions and conditions of the Rights Agreement, which terms, provisions and
conditions are hereby incorporated herein by reference and made a part hereof and to which Rights Agreement reference is hereby made for a full description of the rights, limitations of rights, obligations, duties and immunities hereunder of the
Rights Agent, the Company and the holders of the Right Certificates. Copies of the Rights Agreement are on file at the principal executive offices of the Company. The Company will mail to the holder of this Right Certificate a copy of the Rights
Agreement without charge after receipt of a written request therefor. 
 This Right Certificate, with or without other Right
Certificates, upon surrender at the office or agency of the Rights Agent designated for such purpose, may be exchanged for another Right Certificate or Right Certificates of like tenor and date evidencing Rights entitling the holder to purchase a
like aggregate number of shares of Junior Preferred Stock as the Rights evidenced by the Right Certificate or Right Certificates surrendered shall have entitled such holder to purchase. If this Right Certificate shall be exercised in part, the
holder shall be entitled to receive upon surrender hereof another Right Certificate or Right Certificates for the number of whole Rights not exercised. 
 Subject to the provisions of the Rights Agreement, the Rights evidenced by this Certificate (i) may be redeemed by the Company at a redemption price of $0.0001 per Right or (ii) may be
exchanged, at the option of the Company, in whole or in part for shares of Junior Preferred Stock or shares of the Company’s Common Stock, par value $0.001 per share. 
 No fractional shares of Junior Preferred Stock or Common Stock will be issued upon the exercise or exchange of any Right or Rights evidenced hereby (other than fractions of Junior Preferred Stock which
are integral multiples of one one-thousandth of a share of Junior Preferred Stock, which may, at the election of the Company, be evidenced by depositary receipts), but in lieu thereof a cash payment will be made, as provided in the Rights Agreement.

 No holder of this Right Certificate, as such, shall be entitled to vote or receive dividends or be deemed for any purpose the
holder of the Junior Preferred Stock or of any other securities of the Company which may at any time be issuable on the exercise or exchange hereof, nor shall anything contained in the Rights Agreement or herein be construed to confer upon the
holder hereof, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action,
or to receive notice of meetings or other actions affecting stockholders (except as provided in the Rights Agreement) or to receive dividends or subscription rights, or otherwise, until the Right or Rights evidenced by this Right certificate shall
have been exercised or exchanged as provided in the Rights Agreement. 

  
 B-2

 This Right Certificate shall not be valid or obligatory for any purpose until it shall have
been countersigned by the Rights Agent. 
 WITNESS the facsimile signature of the proper officers of the Company and its
corporate seal. Dated as of                     , 2011. 
  

									
	ATTEST:	 		 	TITAN PHARMACEUTICALS, INC.
					
	By:	 	  
	 		 	By:	 	  

		
	Countersigned:	 	
		
	 CONTINENTAL STOCK TRANSFER & TRUST COMPANY,
 as Rights Agent
	 	
					
	By:	 	  
	 		 		 	
		 	Authorized Signatory	 		 		 	

  
 B-3

 Form of Reverse Side of Right Certificate 

FORM OF ASSIGNMENT 
 (To be executed by the registered holder if such 
 holder desires
to transfer the Right Certificate) 
 FOR VALUE RECEIVED
                    hereby sells, assigns and transfer unto
                     
  

					
		 	  
	 	
		 	(Please print name and address of transferee)	 	
		 	  
	 	

 Rights represented by this Right Certificate, together with all right, title and interest therein, and does hereby
irrevocably constitute and appoint             Attorney, to transfer said Rights on the books of the within-named Company, with full power of substitution. 

Dated:                     ,
         
  

	
	
	  
	Signature

 Signature Guaranteed: 
 Signatures must be guaranteed by a bank, trust company, broker, dealer or other eligible institution participating in a recognized signature guarantee medallion program. 

The undersigned hereby certifies that the Rights evidenced by this Right Certificate are not beneficially owned by, were not acquired by
the undersigned from, and are not being sold, assigned or transferred to, an Acquiring Person (as defined in the Rights Agreement). 
  

	
	
	  
	Signature

  
 B-4

 Form of Reverse Side of Right Certificate — continued 

FORM OF ELECTION TO PURCHASE 
 (To be executed if holder desires to exercise 
 Rights represented
by the Rights Certificate) 
 To the Rights Agent: 
 The undersigned hereby irrevocably elects to exercise                     Rights represented by this
Right Certificate to purchase the shares of Junior Preferred Stock (or other securities or property) issuable upon the exercise of such Rights and requests that certificates for such shares of Junior Preferred Stock (or such other securities) be
issued in the name of: 
  

			
	  
	 	
	(Please print name and address)	 	
	  
	 	

 If such number of Rights shall not be all the Rights evidenced by this Right Certificate, a new Right Certificate for the
balance remaining of such Rights shall be registered in the name of and delivered to: 
  

			
	Please insert social security	 	
	or other identifying number:	 	  

	
	  

	(Please print name and address)
	  

 Dated:                 ,
         
  

	
	  
	Signature
	(Signature must conform to holder specified on Right Certificate)

 Signature Guaranteed: 
 Signatures must be guaranteed by a bank, trust company, broker, dealer or other eligible institution participating in a recognized signature guarantee medallion program. 

The undersigned hereby certifies that the Rights evidenced by this Right Certificate are not beneficially owned by, were not acquired by
the undersigned from, and are not being sold, assigned or transferred to, an Acquiring Person thereof (as defined in the Rights Agreement). 
  

	
	  
	Signature

  
 B-5

 Form of Reverse Side of Right Certificate — continued 

NOTICE 

The signature in the Form of Assignment or Form of Election to Purchase, as the case may be, must conform to the name as written upon the
face of this Right Certificate in every particular, without alteration or enlargement or any change whatsoever. 
 In the event
the certification set forth above in the Form of Assignment or the Form of Election to Purchase, as the case may be, is not completed, such Assignment or Election to Purchase will not be honored. 

 
  

  
 B-6

 EXHIBIT C 
 UNDER CERTAIN CIRCUMSTANCES, AS SET FORTH IN THE RIGHTS AGREEMENT, RIGHTS OWNED BY OR TRANSFERRED TO ANY PERSON WHO IS OR BECOMES AN ACQUIRING PERSON (AS DEFINED IN THE RIGHTS AGREEMENT) AND CERTAIN
TRANSFEREES THEREOF WILL BECOME NULL AND VOID AND WILL NO LONGER BE TRANSFERABLE. 
 SUMMARY OF RIGHTS TO PURCHASE 

Shares of Junior Participating Preferred Stock 
 On December 20, 2011 the Board of Directors of Titan Pharmaceuticals, Inc., a Delaware corporation (the “Company”), declared a dividend of one preferred share purchase right (a
“Right”) for each outstanding share of Common Stock, par value $0.001 per share, of the Company (the “Common Stock”). The dividend is payable to the stockholders of record as of the close of business on
January 3, 2012 (the “Record Date”). Each Right entitles the registered holder to purchase from the Company one one-thousandth of a share of Junior Participating Preferred Stock, par value $0.001 per share (the “Junior
Preferred Stock”), of the Company at a price of $4.41 per one one-thousandth of a share of Junior Preferred Stock (as the same may be adjusted, the “Purchase Price”). The description and terms of the Rights are set forth in
a Rights Agreement, dated as of December 20, 2011 (as the same may be amended from time to time, the “Rights Agreement”), between the Company and Continental Stock Transfer & Trust Company, as Rights Agent (the
“Rights Agent”). 
 Until the close of business on the earlier of (i) the tenth business day after the
first date of a public announcement that a person (other than an Exempted Entity (as defined below)) individually or together with such persons affiliates or associates (collectively, an “Acquiring Person”) has acquired beneficial
ownership of 15% or more of the shares of Common Stock then outstanding or (ii) the tenth business day (or such later date as may be determined by action of a majority of the Board of Directors prior to such time as any person becomes an
Acquiring Person) after the date of commencement of, or the first public announcement of an intention to commence, a tender offer or exchange offer the consummation of which would result in any person becoming an Acquiring person (the earlier of
such dates being herein referred to as the “Distribution Date”), the Rights will be evidenced by the balances indicated in the book entry account system of the transfer agent for Common Stock registered in the names of the holders
thereof or in the case of certificated shares, by certificates for Common Stock outstanding as of the Record Date. 

“Exempted Entity” shall mean (1) the Company, (2) any subsidiary of the Company (in the case of subclauses
(1) and (2) including, without limitation, in its fiduciary capacity), (3) any employee benefit plan of the Company or of any subsidiary of the Company, (4) any entity or trustee holding Common Stock for or pursuant to the terms
of any such plan or for the purpose of funding any such plan or funding other employee benefits for employees of the Company or of any subsidiary of the Company. 
 The Rights Agreement provides that, until the Distribution Date (or earlier redemption or expiration of the Rights), the Rights will be transferable only in connection with the transfer of Common Stock.
Until the Distribution Date (or earlier redemption or expiration 

  
 C-1

 
of the Rights), the transfer of shares of Common Stock outstanding as of the Record Date, even without a notation incorporating the Rights Agreement by reference or a copy of this Summary of
Rights, will also constitute the transfer of the Rights associated with the shares of Common Stock so transferred. As soon as practicable following the Distribution Date, separate certificates evidencing the Rights (“Right
Certificates”) will be mailed to holders of record of the Common Stock as of the close of business on the Distribution Date and such separate Right Certificates alone will evidence the Rights. 

The Rights are not exercisable until the Distribution Date. The Rights will expire following the one year anniversary of the date of the
Rights Agreement. 
 The Purchase Price payable, and the number of shares of Junior Preferred Stock or other securities or
property purchasable, upon exercise of each Right and the number of Rights outstanding are subject to adjustment from time to time to prevent dilution (i) in the event of a stock dividend on, or a subdivision, combination or reclassification
of, the Junior Preferred Stock, (ii) upon the grant to holders of the Junior Preferred Stock of certain rights or warrants to subscribe for or purchase Junior Preferred Stock at a price, or securities convertible into Junior Preferred Stock
with a conversion price, less than the then-current market price of the Junior Preferred Stock or (iii) upon the distribution to holders of the Junior Preferred Stock of evidences of indebtedness or assets (excluding regular quarterly cash
dividends or dividends payable in Junior Preferred Stock) or of subscription rights or warrants (other than those referred to above). 
 Shares of Junior Preferred Stock purchasable upon exercise of the Rights will not be redeemable. Each share of Junior Preferred Stock will be entitled, when, as and if declared, to a minimum preferential
quarterly dividend payment of (A) 1,000 times the amount of dividends payable in respect of one share of Common Stock during such period, and (B) on the last day of March, June, September and December in each year, in an amount per whole
share equal to the excess (if any) of 0.25% of $1,000.00 over the aggregate dividends paid pursuant to the foregoing clause (A). In the event of liquidation, dissolution or winding up of the Company, the holders of the Junior Preferred Stock will be
entitled to a minimum preferential liquidation payment of $1,000.00 per share (plus any accrued but unpaid dividends) but will be entitled to an aggregate of 1,000 times the payment made per share to holders of shares of Common Stock. Each share of
Junior Preferred Stock will have 1,000 votes, voting together with the Common Stock. Finally, in the event of any merger, consolidation or other transaction in which shares of Common Stock are converted or exchanged, each share of Junior Preferred
Stock will be entitled to receive 1,000 times the amount received per share of Common Stock. These rights are protected by customary anti-dilution provisions. 
 Because of the nature of the Junior Preferred Stock’s dividend, liquidation and voting rights, the value of the one one-thousandth interest in a share of Junior Preferred Stock purchasable upon
exercise of each Right should approximate the value of one share of Common Stock. 
 In the event that any person becomes an
Acquiring Person, each holder of a Right, other than Rights beneficially owned by the Acquiring Person (which will thereupon become void), will thereafter have the right to receive upon exercise of a Right and payment of the Purchase Price, that
number of shares of Common Stock (or at the option of the Company, such number of one one-thousandths of a share of Junior Preferred Stock) having a market value of two times the Purchase Price. 

  
 C-2

 In the event that, after a person has become an Acquiring Person, the Company is acquired
in a merger or other business combination transaction or 50% or more of its consolidated assets or earning power are sold, proper provision will be made so that each holder of a Right (other than Rights beneficially owned by an Acquiring Person
which will have become void) will thereafter have the right to receive, upon the exercise thereof at the then-current exercise price of the Right, that number of shares of common stock of the person with whom the Company has engaged in the foregoing
transaction (or its parent), which number of shares at the time of such transaction will have a market value of two times the Purchase Price. 
 At any time after any person becomes an Acquiring Person and prior to the acquisition by such person of 50% or more of the outstanding shares of Common Stock or the occurrence of an event described in the
prior paragraph, the Board of Directors of the Company may exchange the Rights (other than Rights owned by an Acquiring Person which will have become void), in whole or in part, at an exchange ratio of one share of Common Stock, or a one
one-thousandth of a share of Junior Preferred Stock (or of a share of a similar class or series of the Company’s preferred stock having similar rights, preferences and privileges) of equivalent value, per Right (subject to adjustment).

 With certain exceptions, no adjustment in the Purchase Price will be required until cumulative adjustments require an
adjustment of at least 1% in such Purchase Price. No fractional shares of Junior Preferred Stock will be issued (other than fractions which are integral multiples of one one-thousandth of a share of Junior Preferred Stock, which may, at the election
of the Company, be evidenced by depositary receipts) and in lieu thereof, an adjustment in cash will be made based on the market price of the Junior Preferred Stock on the last trading day prior to the date of exercise or exchange. 

At any time prior to the time an Acquiring Person becomes such, the Board of Directors of the Company may redeem the Rights in whole, but
not in part, at a price of $0.0001 per Right (the “Redemption Price”). The redemption of the Rights may be made effective at such time, on such basis and with such conditions as the Board of Directors in its sole discretion may
establish. Immediately upon any redemption of the Rights, the right to exercise the Rights will terminate and the only right of the holders of Rights will be to receive the Redemption Price. 

For so long as the Rights are then redeemable, the Company may amend the Rights Agreement in any manner. After the Rights are no longer
redeemable, the Company may amend the Rights Agreement in any manner that does not adversely affect the interests of holders of the Rights (other than those holders who become Acquiring Persons and whose rights become void). 

Until a Right is exercised or exchanged, the holder thereof, as such, will have no rights as a stockholder of the Company, including,
without limitation, the right to vote or to receive dividends. 

  
 C-3

 A copy of the Rights Agreement has been filed with the Securities and Exchange Commission
as an Exhibit to a Registration Statement on Form 8-A dated December 21, 2011. A copy of the Rights Agreement is available free of charge from the Company. This summary description of the Rights does not purport to be complete and is qualified
in its entirety by reference to the Rights Agreement, as the same may be amended from time to time, which is hereby incorporated herein by reference. 

  
 C-4Exhibit 10.1

 Exhibit 10.1 
 CONFIDENTIAL 
 SUBJECT TO FED. R. EVID.
408 
 PATENT PURCHASE, LICENSE AND SETTLEMENT AGREEMENT 

THIS PATENT PURCHASE, LICENSE AND SETTLEMENT AGREEMENT (“Agreement”), is entered into and effective on this 20th day of
December, 2011 (“Effective Date”), by and among The Nielsen Company (US) LLC, a Delaware limited liability company having a business address at 770 Broadway, New York, NY 10003 (“Nielsen US”), and NetRatings LLC, a
Delaware limited liability company having a business address at 770 Broadway, New York, NY 10003 (“NetRatings”, collectively with Nielsen US, “Nielsen”), on the one hand, and comScore, Inc., a Delaware corporation
having a business address at 11950 Democracy Drive, Suite 600, Reston, VA 20190 (“comScore”), on the other hand. Nielsen US, NetRatings and comScore may be referred to herein individually as “Party” and collectively
as the “Parties.” 
 RECITALS 
 A. Nielsen US commenced a civil action against comScore in the United States District Court for the Eastern District of Virginia, Norfolk Division, bearing docket number 2:11-cv-00168-MSD/TRJ (the
“Norfolk Action”), in which Nielsen US asserted infringement of United States Patent Nos. 6,115,680; 6,418,470; 7,376,722; 7,386,473; and 7,613,635; 
 B. comScore denies the claims asserted by Nielsen US in the Norfolk Action; 
 C.
comScore asserted counterclaims of infringement of United States Patent Nos. 7,849,154 and 7,685,275 in the Norfolk Action; 

D. Nielsen US denies the counterclaims asserted by comScore in the Norfolk Action; 

E. comScore commenced a civil action against Nielsen in the United States District Court for the Eastern District of Virginia, Alexandria
Division, bearing docket number 1:11-cv-00290-LMB-TRJ (the “Alexandria Action”), in which comScore asserted infringement of United States Patent Nos. 7,260,837 and 7,930,285; 

F. Nielsen denies the claims asserted by comScore in the Alexandria Action; 

G. Nielsen US and comScore are concurrently entering into that certain Purchase Agreement, by and between the Nielsen US and comScore of
even date herewith (the “Stock Purchase Agreement”), and that certain Voting Agreement, by and between Nielsen US and comScore of even date herewith (the “Voting Agreement”), pursuant to which (i) comScore
shall issue and sell to Nielsen US, and Nielsen US shall purchase from comScore, certain shares of Common Stock of comScore, and (ii) the parties thereto will agree to certain terms relating to the voting of such shares; and 

H. The Parties desire to settle and compromise disputes, controversies, claims and actions between and among them as set forth in this
Agreement without the need for further or future litigation, and to enter into the transactions contemplated by this Agreement, the Stock Purchase Agreement and the Voting Agreement on the terms and conditions provided in this Agreement and in the
Stock Purchase Agreement and Voting Agreement. 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 NOW, THEREFORE, in consideration of the foregoing Recitals and the promises and
covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows: 
 ARTICLE I 
 DEFINITIONS 

1.1 Defined Terms. Capitalized terms used in this Agreement shall have the meaning set forth in the Recitals or elsewhere in this
Agreement or as set forth below in this Section 1.1: 
 (a) “Acquired Patents” means: 

i. United States Patent Nos. 6,115,680; 6,418,470; 7,376,722; 7,386,473; and 7,613,635 and the patent applications from which the
foregoing patents issued or claim priority to; 
 ii. any and all patents that have issued or may issue from any of the patents
and patent applications described in (i); 
 iii. any and all patents (including all utility models, industrial designs,
inventors certificates, petty patents, patents of importation, patents of addition, and other indicia of ownership of an invention or discovery issued by any governmental authority anywhere in the world) and patent applications anywhere in the world
that, in whole or in part, claim priority to the benefit of the filing date of, or are entitled to claim the benefit of any of the patents or patent applications described in (i) or (ii), including any and all child, continuation,
continuation-in-part, continuing prosecution, divisional, provisional, non-provisional, reissue, reexamination, substitution, extension and counterpart patents and patent applications of any of the patents or patent applications described in
(i) or (ii); 
 iv. any and all patents (including all utility models, industrial designs, inventors certificates, petty
patents, patents of importation, patents of addition, and other indicia of ownership of an invention or discovery issued by any governmental authority anywhere in the world) and patent applications, anywhere in the world, from which any of the
patents or patent applications described in (i), (ii), or (iii), in whole or in part, claim the benefit of priority or otherwise or are entitled to claim the benefit of the filing date, either directly or through multiple tiers, including any and
all direct and indirect parent patents or patent applications of any of the patents or patent applications described in (i), (ii), or (iii); and 
 v. any and all extensions, reexaminations, patents resulting from post-grant proceedings anywhere in the world, including but not limited to oppositions, inter partes review and post-grant review,
reissues, or renewals of any of the patents or patent applications described in (i) through (iv) inclusive. 
 The Acquired Patents
include, but are not necessarily limited to, those listed on Exhibit A to this Agreement. 
 (b)
“Affiliate” means with respect to a Party, any other Person that controls, is controlled by or is under common control with such Party. For purposes of this definition, 

  
 2 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 
“control” (including, with correlative meaning, the terms “controlled by” or “under the common control with”) shall mean the actual power, either directly or
indirectly through one or more intermediaries, to direct or cause the direction of the management and policies of such a Party or Person, and control shall be presumed to exist by the ownership or control by contract of fifty percent (50%) or
more of the voting securities of such entity or of the corporate governance body of such Party or Person. 
 (c)
“Alexandria Action” has the meaning set forth in the Recitals. 
 (d) “Claims” means all
claims, counterclaims, demands, causes of action, damages, liabilities, losses, expenses or obligations of any kind and of whatever nature or character, whether in law or equity, or whether accrued, actual, contingent, latent or otherwise, made or
brought for the purpose of recovering any damages or for the purpose of obtaining any equitable relief or any other relief of any kind. 
 (e) “comScore Claims” has the meaning set forth in Section 4.1. 
 (f) “Covenant Period” has the meaning set forth in Section 4.3. 
 (g) “Covenanting Party” has the meaning set forth in Section 4.3. 
 (h) “Divested Asset” has the meaning set forth in Section 5.6. 
 (i) “Licensed Patents” means: 
 i. United States Patent Nos.
7,260,837; 7,685,275; 7,849,154; and 7,930,285 and the patent applications from which the foregoing patents issued or claim priority to; 
 ii. any and all patents that have issued or may issue from any of the patents and patent applications described in (i); 
 iii. any and all patents (including all utility models, industrial designs, inventors certificates, petty patents, patents of importation, patents of addition, and other indicia of ownership of an
invention or discovery issued by any governmental authority anywhere in the world) and patent applications anywhere in the world that, in whole or in part, claim priority to, the benefit of the filing date of, or are entitled to claim the benefit of
any of the patents or patent applications described in (i) or (ii), including any and all child, continuation, continuation-in-part, continuing prosecution, divisional, provisional, non-provisional, reissue, reexamination, substitution,
extension and counterpart patents and patent applications of any of the patents or patent applications described in (i) or (ii); 
 iv. any and all patents (including all utility models, industrial designs, inventors certificates, petty patents, patents of importation, patents of addition, and other indicia of ownership of an
invention or discovery issued by any governmental authority anywhere in the world) and patent applications, anywhere in the world, from which any of the patents or patent applications described in (i), (ii), or (iii), in whole or in part, claim the
benefit of priority or otherwise or are entitled to claim the benefit of the filing date, either directly or through multiple tiers, including any and all direct and indirect parent patents or patent applications of any of the patents or patent
applications described in (i), (ii), or (iii); and 

  
 3 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 v. any and all extensions, reexaminations, patents resulting from post-grant
proceedings anywhere in the world, including but not limited to oppositions, inter partes review and post-grant review, reissues, or renewals of any of the patents or patent applications described in (i) through (iv) inclusive. 

The Licensed Patents include, but are not necessarily limited to, those listed on Exhibit B to this Agreement. 

(j) “Nielsen Claims” has the meaning set forth in Section 4.2. 

(k) “Nielsen Licensed Product” means any product (hardware and/or software), service, device, system, process, method,
article of manufacture, apparatus or combination of one or more of the foregoing, the manufacture, use, sale, offer for sale or import of which would, but for the rights granted under this Agreement to Nielsen and its Affiliates, directly infringe
or constitute contributory infringement or active inducement of infringement of any claim(s) of an Acquired Patent or a Licensed Patent. 
 (1) “Norfolk Action” has the meaning set forth in the Recitals. 

(m) “Person” means a trust, corporation, partnership, joint venture, limited liability company or other legal entity.

 (n) “Preexisting Licenses” has the meaning set forth in Section 5.7. 

(o) “Red Sheriff Patents” means: 
 i. United States Patent Nos. 5,796,952; 6,138,155; 6,643,696; 6,763,386; and 7,406,516 and the patent applications from which the foregoing patents issued or claim priority to; 

ii. any and all patents that have issued or may issue from any of the patents and patent applications described in (i); 

iii. any and all patents (including all utility models, industrial designs, inventors certificates, petty patents, patents of
importation, patents of addition, and other indicia of ownership of an invention or discovery issued by any governmental authority anywhere in the world) and patent applications anywhere in the world that, in whole or in part, claim priority to, the
benefit of the filing date of, or are entitled to claim the benefit of any of the patents or patent applications described in (i) or (ii), including any and all child, continuation, continuation-in-part, continuing prosecution, divisional,
provisional, non-provisional, reissue, reexamination, substitution, extension and counterpart patents and patent applications of any of the patents or patent applications described in (i) or (ii); 

iv. any and all patents (including all utility models, industrial designs, inventors certificates, petty patents, patents of
importation, patents of addition, and other indicia 

  
 4 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 
of ownership of an invention or discovery issued by any governmental authority anywhere in the world) and patent applications, anywhere in the world, from which any of the patents or patent
applications described in (i), (ii), or (iii), in whole or in part, claim the benefit of priority or otherwise or are entitled to claim the benefit of the filing date, either directly or through multiple tiers, including any and all direct and
indirect parent patents or patent applications of any of the patents or patent applications described in (i), (ii), or (iii); and 
 v. any and all extensions, reexaminations, patents resulting from post-grant proceedings anywhere in the world, including but not limited to oppositions, inter partes review and post-grant review,
reissues, or renewals of any of the patents or patent applications described in (i) through (iv) inclusive. 
 (p)
“Running Royalty” has the meaning set forth in Section 5.7. 
 (q) “Third Party” shall
mean any Person who or which is neither a Party nor an Affiliate of a Party. 
 (r) “Transfer” means any
assignment, conveyance, sale, transfer, exchange, assignment, gift, lien, encumbrance or other disposition. 
 (s)
“Transition Period” has the meaning set forth in Section 5.4. 
 ARTICLE II 

DISMISSAL OF ACTIONS 
 2.1 Dismissal of Pending Litigation and Related Obligations. 
 (a) On the
Effective Date, each Party shall execute and deliver to the other Parties this Agreement. 
 (b) On the Effective Date, each
Party shall execute, or cause their respective counsel to execute, and deliver to the other Parties the Stipulations in the forms attached as Exhibit C and Exhibit D. 

(c) On the Effective Date, each of Nielsen US and comScore shall execute and deliver to the other the Stock Purchase Agreement in the
form attached as Exhibit E, the Voting Agreement in the form attached as Exhibit F and the Patent Assignment in the form attached as Exhibit G. 
 (d) Within three (3) business days after the Effective Date, comScore shall cause its counsel to file the Stipulation of Dismissal for the Alexandria Action (Exhibit C) with the United States
District Court for the Eastern District of Virginia, Alexandria Division. 
 (e) Within three (3) business days after the
Effective Date, Nielsen shall cause its counsel to file the Stipulation of Dismissal for the Norfolk Action Exhibit D with the United States District Court for the Eastern District of Virginia, Norfolk Division. 

  
 5 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 2.2 No Admission of Liability. This Agreement sets forth a compromise and
settlement of disputed claims for the purpose of avoiding the costs, disruptions, and uncertainties associated with further litigation. Such compromise and settlement does not constitute a ruling on the merits, an admission as to any issue of fact
or principle at law or an admission of liability of any Party. Without limitation of the foregoing, the Parties acknowledge that nothing in this Agreement, the Stock Purchase Agreement or the Voting Agreement is intended to constitute an admission
or concession of liability regarding any of the comScore Claims or Nielsen Claims. 
 ARTICLE III 

PAYMENT AND COSTS 
 3.1 Payment in the Form of Securities. As consideration for all sale of the Acquired Patents and the other promises, covenants and agreements in this Agreement, and subject to the terms and
conditions of this Agreement, the Stock Purchase Agreement and the Voting Agreement, comScore shall pay, and Nielsen US shall accept, the shares of the Common Stock of comScore specified in the Stock Purchase Agreement. 

3.2 Taxes. Unless otherwise provided in the Stock Purchase Agreement, all taxes shall be the financial responsibility of the Party
obligated to pay such taxes as determined by the applicable law and no Party shall be liable for any taxes of any other Party incurred in connection with amounts paid under this Agreement. 

3.3 Costs. Except as otherwise expressly provided herein, each Party shall bear its own costs, expenses, and attorneys’ fees
incurred in connection with (a) the Alexandria Action, (b) the Norfolk Action, (c) the negotiation, execution and delivery of this Agreement, its Exhibits and any stipulations, assignments and instruments attached hereto, and (d) the
transactions and the follow-on activities contemplated by and reasonably necessary to implement this Agreement. 
 ARTICLE IV

 RELEASE OF PATENT CLAIMS; COVENANTS NOT TO SUE 

4.1 Release by comScore. comScore, on behalf of comScore, its Affiliates, and the predecessors, successors and assigns of comScore
and its Affiliates (collectively, the “comScore Releasing Parties”), releases and forever discharges Nielsen US and NetRatings, their respective Affiliates, and each of their respective representatives, shareholders, members,
trustees, officers, directors, managers, employees, agents, attorneys, partners, divisions, predecessors, successors and permitted assigns (collectively, the “Nielsen Released Parties”) from (a) any and all Claims that comScore
made, asserted or brought in the Alexandria Action; (b) any and all Claims that comScore made, asserted or brought in the Norfolk Action; and (c) any and all Claims related to the Licensed Patents for activities conducted before the
Effective Date (all of the foregoing in clauses (a), (b), and (c), collectively, the “comScore Claims”); provided, however, that the release in this Section 4.1 is personal to Nielsen US, NetRatings and each of the other
Nielsen Released Parties and is not intended to benefit any unnamed Third Party in any way. 
 4.2 Release by Nielsen US and
NetRatings. Nielsen US and NetRatings, on behalf of Nielsen US and NetRatings, and their respective Affiliates, and the predecessors, successors and permitted assigns of Nielsen US, NetRatings and their respective Affiliates (collectively, the

  
 6 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 
“Nielsen Releasing Parties”), releases and forever discharges comScore, its Affiliates, and each of its representatives, shareholders, members, trustees, officers, directors,
managers, employees, agents, attorneys, partners, divisions, predecessors, successors and permitted assigns (collectively, the “comScore Released Parties”) from (a) any and all Claims that Nielsen US or NetRatings made,
asserted or brought in the Alexandria Action; (b) any and all Claims that Nielsen US and NetRatings made, asserted or brought in the Norfolk Action; and (c) any and all Claims related to the Assigned Patents and/or Red Sheriff Patents for
activities conducted before the Effective Date (all of the foregoing in clauses (a), (b) and (c), collectively, the “Nielsen Claims”); provided, however, that the release in this Section 4.2 is personal to comScore and
each of the other comScore Released Parties and is not intended to benefit any unnamed Third Party in any way. 
 4.3
Covenants Not to Sue. Subject to the terms of this Agreement, (i) for a period beginning on the Effective Date and ending three (3) years thereafter (“Covenant Period”), each Party (“Covenanting
Party”), on behalf of itself and its Affiliates and their respective successors and assigns, hereby covenants not to sue any other Party or its Affiliates for direct or indirect infringement, contributory infringement or active inducement
of infringement of any patent owned by, or licensed to, the Covenanting Party or its Affiliates (whether such patent is now owned or licensed by the Covenanting Party or hereafter owned or licensed by the Covenanting Party), based on any of such
other Party’s or its Affiliates’ efforts to make, use, lease, sell, offer to sell, import, export, or otherwise transfer any product (hardware and/or software), service, device, system, process, method, article of manufacture, apparatus or
combination of one or more of the foregoing, anywhere in the world, and (ii) each Covenanting Party, on behalf of itself and its Affiliates and their respective successors and assigns, hereby waives the right to recover damages and all other
remedies for any such direct or indirect infringement, contributory infringement or active inducement of infringement accruing during the Covenant Period. 
 4.4 Covenants Follow the Patents. No Party shall Transfer any patents that are subject to the covenant not to sue in Section 4.3 unless such Transfer is expressly subject to such covenant for
the term of the Covenant Period then-remaining as of the date of the Transfer. Damages, if any, that would otherwise accrue during the Covenant Period shall not accrue against a Party, its Affiliates or their respective successors and assigns during
the Covenant Period and are hereby released and discharged, subject to the other terms and provisions of this Agreement. The covenants not to sue granted to an Affiliate of Party in Section 4.3 shall (a) apply automatically and commence
without notice on the date such Affiliate becomes an Affiliate of such Party during the Covenant Period; and (b) terminate automatically and without notice on the earlier of (i) the date such Affiliate ceases to be an Affiliate of such
Party, or (ii) the date of expiration of the Covenant Period. The release and discharge of damages in this Section 4.4 shall apply to an Affiliate only as of the date that Affiliate becomes an Affiliate of such Party and expires on such
date the Affiliate ceases to be an Affiliate of such Party. 
 4.5 Unknown Claims. Each Party has been advised by legal
counsel and is familiar with the provision of Section 1542 of the California Civil Code, which is set forth below. Nielsen knowingly waives any rights it may have under Section 1542, and under any similar provision of any other state or
federal law, including at common law with respect to the Nielsen Claims identified in Section 4.2(c), and comScore knowingly waives any rights it may have under Section 1542, and under any similar provision of any other state or federal
law, including at common law with respect to the comScore Claims identified in Section 4.1(c). 

  
 7 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 “A general release does not extend to claims which the creditor does not know or
suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the debtor.” 
 ARTICLE V 
 PATENT PURCHASE AND LICENSES 

5.1 Assignment of Acquired Patents and Reservation of License. Effective as of the Effective Date and subject to the other terms
and conditions of this Agreement and rights reserved herein by Nielsen, Nielsen US hereby sells, transfers, conveys and assigns to comScore all right, title and interest throughout the world in and to the Acquired Patents, and comScore hereby
purchases the Acquired Patents and accepts such assignment from Nielsen US subject to the other terms and conditions of this Agreement and the rights and license reserved herein by Nielsen US. Without limitation of and subject to the foregoing, the
rights acquired by comScore include the following: 
 (a) all rights to make applications for patents or other forms of
protection for the Acquired Patents throughout the world and to apply throughout the world for certificates of invention, utility models, industrial design protections, design patent protections, or other governmental grants or issuances of any type
related to any of the patents, patent applications or the novel inventions disclosed in the Acquired Patents, as well as to claim and receive the benefit of the right of priority provided by the International Convention for the Protection of
Industrial Property, as amended, or by any convention which may henceforth be substituted for it, including the right to invoke and claim such right of priority without further written or oral authorization; 

(b) all causes of action and enforcement rights of any kind throughout the world (whether such causes of action or enforcement rights are
known or unknown; currently pending, filed, to be filed; or otherwise) under the Acquired Patents (excluding Nielsen US’s right to enforce any Preexisting License as provided herein) including for past, current and future infringement of the
Acquired Patents; and 
 (c) all rights to collect royalties or other payments under or on account of the Acquired Patents
throughout the world (excluding Nielsen US’s right to collect payments under the Preexisting Licenses, which right is subject to the conditions set forth in Section 5.7). 

5.2 No Obligation to Transfer Know-How. For the avoidance of doubt, nothing in Agreement shall (a) obligate Nielsen to
disclose, transfer or license to comScore any confidential information, trade secrets or know-how (whether unpatented or patented) regarding the inventions claimed or described in any Acquired Patent, or (b) obligate comScore to disclose,
transfer or license to Nielsen any confidential information, trade secrets or know-how (whether unpatented or patented) regarding the inventions claimed or described in any Licensed Patent or Acquired Patent. 

  
 8 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 5.3 Assistance In Effectuating Assignment. At the reasonable request of comScore,
Nielsen agrees to execute and deliver such other instruments and do and perform such other acts and things within Nielsen’s control as may be reasonably necessary for effecting completely the consummation of the transfer of ownership in and to
the Acquired Patents as contemplated hereby, including the execution, acknowledgment and recordation of other such assignments and other papers as necessary or desirable, for fully perfecting and conveying unto comScore the benefit of the transfer
of ownership in and to the Acquired Patents throughout the world as contemplated hereby. 
 5.4 Assistance in Prosecution and
Maintenance. Nielsen shall use commercially reasonable efforts to assist comScore in preventing abandonment of any of the Acquired Patents during the period beginning on the Effective Date and ending six weeks after the Effective Date, or such
lesser period as comScore may reasonably specify (“Transition Period”). To that end, comScore and Nielsen will cooperate to effect a smooth transfer of the prosecution and maintenance of the Acquired Patents from Nielsen to comScore
as follows: 
 (a) During the Transition Period, Nielsen agrees, upon the reasonable request of comScore, to do all things
necessary, proper, or advisable, on a country-by-country basis, to assist in obtaining, perfecting, or sustaining the Acquired Patents, including continuing to (i) pay annuities and maintenance fees and (ii) respond to official office
actions, in each case using the same standard of care and diligence that it used with respect to the Acquired Patents before the Effective Date. Any response to an official office action made during the Transition Period shall require the prior
approval of comScore. 
 (b) As promptly as reasonably possible after the Effective Date, but not longer than one (1) month
thereafter, Nielsen shall deliver to comScore originals or, if such originals are not in Nielsen’s custody, copies of each patent prosecution (docket) file in its possession for each of the Acquired Patents. Within five (5) business days
of the Effective Date, Nielsen shall also send letters to its patent prosecution counsel of record and, directly or through such patent prosecution counsel, to each foreign associate firm responsible for the preparation and prosecution of any
Acquired Patent informing such firm that Nielsen has assigned all of Nielsen’s right, title and interest in and to the Acquired Patents to comScore as provided in this Agreement and directing that such firm (i) immediately send all
originals or, if such originals are not in such counsel’s custody, copies of Nielsen’s files associated with the Acquired Patents to comScore in accordance with such counsel’s document retention policy; and (ii) invoice Nielsen
for all costs and expenses incurred in connection with the transfer of the files. If necessary, Nielsen agrees to thereafter assist comScore in procuring all such files from such patent prosecution counsel and foreign associate firms. Nielsen shall
also promptly deliver to comScore copies of all assignment agreements in its or such patent prosecution counsels’ possession for the Acquired Patents. 
 (c) comScore will reimburse Nielsen for all costs and expenses actually and reasonably incurred by Nielsen in connection with the activities conducted under Section 5.3 and this Section 5.4
after the Effective Date, including the fees and costs of its patent prosecution counsel and foreign associate firms. Nielsen will invoice comScore for all such costs and expenses, providing in reasonable detail the basis therefore, and comScore
shall pay to Nielsen all such amounts due within thirty (30) days of date of invoice. 

  
 9 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 (d) Nielsen will instruct its patent maintenance fee and annuities payment service and
its outside patent agents/counsel to cease the activities described in this Section 5.4 after the expiration of the Transition Period. Any further activities to prosecute or maintain the Acquired Patents after the expiration of the Transition
Period shall be the sole responsibility and cost of comScore. 
 (e) As promptly as reasonably possible after the Effective
Date, but not longer than one (1) month thereafter, comScore will, at its sole cost and expense, instruct its patent counsel to notify each applicable governmental authority associated with the Acquired Patents of the transfer of responsibility
for ongoing prosecution and maintenance of the Acquired Patents and record the assignment of the Acquired Patents made hereby using a short form of assignment agreement substantially in the form attached as Exhibit G or such other form as is
customary to be used for such purposes in the applicable jurisdiction. 
 5.5 Assistance in Litigation. Nielsen, at the
sole cost of comScore, shall, if reasonably requested to do so by comScore, use commercially reasonable efforts to (a) cooperate in any litigation related to the Acquired Patents, and (b) authorize those persons who are employees of
Nielsen or the Affiliates that it controls at time of comScore’s request and who are also named as inventors on the subject Acquired Patent(s) to cooperate in any litigation relating to the subject Acquired Patent(s). Nielsen further agrees to
provide comScore with copies of correspondence with prospective licensees of the Acquired Patents that are not otherwise subject to a protective order and are in its custody and readily available that relate to past efforts to enforce or license any
Acquired Patent. 
 5.6 Reservation of License by Nielsen. 

(a) The assignment of the Acquired Patents is made, and comScore accepts it, subject to Nielsen US’s reservation to Nielsen US,
NetRatings and each of their Affiliates, and comScore hereby grants to Nielsen US, NetRatings and each of their Affiliates, a worldwide, fully paid up, royalty-free, irrevocable and non-terminable, non-transferable and non-exclusive right and
license (without the right to grant sublicenses), under the Acquired Patents to make, have made, use, offer for sale, sell, import and otherwise transfer Nielsen Licensed Products. The license rights reserved and granted to an Affiliate of Nielsen
US or NetRatings in this Section 5.6 shall (i) apply automatically and commence prospectively without notice on the date an Affiliate becomes an Affiliate of Nielsen US or NetRatings; and (ii) shall continue and survive any merger,
consolidation, asset or equity sale or other event by which such entity ceases to be an Affiliate of Nielsen US or NetRatings. 

(b) The foregoing license shall also continue and shall not terminate in connection with the sale by Nielsen US, NetRatings or any of
their Affiliates of any covered service, line of business, entity, division or product line (“Divested Asset”); provided, however, that (i) such continuing license under Section 5.6(b) will not include products, services
or activities of the acquiring company other than those specific products, services and activities sold by the Divested Asset prior to divestiture, (ii) such continuing license under Section 5.6(b) shall continue only as to a sale whereby
Nielsen US, NetRatings or its Affiliate completely divests itself of said Divested Asset, and (iii) any continuing license that arises as a result this Section 5.6 must be for a legitimate business purpose and not for the purpose of
undermining comScore’s ability to license the Acquired Patents to third parties. 

  
 10 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 5.7 Existing Licenses and Future Royalty Payments. 

(a) The assignment of the Acquired Patents is made, and comScore accepts such assignment, subject to the terms and conditions of the
licenses made before the Effective Date and set forth on Exhibit H (the “Preexisting Licenses”). 
 (b)
If, after the Effective Date, royalty payments (calculated based and paid on the basis of the number of licensed units or, products or services sold or licensed or percentage of gross or net sales as set forth in a Preexisting License
(“Running Royalty”)) become due and payable from a Third Party under a Preexisting License, Nielsen shall use commercially reasonable efforts to collect such Running Royalties and, within thirty (30) days of receipt, remit them
to comScore without deduction, setoff or counterclaim. For the avoidance of doubt, comScore shall not be entitled to receive, and Nielsen shall not be obligated to collect or pay to comScore, any lump sum payment received under a Preexisting
License. 
 (c) Nothing hereunder shall be deemed an assignment of any Preexisting License to comScore, and comScore shall not
be deemed a third party beneficiary of any such Preexisting License. 
 (d) Nielsen shall indemnify, defend and hold comScore
and each comScore Released Party harmless from and against any and all Claims made, asserted or brought by any party to a Preexisting License that are based on, or arise out of, a Preexisting License, including any Claim for indemnification under or
breach of a Preexisting License. 
 5.8 Subsequent Assignments. 

(a) comScore covenants and agrees that any subsequent sale, assignment, other transfer, or conveyance, by operation of law or otherwise,
of any of the Acquired Patents after the Effective Date is made or occurs subject to the license rights granted or reserved in Section 5.6 and 5.9 and the covenant in Section 4.3; and comScore shall ensure the same is documented and
expressly accepted by the purchaser, grantee, assignee or successor as part of any transaction relating thereto. 
 (b) Nielsen
covenants and agrees that any subsequent sale, assignment, other transfer, or conveyance, by operation of law or otherwise, of any Affiliate or Divested Asset after the Effective Date is made or occurs subject to the terms and conditions in
Section 5.6; and Nielsen shall ensure the same is documented and expressly accepted by the purchaser, grantee, assignee or successor as part of any transaction relating thereto. 

(c) comScore shall give written notice to Nielsen within thirty (30) days of the closing of any sale, assignment, other transfer, or
conveyance that is subject to the terms set forth in Section 5.8(a) above; and Nielsen shall give written notice to comScore within thirty (30) days of the closing of any sale, assignment, other transfer, or conveyance that is subject to
the terms set forth in Section 5.8(b) above. 

  
 11 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 5.9 License to Licensed Patents. Subject to the terms and conditions of this
Agreement, comScore hereby grants to Nielsen US, NetRatings and their respective Affiliates, a worldwide, fully paid up, royalty-free, irrevocable, non-terminable and non-transferable, and non-exclusive right and license (without the right to grant
sublicenses) under the Licensed Patents to make, have made, use, offer for sale, sell and import Nielsen Licensed Products. Subject to the terms and conditions of this Agreement, the license rights granted to an Affiliate of Nielsen US or NetRatings
in this Section 5.8 shall (a) apply automatically and commence prospectively and without notice on the date such Affiliate becomes an Affiliate of Nielsen US or NetRatings; and (b) terminate automatically and without notice on the
date such Affiliate ceases to be an Affiliate of Nielsen US or NetRatings. For the avoidance of doubt, no license is granted to any Person that is not an Affiliate. 
 5.10 Marking. If Nielsen US or NetRatings marks any of the Nielsen Licensed Products with patent numbers of the Licensed Patents or Acquired Patents, it shall, and shall cause its respective
Affiliates to, mark all Nielsen Licensed Products sold or offered for sale under the licenses granted or reserved herein in accordance with applicable law. 
 ARTICLE VI 
 REPRESENTATIONS AND WARRANTIES 

6.1 Representations of the Parties. Each Party represents and warrants to each of the other Parties, as of the Effective Date,
that: 
 (a) Such Party is duly organized, validly existing and in good standing under the laws of the jurisdiction of its
incorporation and has full corporate power and authority to enter into this Agreement and Exhibits and to carry out the provisions hereof and thereof; 
 (b) Such Party has taken all corporate action necessary to authorize the execution and delivery of this Agreement and Exhibits and the performance of its obligations hereunder and thereunder; 

(c) This Agreement and Exhibits have been duly executed by such Party and constitute a valid and legally binding obligation of such
Party, enforceable in accordance with their respective terms; 
 (d) The execution, delivery and performance of this Agreement
and Exhibits by such Party does not conflict with any agreement, instrument or understanding, oral or written, to which it is a party or by which it may be bound, nor violate any material law or regulation of any court, governmental body or
administrative or other agency having jurisdiction over it; 
 (e) Such Party represents and warrants that it has been advised
by its counsel of its rights and obligations under this Agreement and Exhibits and enters into this Agreement and Exhibits freely, voluntarily, and without duress; and 
 (f) Such Party represents and warrants that it is not relying on any promises, inducements, or representations other than those provided herein. 

  
 12 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 6.2 Representations and Warranties of Nielsen. Nielsen represents and warrants to
comScore, as of the Effective Date, that: 
 (a) To the best of Nielsen’s knowledge, Exhibit A sets forth a complete
and accurate list of: 
 i. all Acquired Patents that have been or are registered, filed, granted, or issued, or that have been
or are subject to an application for registration, filing, grant or issuance; 
 ii. all jurisdictions in which such Acquired
Patents have been or are registered, granted, or issued or in which registrations, grants or issuances have been applied for; and 
 iii. all registration numbers, issuance numbers, grant numbers, serial numbers and application numbers, as applicable. 
 (b) To the best of Nielsen’s knowledge, Exhibit H sets forth a complete and accurate list of, and Nielsen has provided complete and accurate copies of, each agreement that materially affects,
in any manner, title to, or comScore’s enjoyment of, the Acquired Patents, including each license to one or more of the patents or patent applications in the Acquired Patents, or a right or option to obtain such a license; 

(c) Except for Preexisting Licenses, there has been no previous Transfer or other grant of rights under the Acquired Patents or any other
agreement by Nielsen US or NetRatings that materially affects, in any manner, title to, or comScore’s enjoyment of, the Acquired Patents, including an assignment of full or partial rights in or to one or more of the patents or patent
applications in the Acquired Patents, a license to one or more of the patents or patent applications in the Acquired Patents, or a right or option to obtain such a license; 
 (d) To the best of Nielsen’s knowledge, no Running Royalties are due or payable under any Preexisting License as of the Effective Date, and no Running Royalties will, after the Effective Date, become
due or payable under any Preexisting License; 
 (e) Nielsen is the sole owner of all right, title and interest in and to each
of the Acquired Patents; 
 (f) All maintenance fees, annuities and other payments owed to the USPTO or any non-U.S. patent
office in connection with the Acquired Patents and due and payable before the Effective Date have been paid in full; 
 (g) None
of the Acquired Patents is currently pending in any reexamination, reissue, opposition, or interference proceeding, and, to the knowledge of Nielsen, no such proceedings are pending or threatened. 

(h) Nielsen has the authority to act on behalf of the Nielsen Releasing Parties to the extent that this Agreement recites undertakings,
promises, covenants or obligations of said Persons; 

  
 13 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 (i) Nielsen has not Transferred, in whole or in part, voluntarily or involuntarily, any
Nielsen Claim, and no Person (other than Nielsen) had or has any interest in any Nielsen Claim. 
 (j) The remedies for any
breach of or inaccuracy as of the Effective Date in any of the representations and warranties contained in this Section 6.2 or in any officer’s certificate provided by Nielsen US pursuant to Section 5.7 shall survive the Effective
Date in perpetuity or until the expiration of the applicable statute of limitations, if earlier. 
 6.3 Representations and
Warranties of comScore. comScore represents and warrants to Nielsen, as of the Effective Date, that: 
 (a) To the best of
comScore’s knowledge, Exhibit B sets forth a complete and accurate list of: 
 i. all Licensed Patents that have
been or are registered, filed,-granted, or issued, or that have been or are subject to an application for registration, filing, grant or issuance; 
 ii. all jurisdictions in which such Licensed Patents have been or are registered, granted, or issued or in which registrations, grants or issuances have been applied for; and 

iii. all registration numbers, issuance numbers, grant numbers, serial numbers and application numbers, as applicable. 

(b) To the best of comScore’s knowledge, comScore has the right and authority to grant the license to the Licensed Patents upon the
terms specified herein; 
 (c) None of the Licensed Patents is currently pending in any reexamination, reissue, opposition, or
interference proceeding, and, to the knowledge of comScore, no such proceedings are pending or threatened. 
 (d) comScore has
the authority to act on behalf of the comScore Releasing Parties to the extent that this Agreement recites undertakings, promises, covenants or obligations of said Persons; 
 (e) comScore has not Transferred, in whole or in part, voluntarily or involuntarily, any comScore Claim, and no Person had or has any interest in any comScore Claim. 

(f) The remedies for any breach of or inaccuracy as of the Effective Date in any of the representations and warranties contained in this
Section 6.3 shall survive the Effective Date in perpetuity or until the expiration of the applicable statute of limitations, if earlier. 
 6.4 No Other Representations or Warranties. EXCEPT AS PROVIDED IN SECTIONS 6.1, 6.2 AND 6.3, NO PARTY MAKES ANY REPRESENTATION TO ANY OTHER PARTY AND EACH PARTY HEREBY DISCLAIMS ANY AND ALL SUCH

  
 14 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 OTHER REPRESENTATIONS AND WARRANTIES, WHETHER EXPRESS, IMPLIED, ARISING BY OPERATION OF LAW, OR
OTHERWISE UNDER THIS AGREEMENT AND EXCEPT AS PROVIDED IN SECTIONS 6.1, 6.2 AND 6.3, THE ACQUIRED PATENTS ARE ASSIGNED BY NIELSEN, AND THE LICENSED PATENTS AND ACQUIRED PATENTS ARE LICENSED BY COMSCORE, AS-IS, WHERE-IS, AND WITH ALL FAULTS. Without
limiting the foregoing, nothing contained in this Agreement shall be construed as: (a) a warranty or representation by any Party that any manufacture, sale, use or other disposition of products by any other Party has been or will be free from
infringement of any patents (except the Acquired Patents and Licensed Patents); (b) an agreement by any Party to bring or prosecute actions or suits against Third Parties for infringement, or conferring any right to any other Party to bring or
prosecute actions or suits against Third Parties for infringement; (c) a warranty or representation by any Party as to the patentability, validity, or enforceability of any of the Licensed Patents or Acquired Patents, or (d) conferring any
right to any other Party to use in advertising, publicity, or otherwise, any trademark, trade name or names of any other Party, or any contraction, abbreviation or simulation thereof without the prior written consent of such other Party. 

ARTICLE VII 

TERM AND TERMINATION 
 7.1 Term. This Agreement becomes effective on the Effective Date and remains in effect until terminated in accordance with Section 7.2. 

7.2 Termination. This Agreement terminates with respect to each Acquired Patent or Licensed Patent when such patent expires or is
finally determined (including any appellate process) by a governmental authority of competent jurisdiction to be unpatentable, invalid or unenforceable. This Agreement terminates in its entirety when all Acquired Patents and Licensed Patents have
expired or have been determined by a governmental authority of competent jurisdiction to be unpatentable, invalid or unenforceable. Except as set forth in the preceding sentence, this Agreement, the rights reserved to the Acquired Patents, and the
license grants hereunder may be terminated only by mutual agreement of the Parties, and may not be terminated for any other reason. All other remedies available by law and in this Agreement shall remain in effect. 

7.3 Survival. Termination of this Agreement shall not relieve any Party of any obligation accrued before termination.
Additionally, the provisions of Articles I, VIII and IX and Sections 4.1-4.5, 5.6, 5.7(d), 5.8, 5.9, 6.2(j), 6.3(f), 6.4, and 7.3 shall survive termination as applicable. 
 ARTICLE VIII 
 CONFIDENTIALITY 

8.1 Confidentiality. From and after the Effective Date, no Party shall disclose the terms of this Agreement except: 

(a) with the prior written consent of the other Party; 

  
 15 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 (b) to any governmental body having jurisdiction and specifically requiring such
disclosure; 
 (c) in response to a valid subpoena or as otherwise may be required to comply with any rules or regulations of
any court, provided, however, that prior to any such disclosure pursuant to this Section, the Party seeking disclosure shall promptly, if permitted by law, notify the other Party and, that prior to any such disclosure, take all
reasonable actions in an effort to minimize the nature and extent of such disclosure, including seeking a protective order; 

(d) for the purposes of disclosure in connection with the Securities and Exchange Act of 1934, as amended, the Securities Act of 1933, as
amended, and any other reports filed with the Securities and Exchange Commission, or any other filings, reports or disclosures that may be required under applicable laws, regulations or the rules of any exchange where a Party’s securities are
traded; 
 (e) to a Party’s accountants, legal counsel, tax advisors and other financial and legal advisors, subject to
obligations of confidentiality at least as stringent as those contained herein; or 
 (f) with obligations of confidentiality at
least as stringent as those contained herein, to a counterparty in connection with a proposed merger, acquisition, financing or similar transaction. 
 8.2 Protective Orders. In furtherance hereof, each Party will, and will direct its counsel to, promptly comply with the protective orders in the Alexandria Action and the Norfolk Action with
respect to the return or destruction of confidential information; provided, however that Nielsen agrees that comScore may retain and use for any purpose all information and materials related to the Acquired Patents. For the avoidance of doubt, upon
filing with the Court, any stipulation attached hereto as an Exhibit shall not be confidential. 
 8.3 Publicity. Except
as provided in Section 8.1 (d), no Party will authorize or issue a press release or any other announcement or communication regarding this Agreement or the relationship contemplated herein or therein absent prior mutual agreement in writing by
all Parties. Notwithstanding the foregoing and Section 8.1 above, upon the Effective Date any Party may state that the Parties have entered into a settlement agreement regarding the Norfolk Action and Alexandria Action. 

ARTICLE IX 

MISCELLANEOUS 
 9.1 Reservation of Rights. Except as expressly set forth in this Agreement and its Exhibits, nothing herein shall be deemed a grant or waiver by any Party of any rights, title or interest in, to or
under any patents, technology or other intellectual property rights of such Party or its Affiliates, whether by implication, by estoppel or otherwise. 
 9.2 Assignment. No party may assign or otherwise transfer its rights and obligations under this Agreement except in connection with the sale of all or substantially all of the assets of the Party
or the merger or consolidation of such Party. Except as provided in the preceding sentence, this Agreement may not be assigned or otherwise transferred (by operation of law or otherwise), in whole or in part, by any Party to any other Person and any
attempt to do so shall be null and void. 

  
 16 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 9.3 Notices. All notices and other communications under this Agreement must be in
writing and will be deemed to have been duly given upon (a) delivery by hand (with written confirmation of receipt), (b) transmission by telecopier (with written confirmation of receipt), provided that a copy is sent by registered mail,
return receipt requested, or (c) receipt by the addressee, if sent by a nationally recognized overnight delivery service providing receipt of delivery, and, for any of (a), (b) and (c), using the information set forth below (or such
information as may be provided in the future by written notice that has been provided pursuant to this Section 9.3): 
  

					
	If to Nielsen or NetRatings	  	 The Nielsen Company (US) LLC

770 Broadway
 New York, New York 10003

Attention: Legal Department
 Facsimile: (646)
654-4982
	  	
			
	with a copy (which shall not constitute notice) to:	  	 Jones Day
 1755 Embarcadero
Road
 Palo Alto, CA 94303
 Attention:
Greg Lanier
 Facsimile: (650) 739-3900
	  	
			
	If to comScore:	  	 comScore, Inc.
 11950 Democracy
Drive
 Suite 600
 Reston, VA
20190
 Attention: General Counsel

Facsimile: (703) 376-6604
	  	
			
	with a copy (which shall not constitute notice) to:	  	 Covington & Burling LLP

1201 Pennsylvania Ave., N.W.
 Washington, DC
20004-2401
 Attention: Kevin B. Collins

Facsimile: 202-778-5598
	  	

 9.4 Governing Law and Choice of Forum. The Parties agree that this Agreement shall be governed,
interpreted, and construed in accordance with the laws of the State of Delaware (without regard to its conflict of law principles). Each of the Parties consents to the exclusive jurisdiction and venue of the United States District Court for the
Eastern District of Virginia with regard to any and all dispute(s) arising in connection with this Agreement unless no federal subject matter jurisdiction exists, in which case the action or proceeding shall be brought only in the courts of the
Commonwealth of Virginia located in Fairfax County, VA. 

  
 17 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 9.5 Limitation of Liability. NO PARTY WILL BE LIABLE FOR ANY INDIRECT,
INCIDENTAL, CONSEQUENTIAL, EXEMPLARY, RELIANCE, PUNITIVE OR SPECIAL DAMAGES ARISING UNDER THIS AGREEMENT, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 
 9.6 Severability. If any provision of this Agreement is held to be illegal or unenforceable, such provision shall be limited or eliminated to the minimum extent necessary so that the remainder of
this Agreement will continue in full force and effect and be enforceable. The Parties agree to negotiate in good faith an enforceable substitute provision for any invalid or unenforceable provision that most nearly achieves the intent of such
provision. 
 9.7 Modification; Waiver. No modification or amendment to this Agreement, nor any waiver of any rights
hereunder, will be effective unless assented to in writing by the Party to be charged, and the waiver of any breach or default will not constitute a waiver of any other right hereunder or any subsequent breach or default. 

9.8 Construction. Any rule of construction to the effect that ambiguities are to be resolved against the drafting party will not
be applied in the construction or interpretation of this Agreement. As used in this Agreement, the words “include” and “including” and variations thereof, will not be deemed to be terms of limitation, but rather will be deemed to
be followed by the words “without limitation.” The headings in this Agreement will not be referred to in connection with the construction or interpretation of this Agreement. 

9.9 Counterparts. This Agreement and its Exhibits may be executed in counterparts or duplicate originals, all of which shall be
regarded as one and the same instrument, and which shall be the official and governing version in the interpretation of this Agreement. This Agreement and its Exhibits may be executed by facsimile signatures or other electronic means and such
signatures shall be deemed to bind each Party as if they were original signatures. 
 9.10 Integration. No promise,
inducement or agreement not expressed in this Agreement and Exhibits has been made to any Party in connection with this Agreement. This Agreement and Exhibits constitute the entire agreement among the Parties with respect to the subject matter
hereof. 
 9.11 Binding Effect. This Agreement shall be binding upon and for the benefit of the Parties hereto and their
respective executors, administrators, trustees, successors and permitted assigns. 
 <signature page follows> 

  
 18 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 IN WITNESS WHEREOF, this Agreement has been duly executed and delivered by the duly
authorized officer of each Party hereto as of the date first above written. 
  

									
	THE NIELSEN COMPANY (US) LLC	 		 	NETRATINGS, LLC
					
	By:	 	 /s/ James W. Cuminale
	 		 	By:	 	 /s/ James W. Cuminale

	Name:	 	JAMES W. CUMINALE	 		 	Name:	 	JAMES W. CUMINALE
	Title:	 	CEO	 		 	Title:	 	President
				
	COMSCORE, INC.	 		 		 	
					
	By:	 	 /s/ Kenneth Tarpey
	 		 		 	
	Name:	 	KENNETH TARPEY	 		 		 	
	Title:	 	Chief Financial Officer	 		 		 	

  
 19 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 Exhibit A 
 Acquired Patents 
 NIELSEN US 6,418,470 

 

																			
	 ID
	  	Country	  	App No.	  	Patent No.	 	  	Appl. Type	  	 App Title
	  	Status	  	Appl. Date	  	Grant Date
	81024699	  	US	  	09/111,963	  	 	6,327,619	  	  	Priority	  	METERING OF INTERNET CONTENT USING A CONTROL	  	Granted	  	08 Jul 1998	  	04 Dec 2001
	81025914	  	US	  	09/791,268	  	 	6,418,470	  	  	Continuation	  	METERING OF INTERNET CONTENT USING A CONTROL	  	Granted	  	22 Feb 2001	  	09 Jul 2002
	81024700	  	Canada	  	2,272,506	  	 	2,272,506	  	  	Secondary	  	METERING OF INTERNET CONTENT USING A CONTROL	  	Granted	  	19 May 1999	  	17 Feb 2009

  
 A-1

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 NIELSEN US 7,376,722 

 

																			
	 ID
	  	Country	  	App No.	  	Patent No.	 	  	Appl. Type	  	 App Title
	  	Status	  	Appl. Date	  	Grant Date
	81025283	  	US	  	09/763,338	  	 	7,376,722	  	  	Designated
PCT	  	NETWORK RESOURCE MONITORING AND MEASUREMENT SYSTEM AND METHOD	  	Granted	  	07 Aug 2000	  	20 May 2008
	81025285	  	US	  	12/100,685	  				  	Continuation	  	NETWORK RESOURCE MONITORING AND MEASUREMENT SYSTEM AND METHOD	  	Abandoned	  	10 Apr 2008	  	
	81025282	  	US	  	12/100,698	  	 	7,953,791	  	  	Divisional	  	NETWORK RESOURCE MONITORING AND MEASUREMENT SYSTEM AND METHOD	  	Granted	  	10 Apr 2008	  	31 May 2011
	81054855	  	US	  	12/780,890	  	 	7,953,839	  	  	Continuation	  	NETWORK RESOURCE MONITORING AND MEASUREMENT SYSTEM AND METHOD	  	Granted	  	15 May 2010	  	31 May 2011
	81080416	  	US	  	13/098,358	  				  	Continuation	  	NETWORK RESOURCE MONITORING AND MEASUREMENT SYSTEM AND METHOD	  	Issue Fee
Paid	  	29 Apr 2011	  	
	81025277	  	Australia	  	PQ 206399	  				  		  	NETWORK USER MEASUREMENT SYSTEM AND METHOD	  	Expired	  	06 Aug 1999	  	
	81025284	  	Australia	  	200062543	  	 	781008	  	  	Divisional	  	NETWORK RESOURCE MONITORING AND MEASUREMENT SYSTEM AND METHOD	  	Granted	  	07 Aug 2000	  	28 Apr 2005
	81025279	  	EP	  	00949006.1	  				  	Designated
PCT	  	NETWORK RESOURCE MONITORING AND MEASUREMENT SYSTEM AND METHOD	  	Published	  	07 Aug 2000	  	
	81077187	  	EP	  	10012280.3-1244	  				  	Divisional	  	NETWORK RESOURCE MONITORING AND MEASUREMENT SYSTEM AND METHOD	  	Published	  	07 Aug 2000	  	
	81025280	  	Japan	  	2001-516087	  	 	4799788	  	  	Designated
PCT	  	NETWORK RESOURCE MONITORING AND MEASUREMENT SYSTEM AND METHOD	  	Granted	  	07 Aug 2000	  	26 Oct 2011
	81077132	  	Japan	  	2010-234049	  				  	Divisional	  	NETWORK RESOURCE MONITORING AND MEASUREMENT SYSTEM AND METHOD	  	Published	  	18 Oct 2010	  	
	81025281	  	New Zealand	  	NZ 517638	  	 	517638	  	  	Designated
PCT	  	NETWORK RESOURCE MONITORING AND MEASUREMENT SYSTEM AND METHOD	  	Granted	  	07 Aug 2000	  	
	81025278	  	PCT	  	AU00/00937	  				  	PCT
Application	  	NETWORK RESOURCE MONITORING AND MEASUREMENT SYSTEM AND METHOD	  	Lapsed	  	07 Aug 2000	  	
		  	US	  	13/329,199	  				  	Continuation	  	NETWORK RESOURCE MONITORING AND MEASUREMENT SYSTEM AND METHOD	  	Filed	  	16 Dec 2011	  	

  
 A-2

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 NIELSEN US 7,386,473 - US 7,613,635 

 

																			
	 ID
	  	Country	  	App No.	  	Patent No.	 	  	Appl. Type	  	 App Title
	  	Status	  	Appl. Date	  	Grant Date
	81025615	  	US	  	08/707,279	  	 	6,108,637	  	  	Priority	  	CONTENT DISPLAY MONITOR	  	Granted	  	03 Sep 1996	  	22 Aug 2000
	81026020	  	US	  	09/490,495	  	 	7,386,473	  	  	Secondary	  	CONTENT DISPLAY MONITOR	  	Granted	  	25 Jan 2000	  	10 Jun 2008
	81026027	  	US	  	11/618,055	  	 	7,716,326	  	  	Divisional	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Dec 2006	  	11 May 2010
	81026031	  	US	  	11/618,251	  	 	7,590,568	  	  	Divisional	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Dec 2006	  	15 Sep 2009
	81026036	  	US	  	11/618,233	  				  	Divisional	  	CONTENT DISPLAY MONITOR	  	Rejected	  	29 Dec 2006	  	
	81026037	  	US	  	11/618,213	  	 	7,613,635	  	  	Divisional	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Dec 2006	  	03 Nov 2009
	81026038	  	US	  	11/618,193	  	 	7,756,974	  	  	Continuation	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Dec 2006	  	13 Jul 2010
	81026039	  	US	  	11/618,176	  	 	7,644,156	  	  	Continuation	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Dec 2006	  	05 Jan 2010
	81026040	  	US	  	11/618,144	  	 	7,653,724	  	  	Continuation	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Dec 2006	  	26 Jan 2010
	81026041	  	US	  	11/618,118	  	 	7,720,964	  	  	Continuation	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Dec 2006	  	18 May 2010
	81026042	  	US	  	11/618,102	  	 	7,650,407	  	  	Continuation	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Dec 2006	  	19 Jan 2010
	81026097	  	US	  	11/618,086	  	 	7,720,963	  	  	Continuation	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Dec 2006	  	18 May 2010
	81026043	  	US	  	11/618,072	  				  	Continuation	  	CONTENT DISPLAY MONITOR	  	Abandoned	  	29 Dec 2006	  	
	81076282	  	US	  	12/849,420	  				  	Continuation	  	CONTENT DISPLAY MONITOR	  	Published	  	03 Aug 2010	  	
	81025989	  	Australia	  	42437/97	  	 	735285	  	  	Designated PCT	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Aug 1997	  	05 Jul 2001
	81025997	  	Belgium	  	97940719.4	  	 	0 870 234	  	  	Designated EP	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Aug 1997	  	26 Mar 2003
	81025990	  	Canada	  	2246746	  				  	Designated PCT	  	CONTENT DISPLAY MONITOR	  	Abandoned	  	29 Aug 1997	  	
	81025991	  	China	  	97191556.3	  	 	CN 1174316C	 	  	Designated PCT	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Aug 1997	  	03 Nov 2004
	81026017	  	China	  	200410033715.3	  	 	CN 100380341	  	  	Divisional	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Aug 1997	  	09 Apr 2008
	81026021	  	China	  	200410033713.4	  	 	CN 1306410	  	  	Divisional	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Aug 1997	  	21 Mar 2007
	81026025	  	China	  	200610094354.2	  	 	CN 100507868	  	  	Designated PCT	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Aug 1997	  	01 Jul 2009
	81025998	  	Denmark	  	97940719.4	  	 	0 870 234	  	  	Designated EP	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Aug 1997	  	26 Mar 2003
	81025992	  	EP	  	97940719.4	  	 	0870234	  	  	Designated PCT	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Aug 1997	  	26 Mar 2003
	81026014	  	EP	  	20010106943	  				  		  	CONTENT TRANSFERRING SYSTEM	  	Abandoned	  	29 Aug 1997	  	
	81026019	  	EP	  	20010123166	  				  		  	CONTENT TRANSFERRING METHOD	  	Abandoned	  	29 Aug 1997	  	
	81025999	  	Finland	  	97940719.4	  	 	0 870 234	  	  	Designated EP	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Aug 1997	  	26 Mar 2003

  
 A-3

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

																			
	81026000	  	France	  	97940719.4	  	 	0870234	  	  	Designated EP	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Aug 1997	  	26 Mar 2003
	81026001	  	Germany	  	97940719.4	  	 	DE69720186	  	  	Designated EP	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Aug 1997	  	26 Mar 2003
	81025993	  	Hong Kong	  	99102791.9	  	 	1018327	  	  	Designated PCT	  	CONTENT DISPLAY MONITOR	  	Granted	  	02 Jul 1999	  	28 Oct 2005
	81026018	  	Hong Kong	  	05103917.9	  	 	1071215	  	  	Divisional	  	CONTENT DISPLAY MONITOR	  	Granted	  	10 May 2005	  	30 Apr 2009
	81026022	  	Hong Kong	  	051039160.0	  	 	1071214	  	  	Designated PCT	  	CONTENT DISPLAY MONITOR	  	Granted	  	10 May 2005	  	08 Jun 2007
	81026028	  	Hong Kong	  	071027812	  	 	1097615	  	  	Designated PCT	  	CONTENT DISPLAY MONITOR	  	Granted	  	15 Mar 2007	  	11 Sep 2009
	81026002	  	Ireland	  	97940719.4	  	 	0 870 234	  	  	Designated EP	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Aug 1997	  	26 Mar 2003
	81026003	  	Italy	  	97940719.4	  	 	0870234	  	  	Designated EP	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Aug 1997	  	26 Mar 2003
		  	Liechtenstein	  	97940719.4	  	 	0870234	  	  	Designated EP	  	CONTENT DISPLAY MONITOR	  	Published	  	29 Aug 1997	  	
	81026004	  	Spain	  	97940719.4	  	 	ES2195170	  	  	Designated EP	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Aug 1997	  	26 Mar 2003
	81026005	  	Sweden	  	97940719.4	  	 	0 870 234	  	  	Designated EP	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Aug 1997	  	26 Mar 2003
	81026006	  	Switzerland	  	97940719.4	  	 	0870234	  	  	Designated EP	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Aug 1997	  	26 Mar 2003
	81026007	  	UK	  	97940719.4	  	 	0 870 234	  	  	Designated EP	  	CONTENT DISPLAY MONITOR	  	Granted	  	29 Aug 1997	  	26 Mar 2003
	81025621	  	PCT	  	US97/15353	  				  	PCT Application	  	CONTENT DISPLAY MONITOR	  	Lapsed	  	29 Aug 1997	  	

  
 A-4

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

 NIELSEN US 6,115,680 

 

																			
	 ID
	  	 Country
	  	App No.	  	Patent No.	 	  	 Appl. Type
	  	 App Title
	  	 Status
	  	Appl. Date	  	Grant Date
	 81025665
	  	US	  	08/474,082	  	 	5,675,510	  	  	Priority	  	COMPUTER USE METER AND ANALYZER	  	Granted	  	07 Jun 1995	  	07 Oct 1997
	 81025930
	  	US	  	08/973,173	  	 	6,115,680	  	  	Designated PCT	  	COMPUTER USE METER AND ANALYZER	  	Granted	  	07 Jun 1995	  	05 Sep 2000
	 81026023
	  	US	  	09/616,317	  				  	Continuation	  	COMPUTER USE METER AND ANALYZER	  	Abandoned	  	19 May 2000	  	
	 81026026
	  	US	  	10/037,174	  				  	Continuation	  	COMPUTER USE METER AND ANALYZER	  	Abandoned	  	29 Oct 2001	  	
	 81025691
	  	Australia	  	199662739	  	 	701,813	  	  	Designated PCT	  	COMPUTER USE METER AND ANALYZER	  	Granted	  	07 Jun 1996	  	04 Feb 1999
	 81025692
	  	Brazil	  	PI9609217.3	  				  	Designated PCT	  	COMPUTER USE METER AND ANALYZER	  	Final Rej	  	07 Jun 1996	  	
	 81025693
	  	Canada	  	2,223,919	  	 	2,223,919	  	  	Designated PCT	  	COMPUTER USE METER AND ANALYZER	  	Granted	  	07 Jun 1996	  	09 Jul 2002
	 81025695
	  	Germany	  	0921533	  				  	Designated PCT	  	COMPUTER USE METER AND ANALYZER	  	Published	  	07 Jun 1996	  	
	 81025969
	  	EP	  	07005982.9	  				  	Divisional	  	COMPUTER USE METER AND ANALYZER	  	Published	  	07 Jun 1996	  	
	 81077125
	  	EP	  	10012282.9	  				  	Divisional	  	COMPUTER USE METER AND ANALYZER	  	Published	  	07 Jun 1996	  	
	 81025694
	  	EP	  	96921533	  				  		  	COMPUTER USE METER AND ANALYZER	  	Abandoned	  	07 Jun 1996	  	
	 81025696
	  	Japan	  	502197/97	  	 	3317705	  	  	Designated PCT	  	COMPUTER USE METER AND ANALYZER	  	Granted	  	07 Jun 1996	  	26 Aug 2002
	 81025697
	  	Mexico	  	PA/a/1997/979752	  	 	193,614	  	  	Designated PCT	  	COMPUTER USE METER AND ANALYZER	  	Granted	  	05 Dec 1997	  	07 Oct 1999
	 81025698
	  	Norway	  	975728	  				  		  	Måler og analysator for datamaskinbenyttelse	  	Abandoned	  	05 Dec 1997	  	
	 81025666
	  	PCT	  	US96/10091	  				  		  	COMPUTER USE METER AND ANALYZER	  	Lapsed	  	07 June 1996	  	

 *        *        *

  
 A-5

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
 Exhibit B 
 Licensed Patents 

 

																			
	 IMATTER
 NO.
	  	 COUNTRY

ID
	  	 TYPE
	  	 SERIAL NO.
	  	 PATENT

NO.
	  	 TITLE
	  	 RELATED
	  	 STATUS
	  	 FILE
	  	 ISSUE

	 13186-

0002P01
	  	US	  	PRV	  	60/353,993	  		  	PERFORMANCE MONITORING AND ANALYSIS	  		  	ABANDONED	  	02/05/02	  	
	 13186-

0004001
	  	US	  	UTL	  	10/358,377	  	7,930,285	  	 SYSTEMS AND METHODS OF USER

DEMOGRAPHIC REPORTING USABLE FOR INDENTIFYING USERS AND COLLECTING USAGE DATA
	  	 13186-

0004P01
	  	ISSUED	  	02/05/03	  	04/19/11
	 13186-

0004002
	  	US	  	UTL	  	13/078,667	  		  	SYSTEMS FOR AND METHODS OF USER DEMOGRAPHIC REPORTING USABLE FOR INDENTIFYING USERS AND COLLECTING USAGE DATA	  	 13186-

0004001
	  	PUBLISHED	  	04/01/11	  	

  
 B-1

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

																			
	 IMATTER
 NO.
	  	COUNTRY
ID	  	TYPE	  	SERIAL NO.	  	PATENT
NO.	  	 TITLE
	  	RELATED	  	STATUS	  	FILE	  	ISSUE
	13186- 0004CA1	  	CA	  	UTL	  	2474815	  		  	SYSTEMS AND METHODS FOR USER IDENTIFICATION, USER DEMOGRAPHIC REPORTING AND COLLECTING USAGE DATA	  	13186-
0004WO1	  	PENDING	  	02/05/03	  	
	13186- 0004EP1	  	EP	  	UTL	  	3737601.9	  		  	SYSTEMS AND METHODS FOR USER IDENTIFICATION, USER DEMOGRAPHIC REPORTING AND COLLECTING USAGE DATA	  	13186-
 0004WO1
	  	PUBLISHED	  	02/05/03	  	
	13186- 0004P01	  	US	  	PRV	  	60/355,785	  		  	USER DEMOGRAPHIC REPORTING	  	13186-
 0002P01
	  	ABANDONED	  	02/12/02	  	

  
 B-2

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

																			
	 IMATTER
 NO.
	  	 COUNTRY

ID
	  	 TYPE
	  	 SERIAL NO.
	  	PATENT
NO.	  	 TITLE
	  	 RELATED
	  	 STATUS
	  	 FILE
	  	 ISSUE

	 13186-

0004WO1
	  	WO	  	UTL	  	 PCT/US2003/0

03225
	  		  	 SYSTEMS AND METHODS FOR USER

IDENTIFICATION,
 USER

DEMOGRAPHIC REPORTING AND COLLECTING USAGE DATA
	  	 13186-

0002P01
	  	 NAT
 PHASE
	  	02/05/03	  	
	 13186-

0010001
	  	US	  	UTL	  	09/532,890	  	7,181,412	  	SYSTEMS AND METHODS FOR COLLECTING CONSUMER DATA	  	 13186-

0004P01
	  	ISSUED	  	03/22/00	  	02/20/07
	 13186-

0010002
	  	US	  	UTL	  	11/619,795	  		  	SYSTEMS AND METHODS FOR COLLECTING CONSUMER DATA	  	 13186-

0010001
	  	 ABANDO
 NED
	  	01/04/07	  	
	 13186-

0010CA1
	  	CA	  	UTL	  	2403879	  		  	SYSTEMS AND METHODS FOR COLLECTING CONSUMER DATA	  	 13186-

0010WO1
	  	PENDING	  	03/20/01	  	
	 13186-

0010EP1
	  	EP	  	UTL	  	1922473.2	  		  	SYSTEMS AND METHODS FOR COLLECTING CONSUMER DATA	  	 13186-

0010WO1
	  	 ABANDO
 NED
	  	03/20/01	  	

  
 B-3

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

																			
	 IMATTER
 NO.
	  	COUNTRY
ID	  	TYPE	  	SERIAL NO.	  	PATENT
NO.	  	 TITLE
	  	RELATED	  	STATUS	  	FILE	  	ISSUE
	 13186-

0010MX1
	  	MX	  	UTL	  	PA/a/2002/009
 205
	  		  	SYSTEMS AND METHODS FOR COLLECTING CONSUMER DATA	  	13186-
 0010WO1
	  	CLOSED	  	03/20/01	  	
	 13186-

00l0WOl
	  	WO	  	UTL	  	PCT/US01/087
 85
	  		  	SYSTEMS AND METHODS FOR COLLECTING CONSUMER DATA	  	13186-
 0010001
	  	NAT
 PHASE
	  	03/20/01	  	
	 13186-

0011001
	  	US	  	UTL	  	10/358,391	  	7,493,655	  	SYSTEMS FOR AND METHODS OF PLACING USER INDENTIFICATION IN THE HEADER OF DATA PACKETS USABLE IN USER DEMOGRAPHIC REPORTING AND COLLECTING USAGE DATA	  	13186-
 0010001
	  	ISSUED	  	02/05/03	  	02/17/09
	 13186-

0011002
	  	US	  	UTL	  	12/347,464	  		  	USER IDENTIFICATION IN THE HEADER OF DATA PACKETS	  	13186-
 0011001
	  	PUBLISHED	  	12/31/08	  	

  
 B-4

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

																			
	 IMATTER
 NO.
	  	COUNTRY
ID	  	TYPE	  	SERIAL NO.	  	PATENT
NO.	  	 TITLE
	  	RELATED	  	 STATUS
	  	FILE	  	ISSUE
	 13186-

0012001
	  	US	  	UTL	  	10/358,376	  	7,260,837	  	 SYSTEMS AND METHODS FOR USER

IDENTIFICATION,
 USER

DEMOGRAPHIC REPORTING AND COLLECTING USAGE DATA USING BIOMETRICS
	  	13186-
 0010001
	  	ISSUED	  	02/05/03	  	08/21/07
	 13186-

0012002
	  	US	  	UTL	  	11/836,075	  		  	 SYSTEMS AND METHODS FOR USER

IDENTIFICATION,
 USER

DEMOGRAPHIC REPORTING AND COLLECTING USAGE DATA USING BIOMETRICS
	  	13186-
 0012001
	  	PUBLISHED	  	08/08/07	  	

  
 B-5

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

																			
	 IMATTER
 NO.
	  	 COUNTRY

ID
	  	 TYPE
	  	 SERIAL NO.
	  	 PATENT

NO.
	  	 TITLE
	  	 RELATED
	  	 STATUS
	  	 FILE
	  	 ISSUE

	 13186-

0048001
	  	US	  	UTL	  	11/183,339	  	7,849,154	  	 ACQUIRING, STORING, AND CORRELATING PROFILE DATA OF CELLULAR MOBILE
 COMMUNICATIONS SYSTEM’S USERS TO EVENT
	  	 13186-

0048P01
	  	ISSUED	  	07/18/05	  	12/07/10
	 13186-

0048002
	  	US	  	UTL	  	12/961,092	  		  	 ACQUIRING, STORING, AND CORRELATING PROFILE DATA OF CELLULAR MOBILE
 COMMUNICATIONS SYSTEM’S USERS TO EVENT
	  	 13186-

0048001
	  	PUBLISHED	  	12/06/10	  	
	 13186-

0048P01
	  	US	  	PRV	  	60/694,451	  		  	 ACQUIRING, STORING, AND CORRELATING PROFILE DATA OF CELLULAR MOBILE
 COMMUNICATIONS SYSTEM’S USERS TO EVENT
	  		  	EXPIRED	  	06/27/05	  	

  
 B-6

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

																					
	 IMATTER
 NO.
	  	COUNTRY
ID	  	TYPE	  	SERIAL NO.	  	PATENT
NO.	  	 TITLE
	  	RELATED	  	 STATUS
	  	FILE	  	ISSUE	 
	13186-0049001	  	US	  	UTL	  	11/903,089	  		  	 ACQUIRING, STORING, AND CORRELATING PROFILE DATA OF CELLULAR MOBILE
 COMMUNICATIONS SYSTEM’S USERS TO EVENT
	  	13186-
 0048001
	  	ABANDONED	  	09/20/07	  			
	NA(PITKO
W l)	  	US	  	UTL	  	11/640,441	  	7,685,275	  	 NETWORK

INTERACTION
 ANALYS
	  		  	ISSUED	  	12/15/06	  	 	03/23/10	  
	NA(PITKO
W 2)	  	US	  	UTL	  	11/640,125	  		  	 NETWORK

INTERACTION
 CORRELATION
	  		  	PENDING	  	12/15/06	  			
	NA(PITKO
W 3)	  	US	  	PRV	  	61/007,915	  		  	 NETWORK

INTERACTION
 MONITORING

DEVICE
	  		  	EXPIRED	  	12/15/06	  			
	NA(PITKO
W 4)	  	US	  	UTL	  	11/986,311	  		  	 NETWORK

INTERACTION
 MONITORING

APPLIANCE
	  	PITKOW 3	  	PENDING	  	11/19/07	  			
	NA(PITKO
W 5)	  	US	  	UTL	  	.
12/077,947	  		  	 NETWORK

INTERACTION
 MONITORING

APPLIANCE
	  	PITKOW 4	  	PENDING	  	03/21/08	  			

  
 B-7

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
  

																			
	 IMATTER
 NO.
	  	COUNTRY
ID	  	TYPE	  	 SERIAL NO.
	  	PATENT
NO.	  	 TITLE
	  	 RELATED
	  	STATUS	  	 FILE
	  	ISSUE
	 NA(PITKO
 W
6)
	  	WO	  	UTL	  	 PCT/US2007/0

25133
	  		  	A NETWORK INTERACTION MONITORING APPLICATION	  	PITKOW 1 PITKOW 2 PITKOW 3 PITKOW 4	  	EXPIRED	  	12/07/07	  	
	N/A	  	AU	  	UTL	  	2003210825	  		  	 SYSTEMS AND METHODS FOR USER

IDENTIFICATION,
 USER

DEMOGRAPHIC REPORTING AND COLLECTING USAGE DATA
	  	13186- 0004WO1	  	LAPSED	  	2/5/2003	  	
	N/A	  	AU	  	UTL	  	200149270	  		  	SYSTEMS AND METHODS FOR COLLECTING CONSUMER DATA	  	 13186-

0010WO1
	  	LAPSED	  	3/20/2001	  	

 *        *        *

  
 B-8

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
 Exhibit C 
 Stipulation of Dismissal for Alexandria Action

 (See attached.) 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
 UNITED STATES DISTRICT COURT 
 FOR THE EASTERN DISTRICT OF VIRGINIA

 ALEXANDRIA DIVISION 
  

							
	 COMSCORE, INC.,
	  	 	)	  	  	
		  	 	)	  	  	
	 Plaintiff,
	  	 	)	  	  	Civil Action No. 1:11-CV-290-LMB/TRJ
		  	 	)	  	  	
	 v.
	  	 	)	  	  	
		  	 	)	  	  	
	 THE NIELSEN COMPANY (US), LLC
	  	 	)	  	  	
	 and NETRATINGS, LLC,
	  	 	)	  	  	
		  	 	)	  	  	
	 Defendants.
	  	 	)	  	  	
		  	 	)	  	  	

 STIPULATION OF DISMISSAL 

Pursuant to Fed. R. Civ. P. 41(a)(l)(A)(ii), the Plaintiff and Defendants hereby stipulate and agree that the above action, including all
claims and affirmative defenses, are dismissed WITH PREJUDICE, subject to the terms of that certain agreement entitled “PATENT PURCHASE, LICENSE AND SETTLEMENT AGREEMENT” and dated December 20, 2011 with each party to bear its own costs,
expenses and attorneys’ fees. 

  
 C-1

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
 SO AGREED AND STIPULATED: 
  

			
	Dated: December 20, 2011	  	Dated: December 20, 2011
		
	By:	  	By:
		
	 /s/ Kevin
Collins                                        
                    
	  	 /s/ Walter
Kelley                                        
                    

	 Richard Rainey (pro hac vice)

Kevin B. Collins (pro hac vice)

Paul A. Ainsworth (pro hac vice)

Brian G. Bieluch (pro hac vice)

Erica N. Andersen (VSB No. 76466)

COVINGTON & BURLING LLP

1201 Pennsylvania Avenue, N.W.

Washington, D.C. 20004

Tel: (202) 662-6000

Fax: (202) 778-5598

rrainey@cov.com
 koollins@cov.com
 painsworth@cov.com

bbieluch@cov.com
 eandersen@cov.com
  
 K. Courtney Macdonald (VSB No. 77014)

COVINGTON & BURLING LLP

The New York Times Building

620 8th Avenue
 New York, NY 10018
 Tel: (212) 841-1000

Fax: (212) 841-1010

cmacdonald@cov.com
  

Stephen E. Noona (VSB No. 25367)

KAUFMAN & CANOLES, PC

150 Main Street, Suite 2100

Norfolk, VA 23510

Tel: (757) 624-3239

Fax: (757) 624-3169

senoona@kaufcan.com
  

Attorneys for Plaintiff comScore, Inc.
	  	 Walter D. Kelley, Jr. (VSB No. 21622)
 Tara Lynn R. Zurawski (VSB No. 73602)
 JONES DAY

51 Louisiana Avenue, NW
 Washington, DC 20001
 Tel: (202) 879-3939

Fax: (202) 626-1700
 wdkelley@jonesday.com
 tzurawski@jonesday.com

 
 Tharan Gregory Lanier (pro hac vice)

Joe C. Liu (pro hac vice)
 Heather N. Fugitt (pro hac nice)
 JONES DAY

1755 Embarcadero Road
 Palo Alto, CA 94303
 Tel: (650) 739-3939

Fax: (650) 739-3900
 tglanier@jonesday.com
 jcliu@jonesday.com

hfugitt@jonesday.com
  

Steven J. Corr (pro hac vice)
 JONES DAY
 555 South Flower Street, Fiftieth Floor

Los Angeles, CA 90071-2300
 Tel: (213) 489-3939
 Fax: (213) 243-2539

sjcorr@jonesday.com
  

Attorneys for Defendants The Nielsen Company (US), LLC and NetRatings, LLC

  
 C-2

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
 Exhibit D 
 Stipulation of Dismissal for Norfolk Action 

(See attached.) 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
 IN THE UNITED STATES DISTRICT COURT 
 FOR THE EASTERN DISTRICT OF VIRGINIA

 NORFOLK DIVISION 
  

							
	  
  
 THE NIELSEN COMPANY (US), LLC,
	  	 	)	  	  	
		  	 	)	  	  	
	 Plaintiff/Counterclaim
	  	 	)	  	  	Civil Action No. 2:11-CV-168-MSD/TRJ
	 Defendant,
	  	 	)	  	  	
		  	 	)	  	  	
	 v.
	  	 	)	  	  	
		  	 	)	  	  	
	 COMSCORE, INC.,
	  	 	)	  	  	
		  	 	)	  	  	
	 Defendant/Counterclaim
	  	 	)	  	  	
	 Plaintiff.
	  	 	)	  	  	
	 	  	 	)	  	  	

 STIPULATION OF DISMISSAL 

Pursuant to Fed. R. Civ. P. 41(a)(l)(A)(ii), the Plaintiff and Defendant hereby stipulate and agree that the above action, including all
claims, and counterclaims and affirmative defenses, are dismissed WITH PREJUDICE, subject to the terms of that certain agreement entitled “PATENT PURCHASE, LICENSE AND SETTLEMENT AGREEMENT” and dated December 20, 2011 with each party to
bear its own costs, expenses and attorneys’ fees. 

  
 D-1

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
 SO AGREED AND STIPULATED: 
  

			
	 Date: December 20, 2011
	  	Date: December 20, 2011
		
	 By:
	  	By:
		
	 /s/ Walter
Kelley                                        
    
	  	 /s/ Kevin
Collins                                        
    

	 Walter D. Kelley, Jr. (VSB No. 21622)
 Tara Lynn R. Zurawski (VSB No. 73602)
 JONES DAY

51 Louisiana Avenue, NW
 Washington, DC 20001
 Tel: (202) 879-3939

Fax: (202) 626-1700
 wdkelley@jonesday.com
 tzurawski@jonesday.com

 
 Tharan Gregory Lanier (pro hac vice)

Joe C. Liu (pro hac vice)
 Heather N. Fugitt (pro hac vice)
 JONES DAY

1755 Embarcadero Road
 Palo Alto, CA 94303
 Tel: (650) 739-3939

Fax: (650) 739-3900
 tglanier@jonesday.com
 jcliu@jonesday.com

hfugitt@jonesday.com
  

Steven J. Corr (pro hac vice)
 JONES DAY
 555 South Flower Street, Fiftieth Floor

Los Angeles, CA 90071-2300
 Tel: (213) 489-3939
 Fax: (213) 243-2539

sjcorr@jonesday.com
  

Attorneys for Plaintiff/Counterclaim Defendant
 The Nielsen Company (US), LLC
	  	 Richard Rainey (pro hac vice)
 Kevin B. Collins (pro hac vice)
 Paul A. Ainsworth (pro hac
vice)
 Brain G. Bieluch (pro hac vice)

Erica N. Andersen (VSB No. 76466)
 COVINGTON & BURLING LLP
 1201 Pennsylvania Avenue, N.W.

Washington, D.C. 20004
 Tel: (202) 662-6000
 Fax: (202) 778-5598

rrainy@cov.com
 kcollins@cov.com
 painsworth@cov.com

bbieluch@cov.com
 eandersen@cov.com
  
 K. Courtney Macdonald (VSB No. 77014)
 COVINGTON & BURLING LLP

The New York Times Building
 620 8th Avenue
 New York, NY 10018

Tel: (212) 841-1000
 Fax: (212) 841-1010
 cmacdonald@cov.com

 
 Stephen E. Noona (VSB No. 25367)

KAUFMAN & CANOLES, PC
 150 Main Street, Suite 2100
 Norfolk, VA 23510

Tel: (757) 624-3239
 Fax: (757) 624-3169
 senoona@kaufcan.com

		
		  	 Attorneys for Defendant/Counterclaim Plaintiff
comScore, Inc.

  
 D-2

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
 Exhibit E 
 Form of Stock Purchase Agreement 

(See attached.) 

 CONFIDENTIAL 

SUBJECT TO FED. R. EVID. 408 
 Exhibit F 
 Form of Voting Agreement 

(See attached.)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00197-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00197-of-00352.parquet"}]]